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OF VIRAL AND HOST PROTEINS 
 AND RNA ELEMENTS IN TOMBUSVIRUS REPLICATION 
 
 
Two thirds of plant viruses are positive-strand RNA viruses including the family 
Tombusviridae. One of the best-studied members of this family is Tomato bushy stunt virus 
(TBSV). Like many other viruses, TBSV has much fewer genes when compared to its hosts’ 
genome. Nevertheless, TBSV utilizes its genome very judiciously. To compensate for a lack of 
many proteins of its own, it codes for multi-functional replication protein p33 and also co-opts 
host factors to facilitate its replication.  
 
By using recombinant replication proteins p33 and p92 containing single amino acid 
changes in protein-protein interaction domains (S1 and S2), I demonstrated that the replication 
proteins are required in sequential steps during virus replication. The in vitro cell-free extract 
(CFE) based TBSV replication assays revealed that mutations in S1 and S2 domains affected 
RNA template selection, recruitment and assembly of replicase complex.  TBSV replicates on the 
cytosolic surface of peroxisomal membranes.  
 
To identify the host factor involved in this process of transporting viral replication 
proteins to peroxisome, I tested the peroxisomal transporter proteins for their ability to bind to 
p33 in vitro, which led to the discovery of Pex19p. Pull-down and co-purification experiments 
revealed transient nature of p33-Pex19p binding as expected from a transporter. When pex19p 
was retargeted to mitochondria, a large fraction of p33 was also re-distributed to the mitochondria 
validating the importance of Pex19p in p33 localization.   
 
TBSV also utilizes its genomic RNA for non-template activities during its replication. 
Accordingly, TBSV RNA serves as a platform for the assembly of replicase complex. To further 
characterize the regulatory cis-elements involved in this process, I utilized CFE and different 
TBSV RNA mutants together with recombinant p33 and p92 in vitro replication assays. These 
experiments revealed the role of RNA recruitment element [RIISL(+)] and 3’ non-coding regions 
as minimal cis-elements required to assemble functional replicase complex. The experiments also 
indicated that the RIISL(+) and 3’ non coding regions could be physically separated on two 
different RNA molecules  to assemble TBSV replicase, suggesting insights into viral evolution. 
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Chapter 1. Introduction 
 
Sir Peter Medawar (Nobel Laureate) said-“Viruses are a piece of bad news wrapped up in 
protein.” Precisely, they are nucleic acid piece(s) surrounded by a protective coat. They are very 
simple in structure. They have limited genetic resources but can perform many biological 
activities elegantly. For example, one of the most deadly viruses for human beings is hepatitis B 
virus with only four genes, yet clinically affecting over a million people each year [2]. Viruses 
neither possess the machinery to synthesize proteins nor for energy production but can still make 
millions of progeny very quickly. To do so they usurp the biochemical machinery of the host 
cells. For example, they use cellular ribosomes to translate their own proteins, use cellular 
compartments as microhabitats to multiply and even use cells’ well-established transport 
mechanisms to move within a cell as well as hitch a ride out of the infected cells (reviewed by [3-
7]). Viruses possess all the qualities of successful parasites; they can borrow, steal, and subvert 
host resources. 
Viruses are the only pathogens that can infect most organisms, including bacteria, blue-green 
algae, fungi, plants, insects and animals causing diseases and epidemics in humans, animals and 
plants leading to intense studies. The research has resulted in eradication of several deadly viruses 
like smallpox virus [8]. Nevertheless, emerging and re-emerging viral diseases never let up and 
scientists are working round the clock to tackle them. 
Apart from causing diseases, viruses are also associated with positive effects. For example, 
viruses have taught us seminal lessons in molecular biology and cellular biology. Several Nobel 
Prizes awarded to virologists exemplify this. Likewise, viruses are the most abundant biological 
entity in freshwater and seawater and they help maintain the planktonic populations of the aquatic 
ecosystems (reviewed by [9]). Another example is reconsideration of use of bacteriophages as a 
weapon against antibiotic-resistant bugs (reviewed by [10]). Use of viruses as vectors in gene 
therapy to cure genetic diseases and as vehicle of drug delivery are also progressing (reviewed by 
[11]). On top of this, viruses are now becoming favorite tools in the hands of nanotechnologists 
trying to take advantage of their versatile nature as examples, to make highly efficient material 
for batteries and fuel cells (reviewed by [12]). 
 
THE EXPERIMENTAL SYSTEM 
How do the viruses intricately manipulate their much more complex host cells and take 
over? These are questions and the focus of research for many scientists. To answer some of these 
questions it is highly desirable to have a model virus-host system: A virus that has a small 
genome, is robust enough to be easily detectable; are some of the attractive characteristics of a 
model virus. Similarly, some of the desirable features of a host to work on can be: Simple, easy 
and cheap to maintain in the lab; full genetic resources available; well known cellular and 
biochemical pathways. Tombusvirus and yeast is a winning merger of “model” virus and “model” 
host to study the enigmatic interaction between virus and host. This system has been developed in 
Dr. Peter Nagy’s lab to discover hundreds of host factors affecting tombusvirus multiplication [5, 
6, 13, 14]. Our lab members used the many genetic and proteomic screens available to discover 
the factors affecting tombusvirus multiplication [14-19]. They were also able to observe the real 
time evolution of tombusvirus in yeast in the absence of some particular genes [20, 21]. These 
discoveries have opened up a new era of systems biology approaches in virology [22].  
 
TOMBUSVIRUS GENOME STRUCTURE 
Nagy and Pogany (2006) have described tombusvirus genome structure in their review 
[6]: “Tombusviruses are a group of single-component RNA viruses of plants within the large 
Tombusviridae family. Among the five viral-coded proteins, only p33 and p92 are essential 
replication proteins [23-27]. The sequence of p33 overlaps with the N-terminal region of p92, yet 
the functions of these regions are different in the two proteins. p33 is a replication cofactor, which 
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is involved in binding to the viral RNA via its RNA-binding region (termed RPR), [28]. The RPR 
domain is essential for the function of p33, whereas it plays a lesser role in p92, which functions 
as the RNA-dependent RNA polymerase [29, 30]. p33 also includes two essential membrane-
spanning domains [31] and an N-terminal domain with unknown but essential function in 
replication [30]. In contrast, the corresponding domains in p92 modulate the function of this 
protein, but they are not essential [30]. In contrast, the p33:p33/p92 interaction domain, which is 
important for multimerization of p33 molecules and binding between p33 and p92 [32], is 
essential for tombusvirus replication [30]. Both p33 and p92 are part of the active tombusvirus 
replicase, which is most active when it contains a 10–20-fold larger amount of p33 than p92 [32]. 
Based on biochemical and cellular studies, the emerging picture is that, in spite of the overlapping 
sequences, p33 and p92 perform noncomplementary functions during tombusvirus replication.” 
 
DEFECTIVE INTERFERING RNA AS A TOOL TO STUDY THE ROLE OF 
VIRAL AND HOST FACTORS IN TOMBUSVIRUS REPLICATION 
Viruses are thought to be the ultimate parasites, multiplying inside the host cells and 
utilizing the resources of their hosts to produce vast number of infectious progenies. Intriguingly, 
many viruses have their own parasites, including defective interfering (DI) RNAs, as well as 
satellite viruses and satellite RNAs. For viruses with RNA genomes, the DI molecules consist of 
RNA sequences derived from the parent RNA virus, whereas the origin of satellite RNAs are not 
known in most cases. Both classes of subviral RNA are parasitic, since they have to use proteins 
coded by viruses, called helper viruses, for their replication inside the host cells. This review will 
focus on the DI-RNAs and their intimate relationship with their parent viruses and host cells.   
DI-RNAs are created spontaneously during the replication of the viral genome and they 
multiply rapidly and eventually lead to inhibition of the parent virus’ multiplication [reviewed by 
33, 34]. These RNAs are called "defective" because they have lost the capacity to code for all the 
necessary viral proteins for independent replication and thus are defective in the absence of the 
parent (also called helper) virus. Accordingly, the helper virus is required to provide the missing 
replication protein(s) in trans. DI-RNAs are referred as "interfering" because they can interfere 
with the multiplication of their helper virus [reviewed by 34, 35]. However, some defective 
RNAs do not interfere with multiplication of their helper viruses; in those cases they are simply 
called D-RNAs. In some cases, DI-RNAs can enhance the symptoms caused by their parent 
viruses. Importantly, DI-RNAs are distinct from other parasitic RNAs, called satellite (sat)RNA 
and satellite viruses, which are associated with helper viruses. The primary difference being that 
satRNAs do not show intensive sequence similarities with their helper viruses and the sources of 
their nucleic acid sequences remain uncertain [reviewed by 34]. The hierarchical game of 
parasitism does not stop here. To make the matter more complex, DI-RNA has been discovered 
even for a satellite virus [36]. This satellite derived DI-RNA strongly interfered with the parental 
satellite pancium mosaic virus (SPMV), which is one of the two sub-viral particles associated 
with Panicum mosaic virus (PMV). Thus, there is a unique complexity and dynamism in viral co-
infections that include satellite RNAs, satellite viruses and DI-RNAs. 
DI-RNAs are often observed during RNA virus infections of mammalian cell cultures when 
high multiplicity of infection is used [37]. DI-RNAs associated with plant virus infection has 
been mostly described from greenhouse samples or laboratory experiments [38-47]. DI-RNAs 
associated with viruses in the tombusvirus genus are among the most extensively studied. Also, 
the first DI-RNAs associated with a plant virus identified were derived from Tomato bushy stunt 
virus (TBSV) [43]. I used TBSV DI-RNA in the course of my entire research thus it will be 
discussed in detail. 
There are several reviews [27, 33-35, 48], which comprehensively discuss the occurrence and 
genome structures of DI-RNAs. In this chapter, I will mainly focus on how they have shaped our 
understanding about the biology of parent virus replication. 
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Origin and synthesis of Defective Interfering (DI) RNAs 
DI-RNAs are synthesized by the viral RNA-dependent RNA polymerases (RdRp) that also 
replicate the parental virus genomes. Most of the DI-RNAs consist of non-contiguous portions of 
their helper virus’ genomes [48]. The popular model for DI-RNA formation is the viral 
polymerase driven template-switching mechanism [49].  
RNA recombination plays a major role in producing DI-RNAs or defective RNA particles (i.e. 
packaged DI RNAs). The errors made by the RdRp, including template switching (also called 
replicase jumping), during the standard replication process of the viral genome is likely the main 
mechanism of genomic RNA-RNA recombination and also DI-RNA formation [49].  
The replicase-driven template-switching model is supported by biochemical assays performed 
in cell-free systems with purified recombinant viral RdRps. The list includes two tombusviruses 
(TBSV and Cucumber necrosis virus, CNV), Brome mosaic virus (BMV), Turnip crinkle virus 
(TCV), Cucumber mosaic virus, Bovine viral diarrhea virus, and Hepatitis C virus [50-55]. The 
in vitro data from the above works suggested that breaks, strong hairpin structures, or AU-rich 
stretches in the template (donor) RNA promotes the viral replicase to switch template to the 
acceptor RNA and then use the nascent RNA as a “primer” for resumption of RNA synthesis on 
the acceptor RNA. Interestingly, cis-acting sequences as well as sequence complementarity 
between the nascent RNA and the acceptor RNA may guide the template-switching events [49]. 
Primer extension experiments with RNAs representing the nascent strand revealed that rather 
short (2-to-5 nt) sequence complementarity between the primer and the acceptor template was 
sometimes sufficient to promote re-initiation of the replicase [51, 52, 56-58]. Additional works 
revealed recombination “cold-” and “hot-spots”, i.e. regions of decreased and increased 
recombination, respectively, in the BMV and TBSV genomes [51, 52, 59]. 
The formation of the prototypical TBSV DI-RNAs requires two or three recombination events, 
which likely occur sequentially [38]. For example, the TBSV-associated DI-72 RNA and other 
tombusvirus DI-RNAs are comprised of four noncontiguous RNA segments, namely Region I 
(derived from the 5ʹ′ untranslated region [UTR]), Region II (representing portion of the p92pol 
ORF), Regions III and IV (mostly derived from the 3ʹ′ UTR) (Figure 1.1) [60] [48]. Interestingly, 
the junction sites among the four noncontiguous regions in the above DI-RNAs do not show long 
sequence similarity. Therefore, it has been suggested that the recombination events during TBSV 
DI-RNA formation are unlikely to be random, but guided by cis-acting replication sequences 
[27]. 
Another mechanism for RNA recombination based on RNA ligation has also been reported for 
Q-beta bacteriophage and poliovirus [61, 62]. The major evidence provided for RNA breakage 
and transesterification was the interference with recombination when the 3ʹ′ OH group in the 
acceptor strand was altered to inhibit ligation. It is yet to be seen if this mechanism is involved in 
DI-RNA formation.  
 
Viral replication proteins as factors influencing the formation/accumulation of DI-RNAs  
Evidence to support the roles of replication proteins in DI-RNA formation has been obtained 
with the helicase-like protein 1a of BMV. Mutations within the 1a protein altered the sites of 
RNA recombination when compared with BMV infections containing the wt 1a [63]. In addition, 
mutational studies on BMV 2a polymerase also indicated the replicase’s role in recombination 
[64]. A 2a mutation affected the precision as well as the location of RNA recombination sites. 
Similarly, mutation in the polymerase gene of influenza virus, led to an increase in the synthesis 
of DI-RNAs [65]. The authors proposed that the mutation destabilized the polymerase-viral RNA 
complex during the elongation step. A role for the replicase in RNA recombination was further 
bolstered by studies on the p33 auxiliary replication protein for CNV [66]. Frequency of 
recombination for tombusvirus DI-RNA was affected by mutations in the RNA binding (RPR) 
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domain of p33. Two p33 mutants tested enhanced the recombination and 5 of the 17 mutants 
tested sloId down the accumulation of recombinants. Interestingly, the recombination promoting 
mutants also increased the level of subgenomic RNA transcription [25]. The connection between 
transcription and recombination is not that surprising as both processes utilizes the viral replicase 
complex. Mutations within the N-terminal portion of p92pol polymerase, which overlaps with p33, 
did not have similar affects on recombination, suggesting different roles for RPR in p33 and 
p92pol proteins with respect to RNA recombination. How these mutations affect recombination, or 
how they enhance template-switching remains to be tested.  
Most plant RNA viruses code for two or more replication proteins and the amount and the 
ratio of the replication proteins could be another factor affecting RNA recombination and DI-
RNA formation. This was tested with the tombusvirus p92pol and p33 replication proteins in yeast, 
a surrogate model host [67]. High level of p33 was shown to increase the accumulation of 
recombinant DI-RNA. The effect on recombination was even more profound when p92pol was 
expressed at a high level in yeast. In addition, the ratio of p33 and p92pol also affected 
recombinant DI-RNA formation. It is possible that too high a level of p92pol RdRp makes the 
viral replicase complexes less precise and more prone to template switching. 
 
DI-RNAs as surrogate templates to study virus replication  
DI-RNAs are versatile tools at virologists’ disposal. DI-RNAs often multiply faster, are 
smaller than the full genome of the virus and contain the cis-acting replication elements for 
replication and other steps in viral multiplication cycle. Since many DI-RNAs do not code for 
proteins, mutational studies on DI-RNAs make the results easier to interpret due to separation of 
trans-acting protein factors and cis-acting RNA elements. Thus, critical cis-acting replication 
elements important for different steps in viral replication can be deductively discovered. These 
RNAs also are adapted to use trans (viral and possibly other) factors for their replication enabling 
a more experimental control over those factors so that a virologist can regulate them spatially 
and/or temporally. Indeed, using DI-RNAs combined with other modern tools, many cis-acting 
RNA elements for tombusviruses were deciphered [reviewed by 27, 68]. DI-RNAs also proved to 
be useful in discovering host factors modulating viral replication. To this end, a yeast system 
using TBSV DI-72 as an experimental replicon (rep)RNA was developed [13, 69]. In the above 
yeast system, the repRNA works as an independent replicon, capable of assembling the viral 
replicase complex and performing most of the steps in replication in the absence of a helper virus. 
Based on the yeast/TBSV repRNA system, genome-wide and proteomics-based screens have 
been performed [15-18, 20, 21, 70]. This in turn, accelerated the identification of more than 
hundred host factors affecting TBSV replication and ~40 host factors affecting RNA 
recombination. In addition, the system is also useful in dissection of the mechanisms by which 
these host factors affect viral replication and RNA recombination. To better explain the roles of 
cis-acting replication elements, viral and host factors discovered with the assistance of DI-RNA, I 
divide the replication cycle of the plus-stranded RNA viruses further into different steps in 
chronological order [reviewed by 5, 6].  
 
Template selection and DI-RNA recruitment into replication. 
  Similar to the viral genomic RNA, DI-RNAs should also be recognized selectively from the 
large pool of host RNAs. The selection of the viral RNA requires specific interaction with viral- 
or host proteins. For TBSV DI-RNAs, the selective RNA recognition is mediated by the cytosol-
exposed C-terminal portion of p33 replication protein in yeast [71, 72]. Detailed mutational 
studies on DI-RNA revealed the essential role for a C•C mismatch within the RII(+)-SL sequence 
(Figure 1.1) in binding to p33 [71]. When the C•C mismatch was mutated to G=C, then binding 
of DI-72 to p33 was lost and this DI-RNA was unable to replicate in the yeast system or the full-
length TBSV genomic RNA carrying the comparable mutation in N. benthamiana plants [71, 72]. 
Thus, the C•C mismatch sequence can be regarded as the “identity card” of the virus, allowing 
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the viral replicase complex to achieve high selectivity to replicate only viral RNA. As expected, 
the C•C mismatch region is also required for replication of DI-72 repRNA in a yeast extract 
capable of supporting one full cycle of replication in vitro [55, 73].  
In addition to interacting with the viral replication proteins, DI-RNA is likely bound by select 
host proteins. To identify the host proteins that bind viral RNA, TBSV DI-72 (+)RNA was used 
as a probe to screen RNA binding proteins in a yeast proteome-wide chip carrying 4,100 purified 
yeast proteins [18]. Five of the identified host proteins in the above screen were further confirmed 
with other approaches, e.g., gel-shift and pull-down assays. One of the factors discovered was 
translation elongation factor eEF1A. This protein also co-purified with the tombusvirus replicase. 
Further studies showed that eEF1A binds to the silencer sequence present in the 3’UTR (Figure 
2.2) [18], which is required for the assembly of the tombusvirus replicase complex [74, 75]. A 
mutation affecting guanine exchange factor requirement of eEF1A inhibited DI-72 repRNA 
accumulation in yeast. It has been proposed that eEF1A interaction with DI-72 RNA might be 
needed for RNA recruitment into replicase complex or viral RNA synthesis [76]. Another host 
factor that exerts its effect on viral replication directly via binding to the viral RNA is Nsr1p (also 
known as nucleolin). This factor was discovered during screening of the yeast knock out (YKO) 
library for TBSV replication [15]. Virus replication was boosted three folds in the absence of 
NSR1. Further analysis revealed that Nsr1p binds to RIII in DI-72 (+)RNA [77]Indeed the Nsr1p 
mediated inhibitory effect on DI-72 repRNA accumulation in vivo was lost when DI-72 repRNA 
missing RIII, the target for Nsr1 binding, was used as a replicon RNA in above study. This 
protein may inhibit TBSV replication via specific binding to the viral RNA and, thus, resulting in 
inefficient repRNA recruitment for replication. 
After the RNA has been selected for replication, the viral proteins and RNA complex has to be 
transported to the site of replication. TBSV assembles the replicase complex on the cytosolic 
surface of peroxisomal membranes [30, 78, 79]. It has been shown that the host shuttle protein 
Pex19p, which is involved in peroxisomal membrane protein transport, play a role in TBSV 
protein transportation to the site of replication [80]. Another host protein involved in 
localization/transportation of the viral replication proteins is the heat shock protein 70 (Hsp70). 
Using a temperature-sensitive mutant of Hsp70 at nonpermissive temperature has led to cytosolic 
localization of p33 replication protein [81]. Shifting down to permissive temperature resulted in 
re-localization of p33 to the peroxisome membrane surface in yeast.  
 Overall, the above studies revealed that both viral- and host proteins are involved in RNA 
template selection and the recruitment of the viral RNA/p33/p92pol complex to the site of 
replication. 
 
Factors affecting the assembly of the viral replicase complex. 
 The assembly of the viral replicase complex is still a poorly understood process. Interestingly, 
the viral RNA plays an essential role in the replicase assembly both in vivo and in vitro [73, 75, 
82, 83]. Detailed work with TBSV RNA revealed that RII(+) (Figure 1.1) is also crucial for the 
assembly of tombusvirus replicase complex in yeast [75]. In this study, the minimal cis-acting 
elements required for the assembly of the tombusvirus replicase complex was defined. The 
affinity purified viral replicase complex was active on external templates only when the full-
length DI-72 repRNA was co-expressed with the p33 and p92pol replication proteins in yeast. The 
minimal repRNA still capable of supporting the assembly of the replicase complex consisted of 
RII(+)-SL hairpin, the replication silencer element and genomic promoter (Figure 1.1) [75]. The 
exact role of the viral RNA in the assembly process is currently under heavy investigation and 
presented in the next chapter. The viral RNA might provide an assembly platform to bring 
together the viral and host proteins. The RNA may also play a role in making structural change(s) 
in the viral RdRp required for activation of the polymerase function of the RdRp. Recently long-
range RNA interacting elements UL and DL in the TBSV genomic RNA have been discovered 
that play a role in replicase assembly [84]. Long distance base pairing between UL and DL 
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sequences juxtapose RII(+)-SL and the replication silencer and gPR within the 3'-UTR (Figure 
1.1). These latter two elements had already been shown to be important in replicase assembly [73, 
75]. It is interesting to note that UL-DL interaction is not crucial for replicase assembly in DI-73, 
probably because RII(+)-SL and the 3'-UTR are already in close proximity (Figure 1.1B), unlike 
in the genomic RNA, where they are 3000 nt apart (Figure 1.1A). 
Both viral replication proteins of TBSV are essential for the assembly of the functional virus 
replicase [73, 82]. Interestingly, the p33:p33/p92pol interaction domains in these replication 
proteins seem to be critical for the assembly, suggesting that these proteins are participating in 
multimeric complex formation, which is likely needed for the formation of membrane 
invaginations, called spherules. These spherules are the predicted structures supporting TBSV 
replication [78].  
In addition to the viral RNA and viral replication proteins, host factors play a role in 
tombusvirus replicase assembly. The best-characterized host factor in the replicase assembly 
process is Hsp70. Proteomics analysis of the tombusvirus replicase complex revealed the 
presence of Hsp70 and 5-10 other host proteins within the replicase complex [17, 18, 70]. In vitro 
work indicated that Hsp70 plays a role in membrane insertion of the viral replication proteins 
[85]. The essential role of Hsp70 in the assembly of the TBSV replicase was confirmed by 
Pogany and colleagues, using a yeast extract depleted in Hsp70 [73]. The addition of purified 
recombinant Hsp70 to the above cell-free assay complemented the defect, leading to the assembly 
of the viral replicase complex and active replication of the DI-72 (+)repRNA in vitro [73]. 
 
Factors affecting the replication of DI-RNA. 
After the assembly of the replicase complex is finished, the synthesis of the complementary (-) 
strand from the plus (+) stranded DI-RNA takes place. The newly made (-) strand then serve as a 
template for synthesis of new (+)DI-RNAs. The replication process of (+) stranded RNA viruses 
and associated DI-RNAs is asymmetrical, leading to 20-100-fold more copies of (+) RNAs than 
(-) strand RNA. One of the major factors in regulation of DI-RNA replication is the DI-RNA 
carrying cis-acting elements in both strands [reviewed by 27]. The cis-acting elements include the 
genomic promoter (gPR) in the 3ʹ′ end of (+)DI-RNA [86], a complementary promoter element in 
the 3ʹ′ end of (-)RNA [87] and replication enhancer elements in RI(-) and RIII(-) [88]. An 
intriguing replication modulator element is the replication silencer (Figure 1.2), which is involved 
in the assembly of the replicase complex and possibly in the regulation of the (-)-strand synthesis 
[74]. This element interacts with gPR, making the promoter recognition by the RdRp weaker in 
vitro. It is currently under investigation how this interaction is regulated and what viral- or host 
proteins are involved in modulating this interaction. 
The asymmetrical RNA synthesis is affected not only by cis-acting RNA replication elements, 
but host factors as well. One such host factor is a metabolic enzyme called glyceraldehyde-3-
phosphate dehydrogenase (GAPDH), which was discovered as a component of the tombusvirus 
replicase complex via a proteomics analysis of a purified viral replicase preparation [17]. When 
TBSV DI-72 RNA was replicated in yeast cells, the cellular distribution for GAPDH changed 
dramatically due to re-localization from the cytosol to the site of replication (peroxisome) [89]. 
Down-regulation of GAPDH levels in yeast correlated with reduced level of (+)-strand DI 
repRNA. GAPDH was shown to bind to (-)-strand of DI-72 repRNA via an AU pentamer 
sequence. It was proposed that the role of GAPDH is to retain the (-)-strand repRNA intermediate 
in the replicase complex, thus facilitating asymmetrical replication. The data from the yeast host 
were also validated in N. benthamiana host [89].  
 
Release of (+) DI-RNA progeny from the replicase complex and disassembly of replicase 
complex.  
After the synthesis of the new (+)DI-RNA progeny by the replicase, (+)RNA is released to the 
cytosol while the (-) RNA intermediate is kept within the spherule most or all the time [30].  
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So far host factors and viral RNA sequences have not been discovered playing role(s) in the 
release of (+)RNA progeny. However, viral protein modification has been proposed to modulate 
this process [90]. This is based on the observation that p33 gets phosphorylated in vivo and in 
vitro as well [90, 91]. The phosphorylated form of p33 lost its ability to bind to (+)DI-72 RNA 
associated with TBSV and in vitro phosphorylation of the p33:DI-72 RNA complex led to the 
release of the RNA from the complex [90]. In contrast, p33 mutants mimicking the 
unphosphorylated stage of the protein bound efficiently to DI-72 RNA, suggesting that 
phosphorylation/unphosphorylation of p33 might regulate the release of (+)RNA from the 
replicase complex.  
Roles of other host proteins in viral protein modification have also been demonstrated. A host 
ubiquitin conjugating enzyme Cdc34p as well as Rsp5p ubiquitin ligase have been shown to 
ubiquitinate p33 in vitro [70, 92]. However, the actual role of p33 ubiquitination is currently 
unknown. It is possible that this protein modification modulates the viral protein-protein or viral 
protein-host protein interactions important for viral replication. 
Altogether, the use of DI-RNA as surrogate template contributed a great deal to our 
understanding of viral RNA replication and virus - host interactions.  
I exploited DI-RNAs to dissect the mechanism of virus replication: particularly the role of 
non-template function of RNA; the role of auxiliary protein p33 in assembly of replication 
complex and the role of a host protein. The subsequent chapters present my work in detail about 






Figure 1Figure 1.1. Genome and structural organization of TBSV genomic RNA and the 
prototypical DI-73 and DI-72 RNAs.  
(A) A cartoon showing structural details of the ~4,800 nt TBSV genome (not to scale). The p33, 
p92pol, p41 and the overlapping p19/p22 ORFs are depicted as black ovals and labeled 
accordingly. Note that p92pol overlaps with p33, sharing the same initiation codon. Sequences 
playing role(s) in translation, genome replication and sgRNA transcription are shown in turquoise 
blue, red and purple, respectively. Sequences involved in RNA-RNA interactions are shown in 
matching colors. Note that translation requires SL3-SLB interaction, UL-DL and RSE-gPR 
interactions are required for replicase assembly and AS1-RS1, AS2-RS2 and DE-CE interactions 
are crucial for sgRNA synthesis. (Abbreviations used are DSD: downstream domain; TSD: T-
shape domain: RSE: replication silencer element; AS: activator sequence; RS: receptor sequence; 
CE: core element; DE: distal element; UL: upstream linker; DL: downstream linker; CITE: cap 
independent translation enhancer; SL: stem loop) [84] (B) Structure of the ~800 nt DI-73 carrying 
three noncontiguous segments of the genomic RNA. Generation of DI-73 preserves critical 
replication elements (red) and the 3’CITE. The blue bars and dotted arrows depict the segments 
corresponding to genomic RNA. (C) Note that the other prototypical DI of ~620 nt, named DI-72 







Figure 2Figure 1.2. The predicted secondary and tertiary structure of the 3' UTR in DI-
72(+) RNA.  
A 5 nt base-pairing between RSE in the internal loop sequence of SL3 and gPR stabilizes the 
tertiary structure. This interaction is critical for the assembly of the functional TBSV replicase 
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Chapter 2. Defining the roles of cis-acting RNA elements in tombusvirus replicase assembly 
in vitro 
        This chapter is published [epub ahead of print] in Journal of Virology, 2011 Oct 19
 
INTRODUCTION 
Plus-stranded (+) RNA viruses exhibit many similarities during genome replication, 
including the formation of membrane-bound viral replicase complexes, the production of (-)-
strand and abundant (+)-strand RNAs, and the use of co-opted host factors [3, 5, 7, 94]. One of 
the best-studied (+)RNA viruses is Tomato bushy stunt virus (TBSV), which has a single 4,800 nt 
long RNA genome [27]. The two viral-coded replication proteins, p33 RNA chaperone and p92pol 
RNA-dependent RNA polymerase (RdRp), participate in the formation of the membrane-bound 
viral replicase complex that also contains several host proteins [7, 17, 76, 95, 96].   
Replication of TBSV and other (+)RNA viruses involve several sequential steps, 
including: selection of the viral (+)RNA template for replication; recruitment of the viral (+)RNA 
and the viral replication proteins from the cytosol to the subcellular membrane surfaces where 
replication takes place; the assembly/activation of the viral replicase; (-)-strand and then (+)-
strand RNA synthesis; and the release of progeny (+)-strand RNAs from the replicase complex 
[5, 6, 97]. This complex process helps to ensure that authentic viral templates are replicated and 
that the replication process is rapid and efficient.  
The TBSV (+)RNA plays multiple roles during viral replication. In addition to its main 
function as a store of genetic information, the viral (+)RNA also regulates its own intracellular 
localization and recruitment to the site of RNA replication [30, 71, 73, 75, 84]. Moreover, the 
TBSV (+)RNA serves as an assembly platform for the viral replicase, consisting of viral 
replication proteins, co-opted host proteins and host lipids/membranes [17, 18, 55, 73].  These 
replication related functions are guided by various cis-acting elements within the TBSV (+)RNA, 
most notably by RII(+)-SL located internally and RIV, positioned 3’-terminally [71, 72, 75, 84].  
These two RNA segments (RII and RIV), along with additional cis-acting elements RI and RIII, 
are retained in TBSV defective interfering (DI) RNAs, which are small virus-derived replicons 
used to study sequence functions (Figure 1A) [98].   
Other plant viruses also contain specific sequences in their viral (+)RNAs that affect RNA 
recruitment and the assembly of their cognate replicase complexes. For example, short stem-loops 
within the 3’ UTR of Tobacco mosaic virus (TMV) (+)RNA can bind specifically to the TMV 
126K replication protein in vitro [99, 100]. The Brome mosaic virus (BMV) 1a protein 
participates in template selection/recruitment via interaction with the 1a responsive element 
present in the BMV RNAs [101, 102]. A Y-shaped RNA element in the 3’UTR in RNA2 of Red 
clover necrotic mosaic virus is specifically recognized by its cognate viral replication proteins, 
aiding recruitment of this viral RNA into replication [103, 104].     
Dissection of the actual function(s) of cis-acting RNA elements such as those mentioned 
above can be hindered by the sequential and cycling nature of the (+)RNA replication; i.e. where 
a particular replication step depends on the previous step(s) and portions of the process are 
repeated in many cycles.  Consequently, mutations introduced into a viral RNA could directly or 
indirectly affect multiple steps in replication, making assignment of functions of specific cis-
acting RNA sequences/structures challenging.  To circumvent some of the above problems, I 
have previously developed an in vitro replicase assembly assay based on yeast cell-free extract 
(CFE) and purified recombinant tombusvirus replication proteins [73].  In our CFE assay, the 
viral (+)RNA has to be recruited to the membrane (derived from the organelles of yeast), 
followed by the assembly of the viral replicase complex and a single cycle of replication 




Copyright © American Society for Microbiology., 2011 
12 
In this paper, I employed the CFE assay to dissect the functions of various known cis- 
acting elements in the TBSV (+)RNA.  I show that an essential internal stem-loop structure, 
RII(+)-SL, has a dual function: serving both as a (+)RNA recruitment element and mediator of  
viral replicase assembly, with the former activity being able to function in trans.  Using a novel 
two-component RNA system in the replication assay, I also show that another cis-acting element, 
located in RIV and termed the replication silencer element (RSE), has to be present in the viral 
(+)RNA in order for it to serve as a functional template.  These findings have provided further 




Defining a minimal RNA sequences required for the assembly of the tombusviral 
replicase complex in vitro.  
Previous work with TBSV identified the extended stem-loop RII(+)-SL in RII and the 
two sub-elements RSE and SL1-gPR in RIV as distinct cis-acting RNA elements, required for the 
assembly of the TBSV replicase in vivo, either in plant cells or in yeast, a surrogate host [75, 84] 
(Figure 2.1A).  The RSE and SL1-gPR interact via a 5 bp interaction and this feature is important 
for replicase assembly (Figure 2.1A) [74, 75].  In the context of the TBSV genome, RII and RIV 
are separated ~3 kb, but they can be brought into close proximity by an RNA base pairing bridge 
that forms between the UL (upstream linker) sequence just 3’ to RII(+)-SL and its 
complementary DL (downstream linker) sequence, positioned near RIV (Figure 2.1A, lower 
panel).  Formation of this UL-DL bridge mediates efficient replicase assembly in vivo in both 
yeast and plant cells [84].   
To further define and dissect the functions of the abovementioned cis-acting RNA 
sequences during replication, I measured their effects on the assembly of the tombusvirus 
replicase complex in vitro (i.e. separate from their effects on template amplification) using our 
recently developed in vitro replicase assembly assay based on yeast CFE [73].  In this assay, the 
recombinant viral proteins are affinity-purified from E. coli, the various (+)-stranded TBSV DI-
RNA-based templates, termed (rep)RNAs, are made via T7 transcription, while the CFE is 
prepared from yeast BY4741 strain (free of any TBSV components). The assembly assay 
contains ATP and GTP, but lacks CTP and UTP, thus preventing complementary RNA synthesis 
or replication (Figure 2.2A).  After mixing these components the assembly assay is allowed to 
occur and then any assembled replicase complex is solubilized and affinity-purified; a process 
that leads to the loss of the original repRNA template. Subsequently, a (-)RNA template, DI-72(-
), is added to the purified replicase preparations to measure the copying activity of the replicase 
in vitro, which provides a measure of the efficiency of replicase assembly (Figure 2.2A).  In this 
replicase assembly assay, the originally added repRNA functions only in template recruitment 
and replicase assembly and does not act as a template for complementary strand synthesis or 
replication. 
 To determine if the UL-DL long-distance base-pairing interaction is required for the 
assembly of the tombusvirus replicase complex in vitro, I used wt DI-73 repRNA and mutants 
containing substitutions in UL, DL or both [84], as shown in Figure 2.2B.  Mutations in either 
the UL or DL regions (mutants dD and dU in Figure 2.2B), which reduced base-pairing between 
UL-DL, decreased the in vitro assembly of the replicase by ~85% (lanes 2-3, 6-7 in Figure 2.2C-
D). Restoring the base-pairing between UL-DL via complementary mutations in UL and DL 
(mutant cUD in Figure 2.2B) resulted in ~3- to 4-fold more efficient replicase assembly, versus 
the single mutants, for both replication competent and incompetent repRNAs (lanes 4 and 8, 
respectively, in Figure 2.2C).  Including all four ribonucleotides in the assembly assay led to 
slightly increased recovery levels for the compensatory mutant (Figure 2.2D, lane 4), while not 
adding template under the same conditions resulted in no products (Figure 2.2E).  Overall, as 
observed in vivo [84], the UL-DL interaction is also important for promoting replicase assembly 
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in vitro.  Since the UL-DL interaction was not essential for this process, but did stimulate the in 
vitro assembly of the replicase (albeit, in a sequence independent manner), we define it as an 
enhancer element for a replicase assembly (EERA).  
  
RII(+)-SL and RSE-gPR constitute the minimal RNA elements required for the 
assembly of the tombusviral replicase complex in vitro.  
To test if RII(+)-SL and RSE-gPR elements (Figure 1.1A) together were sufficient for 
the assembly of the replicase in vitro, I constructed a minimal RNA (called “mini”) containing 
only these elements as shown in Figure 1.1B [75]. Comparing the in vitro replicase assembly 
efficiency of the mini RNA versus the full-length DI-72 (+)repRNA revealed comparable levels 
of replicase assembly in the CFE-based replicase assembly assay (Figure 2.3A, lanes 2 and 4 
versus 1 and 3). Thus, these data demonstrate that RII(+)-SL and RSE-gPR elements together are 
sufficient for the efficient assembly of the TBSV replicase in vitro. 
 In the in vitro replication assay in CFE, all four ribonucleotides are added, along with the 
repRNA and purified p33 and p92, to the yeast extract, allowing for both assembly and RNA 
synthesis from the repRNA in the reaction (Figure 2.3B).  Comparing the replication efficiency 
of the mini template versus DI-72 repRNA in the CFE revealed that the mini template was highly 
deficient in this replication assay (Figure 2.3B, lanes 3-4 versus 1-2). The larger RII/IV(+) 
template, carrying the additional sequences flanking RII(+)-SL and RSE-gPR, was also very 
inactive for RNA replication in vitro (Figure 2.3B, lanes 5-6). Interestingly, at the 40 min time 
point of the replication assay, both mini and RII/IV(+) templates were about two-times more 
sensitive to micrococcal nuclease treatment than DI-72 (+)repRNA (Figure 2.3C), suggesting 
that replicase assembly in vitro in the presence of the shorter templates could only partially 
protect these RNA templates from this nuclease.   
The efficiency of in vivo assembly of replicase by DI-72 repRNA and mini template 
were also assessed using a modified in vitro replicase assay (Figure 2.3D, top).  The affinity-
purified replicase from yeast cells co-expressing the mini template and his-tagged p33/p92 
(Figure 2.3D, bottom) showed reduced ability to copy the exogenously provided RI/III(-) 
template when compared with the replicase preparation from yeast co-expressing DI-72 and 
p33/p92 (Figure 2.3D, middle, lanes 3-4 versus 1-2). The decreased isolated replicase activity 
from yeast cells for the mini RNA is consistent with it being a poor template for replication in 
vitro (Figure 2.3B), thus there would be less of this template available for replicase assembly.  
These results show that the mini repRNA is good at facilitating the assembly of the TBSV 
replicase, but it is a poor replicon.  This is likely due, at least in part, to the absence of important 
cis-acting replication elements such at RI, which is present in DI-72 (+)repRNA [27, 86-88, 105].   
 
Template competition reveals that the C•C mismatch in RII(+)-SL is important for 
competitiveness of an RNA template during in vitro replication.  
RII(+)-SL and RSE-gPR are important for forming an assembly platform for the 
replicase and RII(+)-SL is proposed to aid in RNA recruitment to the cellular membranes [73].  
TBSV p33 is targeted to peroxisomal membranes [30, 78, 80, 106] and binds to RII(+)-SL with 
high affinity [71].  Accordingly, it has been proposed that a key function of RII(+)-SL is to 
facilitate the recruitment of the TBSV repRNA to the site of viral replication on membranes via 
its interaction with p33 [30, 71, 72].   
To determine the importance of RII(+)-SL and RSE-gPR for replication in the CFE, I 
performed template competition experiments in our CFE replication assay (Figure 2.4 top).  This 
involved adding defined viral segments containing different cis-acting elements as competitors to 
a replication assay for DI-72 (+)repRNA.  Added the plus-stranded RI, RIII or RIV, as well as 
heterologous TCV satC RNA, exhibited relatively poor competition against the accumulation of 
DI-72 (+)repRNA template in vitro (Figure 2.4A, lanes 3-4, 1-2, 9-10 and 15-18, respectively), 
while RII was more competitive (Figure 2.4A, lanes 13-14). The C•C mismatch in mutant RII*, 
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which prevents the p33-RII(+)-SL interaction [71], reduced its competiveness in vitro compared 
to wt RII (Figure 2.4A, cf. lanes 11-12 with 13-14). The mutant RIV*, in which the RSE-SL1-
gPR interaction was disrupted (Figure 2.1A) [74], was slightly more competitive than its wt RIV 
counterpart (Figure 2.4A, cf. lanes 7-8 with 9-10).  Since none of the above short RNA templates 
are replication competent in the CFE assay, these RNAs likely inhibit replication of DI-72 
(+)repRNA in vitro by competing for diffusible factors during RNA recruitment or replicase 
assembly.  Results from competition assays with larger RNAs containing two or more of the 
above segments were also consistent with the single segment results and indicated that wt RII has 
the greatest negative effect on DI-72(+) replication (Figure 2.4B).  This effect was partially 
related to RII’s ability to bind to p33, as RNAs containing mutant RII* [that are unable to bind to 
p33 [71]] showed a marked reduction in competitiveness. (Figure 2.4B).  Thus, in this factor-
limited in vitro environment, RII, alone or with other RNA elements, likely sequesters p33 or 
p92 away from the DI-72(+), leading to reduced replicase assembly and replication of DI-72(+). 
 
A novel two-component RNA system supports TBSV replication in vitro.  
To further dissect the roles of RII(+)-SL and RSE-gPR elements in TBSV RNA replication, 
I developed a novel two-component RNA replicase assembly assay based on CFE. One RNA, 
construct A (Figure 2.5A) contained RII(+)-SL and the other RNA, construct B, (Figure 2.5A) 
carried the RSE-gPR sequence.  Constructs A and B also contained a 23 nt long region of 
complementarity at their 3’ and 5’ ends, respectively, that would allow them to interact via base 
pairing (Figure 2.5A).  Testing the replicase activity of the affinity-purified TBSV replicase from 
CFE revealed that neither construct A nor construct B was able to efficiently support the 
assembly of the TBSV replicase when provided individually in the assembly assay (Figure 2.5B, 
lanes 4 and 5, respectively).  However, when both RNAs were present, the assembly of the 
TBSV replicase was as efficient as the single-component mini-construct or DI-72(+)repRNA 
(Figure 2.5B cf. lane 3 with lanes 1-2,). This result demonstrates that both RII(+)-SL and RSE-
gPR RNA elements are required for replicase assembly, but they do not have to be present in the 
same RNA molecule. 
The complementary between constructs A and B was important for in vitro RNA synthesis 
in the CFE replication assay, since constructs with 23 nt complementarity supported RNA 
synthesis more efficiently than constructs with 12 nt of complementarity (Figure 2.6B, lanes 5 
versus 2) or that lacking extensive base pairing (Figure 2.6B, lanes 5 versus 3).  Interestingly, 
mixing construct A(5’-29) and construct B, which share a tract of 29 bp complementarity, did not 
support RNA synthesis in the CFE assay (Figure 2.6B, lane 1).  However, relative to construct 
A(23), the section of complementarity in construct A(5’-29) is at the opposite end of the RNA, 
which would result in a different and less proximal positioning of the RII(+)-SL and RSE-gPR 
[Figure 2.6, cf. A(23)+B with A(5’-29)].  This result suggests that not only do the two RNAs 
have to be physically close together in order to efficiently promote the assembly of the replicase 
and allow for RNA synthesis; there are also additional structural requirements with respect to 
their precise spatial orientation/proximity relative to each other.  Another interesting finding from 
this analysis is that the functional replicase that assembled with the two-component system 
showed a preference for copying construct B, which contained RSE-gPR. 
 
RSE-gPR defines the template for RNA synthesis in the two-component RNA system in 
vitro.  
Results from Figure 2.6 indicated the TBSV replicase preferentially used construct B, 
carrying the RSE-gPR, as a template to make (-)RNA and this notion was confirmed by PAGE 
analysis of the RNA products synthesized (seen as a dsRNA in Figure 2.7B, lane 6).  As 
expected, when heat-denatured, the dsRNA product became single-stranded (ssRNA in Figure 
2.7B, lane 5) and similar results were observed when the samples were treated with S1 nuclease 
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prior to heating and gel analysis (Figure 2.7B, lanes 7 and 8), supporting the double-stranded 
nature of the faster moving product. 
 To test if construct A could be converted to an active template, I introduced SL1-gPR 
sequence (construct A/gPR, Figure 2.7A) or SL1-gPR and SL2 sequences (construct A/gPR/SL2) 
into RII(+)-SL-containing construct A at a 3’ position.  These new construct A-derivatives were 
able to serve as promoters in an in vitro replicase assay based on an active RdRp (Figure 2.7C, 
lanes 5-6 and not shown).  In contrast, constructs A/gPR or A/gPR/SL2 did not produce 
complementary RNA products when mixed with construct B in the CFE replication assay (Figure 
2.7B, lanes 9-16) and only construct B was copied in these two-component RNA systems.  These 
data suggest that the RSE is an important determinant of template copying by the replicase and 
that, for in vitro replicase assembly in association with viral RNA, only an RNA carrying a 
complete RSE-gPR is used in cis by the replicase as a template for RNA synthesis. 
 
  The RII(+)-SL is needed for the assembly of the TBSV replicase in vitro.  
RII(+)-SL has been designated as a template recruitment element [6, 71], However it is 
not known if this RNA element is also required for the subsequent replicase assembly step. To 
test this, I inactivated the recruitment function of RII(+)-SL [via a C-to-G mutation in the critical 
C•C mismatch, Figure 2.1A, [71]], but also introduced a heterologous "recruitment element", 
namely six RNA hairpins from bacteriophage MS2 that bind selectively to the coat protein (CP) 
of MS2 [30, 107] to obtain construct RII-G/C-M (Figure 2.8A). I also tagged the TBSV p92 
protein with a monomer of MS2 CP [108], creating MS292 (Figure 2.8A) in order to promote 
binding of RII-G/C-M to the TBSV replicase via the heterologous MS2 CP domain (as depicted 
in Figure 2.8A).  This arrangement was predicted to promote the viral RNA recruitment into 
replication by the binding of the MS2 hairpins in RII-G/C-M to the MS2-CP part of the p92 
fusion protein, MS292. 
 In vitro assembly of the TBSV replicase with purified recombinant p33 and MS292 
fusion protein (Figure 2.8C) in the CFE assay revealed that construct RII-G/C-M did not support 
replication (Figure 2.8B, lane 2.8). However, the in vitro RNA recruitment assay in CFE showed 
that wt p33 and the MS292 fusion protein did recruit RII-G/C-M RNA to the membrane ~ 3-fold 
more efficiently than did wt p33 and p92 (Figure 2.8D, cf. lane 9 with 8).  Thus, I conclude that 
the heterologous MS2-CP hairpins work with p33/MS292 fusion proteins in template recruitment.  
Importantly, the insertion of the six MS2-CP hairpins did not hinder replication when inserted in 
wt DI-72 (i.e. construct WM, Figure 2.8A) (Figure 2.8B, lanes 2) and the hybrid MS292 was 
functional for replication (Figure 2.8B, lane 6). 
I also performed a second test with a dual MS2-CP-tagged p33 [(MS2)233] where the viral 
replication proteins were expressed in yeast [55] via co-expression of (MS2)233 fusion protein 
and p92 only (in the absence of TBSV repRNA, Figure 2.9B). After preparing the CFE from the 
above yeast, various RNA templates were introduced and an in vitro replication assay was 
performed (Figure 2.9A).  Although (MS2)233 was expressed at a lower level than wt p33 in 
yeast (Figure 2.9B), the CFE containing (MS2)233/p92 supported the replication of wt DI-72 
(+)repRNA to similar levels as p33/p92 (Figure 2.9A, compare lanes 4 and 1).  The same CFEs 
also allowed for replication of WM, albeit at reduced levels (Figure 2.9A, lanes 2 and 5), but did 
not support the replication of RII-G/C-M RNA (Figure 2.9A, lanes 3 and 6).  The in vitro RNA 
recruitment experiments with CFE containing (MS2)233/p92 revealed efficient recruitment of 
RII-G/C-M RNA to the membrane (Figure 2.9C, lanes 12), suggesting that this step was 
performed more efficiently by (MS2)233/p92 with RII-G/C-M RNA than p33/p92 did with the wt 
DI-72 (+)repRNA (Figure 2.9.C, lane 2). Based on these data, I conclude that replacing the 
recruitment function of RII(+)-SL with the heterologous MS2-CP hairpins is sufficient for RNA 
recruitment to the membrane, but not sufficient to promote the functional assembly of the TBSV 
replicase. Thus, RII(+)-SL may have an additional essential function during the assembly of the 
TBSV replicase complex.  
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DISCUSSION 
The role of UL-DL in replication assembly. 
 The two critical cis-acting elements, RII(+)-SL and RSE-gPR, are located ~3 kb apart in 
the TBSV genomic RNA. However, a long-distance base-pairing interaction between UL-DL 
sequences brings RII(+)-SL and RSE-gPR into close proximity (Figure 2.2B) [84].  I found that 
UL-DL interaction is not necessary for the assembly of the TBSV replicase in vitro, but it boosts 
the assembly by ~10-fold (Figure 2.2). The UL-DL interaction is not needed when RII(+)-SL and 
RSE-gPR are located at nearby positions (see template “mini” lacking UL-DL, Figure 2.3), 
therefore, it represent a unconventional type of enhancer element for replicase assembly (EERA) 
that does not directly interact with proteins. 
 The two-component system confirmed the importance of the UL-DL interaction and 
revealed that RII(+)-SL and RSE-gPR could function when not covalently linked to each other.  
This suggest that there is no processive tracking of components along the RNA between RII(+)-
SL and RSE-gPR during replicase assembly.  Nonetheless, the base-pairing requirement between 
the two RNAs underscored the importance of proximity for these two elements.  In addition to 
general proximity, their relative orientations and/or precise proximity also seem to be significant, 
as base pairing between sites that were not similar in relative location to the UL-DL interaction, 
did not lead to functional replicase assembly [Figure 2.6, A(5’-29)+B].  Thus, the UL-DL 
interaction acts indirectly to enhance the assembly process by optimally positioning RII(+)-SL 
and RSE-gPR relative to one another. 
 
Dual role of RII(+)-SL during template recruitment and the assembly of the viral 
replicase. 
 Two of the most intriguing non-template roles of the viral (+)RNA are essential function 
for template recruitment and assembly of the viral replicase complex [73, 75, 84].  These 
functions are mediated by distinct cis-acting elements in the viral (+)RNA.  In tombusviruses, 
one these elements is the internally located RII(+)-SL (Figure 2.1A), which binds to p33/p92 
replication proteins via a C•C mismatch present in an internal loop [71, 72]. Template 
competition experiments using our CFE replication assay revealed that RII(+)-SL, and 
particularly the C•C mismatch, is required for the template to inhibit the replication of the full-
length DI-72 repRNA in vitro (Figure 2.4). In contrast, other important regions of DI-72 
(+)repRNA did not efficiently compete in the CFE-based replication assay, suggesting the lack of 
contribution by these sequences to viral RNA recruitment or directbinding to the viral replicase. 
These observations are consistent with the model that RII(+)-SL is an authentic RNA recruitment 
element that determines if a particular RNA is selected/recruited for replication by the 
tombusvirus replicase. 
 However, this result or previous data [71, 75, 84] have not precluded the possibility that, 
independent of template recruitment, RII(+)-SL also plays a role in the assembly of the replicase 
complex.  These two activities are difficult to separate, since the assembly of the replicase 
depends on the prior RNA recruitment step.  Consequently, in order to separate these two 
functions, I utilized a heterologous recruitment approach based on the specific MS2 CP-MS2 
RNA hairpin interaction [30, 107, 108] using chimeric RNAs and fusion proteins.  This 
alternative recruitment scheme was able to direct RNA templates to membranes, however no 
replicase assembly was observed (Figs. 2.8 and 2.9).  This suggests that the RII(+)-SL-p33/p92 
interaction mediated by the C•C mismatch is also critical for replicase assembly.  Indeed it is 
possible that this interaction both tethers the template for protein-mediated transport to 
membranes and, at the same time, establishes the foundation from which a replicase complex can 
assemble.  The requirement for this specific interaction may be related to allosteric effects on 
p33/p92 that are important for subsequent interactions and/or for precise positioning of these 
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viral factors relative to host factors, which facilitates complex formation.  Indeed, such a strategy 
of coupling the RNA-protein interaction with template recruitment and replicase assembly would 
streamline these consecutive processes and potentially provide a fitness benefit to the virus by 
minimizing unnecessary steps. 
 
Cis-replication of the RNA template by the tombusvirus replicase depends on the 
presence of RSE.  
 The novel two-component RNA system was used to confirm that the RSE-gPR cis-
acting sequence is also absolutely necessary for the assembly of the viral replicase in vitro (Figs. 
5-6).  Surprisingly, however, this system also revealed that only one of the two RNAs is used as a 
template by the newly assembled/activated membrane-bound replicase.  Analysis of various 
modified template pairs indicated that selection of an RNA for copying required the presence of 
the RSE element in that template and that neither the promoter for minus strand synthesis, gPR, 
nor a longer version of it, gPR+SL2, would suffice for this function (Figure 2.7).  This finding is 
in contrast with the data obtained with the solubilized and purified tombusvirus replicase, which 
efficiently used RNAs carrying gPR or gPR+SL2 sequences at 3’ terminal positions, but lacking 
RSE (Figure 2.7).  Indeed, this solubilized replicase is not associated with viral RNA and thus is 
able to encounter promoter sequences in the template RNAs added to the reaction.  Conversely, 
in de novo replicase assembly, our data indicates that the nascent replicase may assemble with 
the viral RNA in such a manner that positions its active site in proximity to the gPR, where 
minus-strand synthesis initiates.  Our results also suggest that RSE, in cooperation with 
covalently linked gPR, would be integral for this to occur.  This type of tight coupling could be 
limited to the pioneering round of minus-strand synthesis, as initial copying of the template 
would presumably dislodge any replicase/cofactor contacts involved in replicase assembly that 
were not involved in the RNA synthesis step.  Nonetheless, this strategy would help to ensure 
that only templates capable of assembling functional replicase would be templates for replication.  
This and other cis-preferential replication strategies would be particularly beneficial at the early 
stage of infections initiated at low multiplicity of infection.    
 
Summarizing template recruitment and replicase assembly.   
Replication of a viral RNA requires the preceding processes of template recruitment and 
replicase assembly.  In TBSV, RII(+)-SL interacts with p33/p92 which targets the RNA for 
replication by shuttling it to membranes (Figure 2.10).  RII also likely directly contributes to 
replicase complex assembly in a manner that is, at least partially, linked to its p33/p92 binding 
activity. RSE-pPR forms part of the replicase assembly platform (Figure 2.10) and binds to 
eEF1A, which is a component of the replicase complex [18, 76].  RSE-gPR also specifies the 
template for minus-strand synthesis and harbors the core promoter for initiation, gPR.  UL-DL 
plays an indirectrole in replicase assembly by bringing RII(+)-SL and RSE-gPR into proximity in 
the proper orientation.  Collectively, this diverse group of core RNA elements function jointly to 
mediate efficient replicase complex assembly. 
 
MATERIALS AND METHODS 
Yeast and Bacterial strains.  
Saccharomyces cerevisiae strains BY4741α (MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0) 
was obtained from Open Biosystems (Huntsvwelle, AL, USA). Escherichia coli Top10 
(Invitrogen, Carlsbad CA, USA) and Epicurion BL21-codon-plus (DE3)-RIL cells (Stratagene, 
La Holla, CA, USA) were used to propagate plasmids and for expression of recombinant proteins, 
respectively. E. coli strain Stbl2 (Invitrogen, Carlsbad CA, USA) was used for maximizing the 
stability of the plasmids containing directrepeats [such as (MS2)2p33]. Also, I changed the typical 
growing temperature from 37°C to 30°C when using Stbl2. 
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E. coli expression plasmids.  
pMAL-33 and pMAL92 were described earlier [28]. pET-His-MBP-p33, expressing p33 
with dual tags 6xHis/MBP, was also obtained earlier [73]. pMAL-MS233, containing TBSV p33 
fused in-frame with bacteriophage MS2 coat protein (MS2-CP), was obtained by PCR 
amplification of MS2-CP open reading frame (ORF) from pGBK-MS2-CFP [30] using primers 
#1576 (5’-GGAGTCTAGAGCTTCTAACTTTACTCAG) and #3269 (5’-
CCGCCATGGGTAGATGCCGGAGTTTGC) appended with XbaI and NcoI restriction sites. 
While TBSV p33 ORF was amplified from pMAL92 using primers #3313 (5’-
CGGACCATGGGAGACCATCAAGAGAATG) and #2744 (5’-
CGGCTGCAGCTATTTGACACCCAGGGAC) appended with NcoI and PstI respectively. To 
get the desired clone, after gel-isolation of the restriction enzymes digested PCR products, I 
ligated the PCR products into pMAL-c2X digested with XbaI and PstI. 
To obtain pMAL-MS292, the TBSV p92 ORF was fused in-frame in fusion with MS2-CP 
ORF, which was PCR-amplified from pGBK-MS2-CFP [30] using primers #1576 and #3269 
appended with XbaI and NcoI restriction sites. The TBSV p92 ORF was PCR-amplified from 
pMAL92 using primers #3313 and #3529 (5’-
CCAGCTGCAGTCAAGCTACGGCGGAGTCGAGG) appended with NcoI and PstI 
respectively. After gel-isolation of the restriction enzymes digested PCR products, I ligated the 
PCR products into pMAL-c2X digested with XbaI and PstI. 
 
Yeast expression plasmids.  
pGBK-His33 and pGAD-His92, expressing only 6xHis-tagged p33 and p92, respectively, 
from the ADH1 promoter and pYC-DI72 were described previously [13]. pGBK-Cup-(MS2)2-33 
was obtained by fusing the CNV p33 ORF in-frame with two copies of bacteriophage MS2-CP 
[(MS2)2 representing directrepeats of MS2-CP ORF linked with a short linker (GAPGIHPGM) 
and also containing an internal polyHis-tag]. The sequence of (MS2)2 was amplified from 
p(MS2)2PCBP2 [108] using primers #4194 (5’-
CGGACCATGGCGGATATCGAAGGTCCCACC) and #4196 (5’ 
CCAGCCATGGGTCGTTTGGGTGATGGTGATGGTGGTGGCTGCCGCGTGG) appended 
with NcoI restriction site and cloned into NcoI digested and dephosphorylated vector pGBK-
His33/Cup1 [67]. Similarly, pGAD-Cup-(MS2)2-92 was obtained by fusing the CNV p92 ORF 
in-frame with (MS2)2 using primers #4194 and #4196 appended with NcoI restriction site and 
cloned into NcoI digested and dephosphorylated vector pGAD-His92-Cup1 [70].  
pYC-DI(C:G)6XMS2(+) was generated by PCR-amplifying Region I and II of DI-72(+) 
from pYC-DI/(C99:G) [71] using primers #542 and 1565 [88]. The PCR product was digested 
with HindIII and BamHI and used to replace the corresponding region in pYC-DI72(+)/MS2 [30] 
treated with the same pair of enzymes. To create pYC-DI(C:G)-6XMS2(-), similar strategy was 
used based on the vector pYC-DI72(-)/MS2 [30].  
 
RNA template production and annealing.  
Single-stranded (ss)RNA templates were obtained by in vitro transcription with T7 RNA 
polymerase using PCR amplified DNA templates [88, 109]. The reaction mixture was incubated 
at 37°C for 2 hours. 2 µl of DNaseI (10 U/ml from Roche) was added, and incubated for ~20 min 
at 37°C. After phenol-chloroform extraction, RNA was precipitated twice with isopropanol-
ammonium acetate (10:1). To synthesize radioactively labeled RNA similar T7 reaction was 
performed, except for using 5 µl of 10 mM rATP, rGTP rCTP and 1mM of rUTP supplemented 
with 0.1 µl of [32P]UTP. RNA annealing was done with RNA samples mixed in equimolar ratio 
(20 pmols each) in 20 µl buffer containing 50 mM NaCl, 10 mM Tris-Cl and 1 mM EDTA. The 
samples were incubated in a thermocycler at 95°C for 5 min and then cooled to 25°C by reducing 
the annealing temperature by 1°C per minute. 
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In vitro replication assay based on yeast CFE.  
The cell-free extract was prepared from yeast strain BY4741, untransformed or 
transformed with pair-wise combinations of pGBK-His33/Cup1; pGAD-His92-Cup1; pGBK-
Cup1-(MS2)2-33; and pGAD-Cup1-(MS2)2-92 (see Figure 2.9) as described [55, 73]. Briefly, the 
CFE (1 µl) was pre-incubated on ice for 10 min in 10 µl cell-free replication buffer containing 50 
mM HEPES-KOH, pH 7.4, 150 mM potassium acetate, 5 mM magnesium acetate, 0.2 M sorbitol, 
and 0.4 µl actinomycin D (5 mg/ml). Then, the reaction volume was adjusted to 20 µl with 1x 
cell-free replication buffer also containing 2 µl of 150 mM creatine phosphate; 2 µl of 10 mM 
ATP, CTP, and GTP and 0.25 mM UTP; 0.3 µl of [32P]UTP, 0.2 µl of 10-mg/ml creatine kinase, 
0.2 µl of RNase inhibitor, 0.2 µl of 1 M dithiothreitol, and 0.5 µg RNA transcript. The reaction 
mixture also contained 4 pmol MBP tagged TBSV p33 and 1 pmol MBP-p92 purified from E. 
coli cells.  This reaction mixture was incubated at 25°C for 3 h. The reaction was terminated by 
adding 110 µl stop buffer (1% sodium dodecyl sulfate [SDS] and 0.05 M EDTA, pH 8.0), 
followed by phenol-chloroform extraction, isopropanol-ammonium actetate precipitation, and a 
washing step with 70% ethanol as described earlier. The RNA samples were electrophoresed 
under denaturing conditions (5% PAGE containing 8 M urea) and analyzed by phospho-imaging 
using a Typhoon (GE) instrument as described [75]. 
 
Micrococcal nuclease protection assay.  
The CFE-based in vitro replication assay was conducted as described above. Micrococcal 
nuclease digestion of the samples was performed at 25°C for 15 min using 0.04 U/ml, final 
concentration, and 1 mM CaCl2 at various time points as described [55, 73]. To terminate the 
action of micrococcal nuclease, I added EGTA (2.5 mM, final concentration), followed by further 
incubation of the cell-free replicase assay mixture at 25°C for 2.5 hrs. In the control assay, only 
CaCl2 and EGTA were added to the reaction mixture in the absence of the nuclease. 
 
Purification of the recombinant tombusvirus replicase from yeast. 
 Yeast cells transformed with pGBK-His33, pGAD-His92 and pYC-DI72 were pre-
grown in SC-ULH- medium containing 2% glucose for 15 h at 29 °C with shaking at 250 rpm. 
The affinity-purification of the solubilized tombusvirus replicase was performed using ProBond 
resin (Invitrogen) as described [82]. The obtained template-dependent replicase was then used in 
a standard replicase reaction using either DI-72(-) or RI/RIII(-) exogenous templates and 
[32P]UTP [75, 82]. 
 
In vitro assembly and purification of the TBSV replicase.  
The cell free replication assay was conducted at 20°C for 1 h as described above except 
for following changes: The reaction volume was increased to 200 µl, while the final concentration 
of DTT was reduced from 10 mM to 2.5 mM. In addition, only rATP and rGTP were used, while 
[32P]UTP was omitted. The recombinant p33 was dually tagged with both MBP and 6xHis. After 
incubation, the assay mixture was diluted with 800 µl chilled solubilization buffer and affinity-
purification was done exactly as described [75, 82]. 
 
Protein purification from E. coli.  
The MBP-tagged p33, p92, MS233, MS292 and Turnip crinkle virus p88C were purified 
from E. coli as described previously [28, 110]. Briefly, expression of the MBP tagged proteins 
was induced by isopropyl-d-thiogalactopyranoside (IPTG) in Epicurion BL21-codon-plus (DE3)-
RIL cells (Stratagene). Cells were suspended in the column buffer (10 mM Tris–HCl [pH 7.4], 1 
mM EDTA, 25 mM NaCl, 10 mM β-mercaptoethanol) and were broken by sonication, and then 
the cell lysate was passed through the equilibrated amylose columns to bind MBP tagged 
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proteins. After passing the cell lysate, the columns were washed three times with ice-cold column 
buffer and eluted with column buffer containing 10 mM maltose and stored at -80°C until further 
use. 
 
In vitro RNA recruitment assay.  
The recruitment assay was performed as described [76]. Briefly, recruitment assay based 
on yeast CFE and recombinant p33/p92 is similar to the replication assay, except for the 
following changes: [32P]-labeled RNAs (2 pmol) were added to the CFE. In addition, only rATP 
and rGTP were used, while [32P]UTP was omitted. The assay was performed at room temperature 
for 1 h. Then, the mixture was suspended in 980 µl of pre-chilled Buffer A and centrifuged at 
35,000g for 30 min at 4°C. Supernatant was discarded and the washing of the membrane pellet 
was repeated twice. After final washing, the pellet was dissolved in 120 µl of stop buffer (1% 
sodium dodecyl sulfate [SDS] and 0.05 M EDTA, pH 8.0). Afterwards standard RNA extraction 
and purification was performed followed by autoradiography of the electrophoresed RNA 
samples as described [75]. 
 
In vitro RdRp reaction.   
Affinity-purified recombinant TCV p88C or affinity-purified CNV replicase from yeast 
in an RdRp assay were used as described [82, 110]. Briefly, the RdRp reaction was performed in 
100 µl volume containing RdRp buffer [40 mM Tris pH 8.0, 10 mM MgCl2, 10 mM DTT, 0.2µl 
RNase inhibitor, 1 mM ATP, CTP, GTP, 0.1 µl radioactive [32P]UTP and 50 µl RdRp fraction. 
As an external template, 300 ng of DI-72(-) RNA or RI/III(-) RNA were added. Samples were 
incubated at 25 °C for 2 h. The reaction was terminated by adding 70 µl SDS/EDTA (1% SDS, 
50 mM EDTA pH 8.0) and 100 µl phenol-chloroform (1:1). The analysis of RdRp products was 
as described [82, 110]. 
 
S1 nuclease digestion of the RdRp products.  
The RNA products from the in vitro RdRp assays were purified and divided into two 
aliquots of 8 µl each. S1 digestion was performed with one aliquot in a 20 µl reaction containing 
0.1 µl S1 nuclease (400U/µl from Boehringer), 1X S1 nuclease buffer and 2.5 µl 3M NaCl. The 
other aliquot was treated similarly, except without S1 nuclease. After incubation at 37°C for 30 







Figure 3 Figure 2.1 Schematic representation of TBSV DI-73 (+)repRNA and its derivatives 
carrying the three known cis-acting replication elements.  
 
(A) Top: The three cis-acting sequences are circled. The characteristic C•C mismatch, which is 
critical to bind to p33/p92 replication proteins, within the RII(+)-SL is highlighted. The 
complementary nucleotides in the replication silencer element (RSE) and the genomic promoter 
(gPR) that form a 5 bp-long region are depicted with an arrow. Note that R3.5 serves as a 
translation enhancer, which is missing from DI-72 repRNA. Bottom: A long-range interaction 
between UL-DL elements brings RII(+)-SL and RSE/gPR into proximal positions as shown. (C) 
Predicted secondary structure of mini RNA used as a model template for testing the assembly of 
the TBSV replicase complex in vitro in yeast CFE. Note that the UL-DL interaction and other 




Figure 4 Figure 2.2. UL-DL cis-acting element functions as an enhancer element for the 
replicase assembly (EERA).  
 
(A) The scheme of the in vitro TBSV replicase assembly assay performed with yeast CFE. Note 
that the recombinant p33 and p92pol are purified from E. coli, while the CFE was prepared from 
BY4741. After 1-hour reconstitution, the membrane-bound replicase was solubilized with Triton 
X-100/SB3-10 detergent, followed by purification on Ni-column of the 6xHis/MBP-tagged p33, 
which is integral part of the replicase complex. The activity of the affinity-purified TBSV 
replicase was tested on DI-72(-) RNA added to each sample using the same amount of RNA. (B) 
Mutations within UL-DL, which interfere with base-pairing, or reform base-pairing due to 
complementary mutagenesis, are shown. (C-D) Representative denaturing gels of 32P-labeled 
RNA products synthesized by affinity-purified TBSV replicase preparations obtained in TBSV 
replicase assembly assays in vitro with yeast CFE in the presence of all four or two rNTPs.  The 
replicase assembly assay contained the wt DI-73 (+)repRNA or mutated versions within UL-DL 
region as shown in panel A. The replication competent RNA was DI-73-based, while the 
replication-incompetent carried a debilitating mutation in RI in DI-73 repRNA. The template 
RNA was DI-72(-)repRNA, which produces both full-length (terminal initiation [ti]) and shorter 
(due to internal initiation [ii]) complementary products in the in vitro assay with the purified 
TBSV replicase. The level of full-length RNA synthesis was compared to that of the replicase 
activity obtained with DI-73 (+)repRNA (100%). (E) No RNA template was added into the in 
vitro assays with the purified TBSV replicase preparations, while the shown repRNAs were used 
during the TBSV replicase assembly assays in vitro with yeast CFE prior to affinity-purification 







Figure 5 Figure 2.3. A mini template with RII(+)-SL and RSE-gPR can efficiently support 
the in vitro assembly of the TBSV replicase.  
 
(A) Denaturing PAGE analysis of the in vitro reconstituted TBSV replicase in the presence of 
repRNAs. The replicase reconstitution assay contained CFE, affinity purified recombinant TBSV 
p33 and p92pol, ATP/GTP and the same amount of TBSV repRNAs. After assembly and affinity-
purification, the activity of the replicase preparations was tested on DI-72(-)RNA template in 
vitro. See further details in Figure 2. (B) Denaturing PAGE analysis of the CFE-based replication 
assay. The in vitro replication assay contained yeast CFE, affinity purified recombinant TBSV 
p33 and p92pol, and 4 pmol of various TBSV repRNAs (as shown in Figure 1). The full-length 
products are depicted with arrowheads on the right. Note that the repRNA serves both as an 
assembly factor and a template in this assay. (C) The in vitro assembled TBSV replicase with DI-
72(+) forms a structure more ribonuclease-resistant than with mini or RII/IV(+) repRNAs in the 
CFE. The in vitro replicase assay in CFE was done using one of the shown RNAs. Note that I 
applied a 15-min treatment with ribonuclease (micrococcal nuclease) at the 0, 20, 40 or 60 min 
time points for 15 minutes, followed by inactivation of the nuclease and continuation of the in 
vitro replicase assay up to 2 hours. The denaturing PAGE analysis of the 32P-labeled repRNA 
products obtained is shown. (D) Denaturing PAGE analysis of the in vitro replicase assay. The 
assay contained the purified replicase from yeast co-expressing p33 and p92pol, and the 
(+)repRNAs (as shown). The activity of the affinity-purified TBSV replicase was tested on 
RI/RIII(-) RNA added to each sample using the same amount of RNA. Note that the assembly of 
the replicase took place in yeast cells in the presence of co-expressed p33/p92 and actively 
replicating repRNA. The bottom image shows a Western blot demonstrating equivalent amount 






Figure 6 Figure 2.4. RII(+) RNA inhibits the in vitro assembly of the TBSV replicase.  
 
(A) Denaturing PAGE analysis of the CFE-based replication assay. The in vitro replicase 
reconstitution assay contained yeast CFE, affinity purified recombinant TBSV p33 and p92pol, 
and the same amount of TBSV DI-72 (+)repRNA plus increasing amounts of competitor TBSV-
derived RNA templates (RI, RII, RIII and RIV are shown in Figure 2.1) or the TCV associated 
satC templates. The samples contained 0, 2 and 8 mg of competitor RNA and each had 0.4 mg of 
DI-72(+) RNA template. The full-length DI-72-derived RNA products are depicted with 
arrowheads on the right. Note that the repRNA serves both as an assembly factor and a template 
in this assay, while the competitor RNA cannot assemble a functional replicase, but it can 
interfere with the replicase assembly process. The level of DI-72 repRNA replication in the “no 
competitor” samples was chosen as 100%. (B) Another template competition in CFE-based 
replication assay. The competitor RNA contains the wt regions (RII, RIII or RIV), a mutated RII 
(marked with an asterisk, and represents a C-to-G mutation in C•C mismatch, Figure 2.1A) or a 
mutated RIV (marked with an asterisk, and represents a G-to-C mutation in gPR, Figure 2.1A). 
These mutations are known to interfere with the cis-acting replication functions of these regions. 
See further details in panel A. The samples contained 0, 3 and 9 mg of competitor RNA and each 








Figure 7 Figure 2.5. An efficient two-component RNA-based TBSV replicase assay.   
 
(A) Schematic representation of the RNA constructs used in the replicase assembly assay. 
Construct A contains functional RII(+)-SL, while construct B carries RSE-gPR element. Note 
that constructs A and B can form a 23 bp heteroduplex that holds the two RNAs together as 
shown for “A+B”. (B) Denaturing PAGE analysis of the CFE-based replication assay. The in 
vitro reconstitution assay contained yeast CFE, affinity purified recombinant TBSV p33 and 
p92pol, and the same amount of various TBSV repRNA templates (as shown). After the in vitro 
reconstitution, the activity of the purified replicase preparations was tested using RI/RIII(-) 
template. The full-length RNA product is depicted with an arrowhead on the right. Note that the 







Figure 8 Figure 2.6. RII(+)-SL and RSE-gPR sequences must be located in close vicinity 
during the assembly of the TBSV replicase.  
 
(A) Schematic representation of the two-component RNA constructs used in the replicase assay. 
See further details in Figure 2.5A. (B) Denaturing PAGE analysis of the CFE-based replication 
assay. The in vitro reconstitution assay contained yeast CFE, affinity purified recombinant TBSV 
p33 and p92pol, and the same amount of various TBSV repRNA templates (as shown). Note that 
the repRNAs (panel A) serve both as assembly factors and templates in this assay. The full-length 







Figure 9 Figure 2.7. cis-replication of the template RNA carrying RSE-gPR in vitro. 
 
 (A) Schematic representation of the two-component RNA constructs used in the replicase assay. 
See further details in Figure 2.5A. (B) Non-denaturing PAGE analysis of the CFE-based 
replication assay. The in vitro reconstitution assay contained yeast CFE, affinity purified 
recombinant TBSV p33 and p92pol, and the same amount of various TBSV repRNA templates (as 
shown). Note that the repRNAs (panel A) serve both as assembly factors and templates in this 
assay. The full-length ssRNA and dsRNA products are depicted with arrowheads on the right. 
Note that only construct B carrying RSE-gPR can produce complementary (-)RNA product in 
vitro, since ssRNA is only visible after denaturation of dsRNA product. (C) Representative 
denaturing gel of 32P-labeled RNA products synthesized by TCV p88C RdRp in vitro in the 
presence of 1 mg of RNA transcripts as shown. The de novo-initiated terminal products are 
marked with arrowheads (“ti”). The samples were treated with S1 nuclease to show the 3’-
terminal extension products (shown as “pe”), which change migration after treatment [110]. Each 







Figure 10 Figure 2.8. RII(+)-SL is required for the in vitro assembly of the TBSV replicase.  
 
 (A) Schematic representation of the RNA constructs used in the in vitro replication assay. 
Constructs WM and RII-G/C-M contain 6 copies of the MS2-CP hairpin (green), which can 
specifically bind to MS2 CP. p92 was fused to MS2 CP (green) as indicated. Constructs WRM 
and RII-G/C-RM contain 6 copies of the complementary MS2-CP hairpin sequence (red), which 
cannot bind to MS2 CP. The predicted binding of the RNA constructs to p33/p92 or the MS2-CP 
fusion proteins is shown with black arrows (positive binding) or crossed with red (no binding). 
(B) Denaturing PAGE analysis of the CFE-based replication assay. The in vitro replication assay 
contained yeast CFE, affinity purified recombinant TBSV p33 and p92pol, or the MS2 CP fusion 
p92 protein and the same amount of various TBSV repRNA templates (as shown). The full-length 
products are depicted with arrowheads on the right. Note that the repRNAs serve both as 
assembly factors and templates in this assay. (C) SDS-PAGE analysis of the affinity-purified 
recombinant proteins. (D) Denaturing PAGE analysis of the in vitro RNA recruitment assay. The 
assay contained CFE, affinity purified recombinant TBSV p33 and p92pol or the MS2 CP fusion 
p92 protein, and the same amount of 32P-labeled TBSV repRNA templates. After the recruitment 
assay, the membrane-associated P32-labeled repRNAs were quantified. 
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Figure 11 Figure 2.9. RNA templates containing the MS2 CP hairpins are efficiently 
recruited, but they are replication incompatible in vitro.   
 
(A) Denaturing PAGE analysis of the CFE-based replication assay. The in vitro replication assay 
contained CFE prepared from yeast co-expressing p33 and p92 or (MS2)233 fusion protein 
(containing the dimeric CP of MS2) and p92, and the same amount of various TBSV repRNA 
templates (as shown). The full-length products are depicted with arrowheads on the right. Note 
that the repRNAs serve both as assembly factors and templates in this assay. (B) Western blot 
analysis of p33, p92 and (MS2)233  fusion proteins in yeast CFE. (C) Denaturing PAGE analysis 
of the in vitro RNA recruitment assay. The assay contained CFE (as in panel A), and the same 
amount of P32-labeled TBSV repRNA templates. After the recruitment assay, the membrane-




Figure 12 Figure 2.10. The known functions of the cis-acting replication elements in TBSV 
(+)RNA.  
 
Since RII(+)-SL could not be replaced by a heterologous RNA recruitment element, I propose 
that RII(+)-SL is not only needed for RNA recruitment into replication, but it is also required for 
the assembly of the replicase complex. The RSE-gPR element is required for the assembly of the 
replicase and also determination of the template for the replicase, since only those RNAs, which 
carry the RSE element, are used as templates by the TBSV replicase. I propose that the role of 
UL-DL is not only to bring the RII(+)-SL and RSE-gPR elements into close proximity, but to 
























Chapter 3. The host Pex19p plays a role in peroxisomal localization of tombusvirus 
replication proteins. 
 
                              This chapter is published in Virology, 2008, 379(2):294-305. 
 
INTRODUCTION 
Similar to animal viruses, plant viruses containing RNA genomes of plus-strand polarity 
replicate on the cytosolic surfaces of intracellular membranes. For different viruses, these 
membranes include different organelles, such as endoplasmic reticulum, mitochondria, 
chloroplast, peroxisomes, vacuoles or unique subcellular membranes induced specifically by viral 
infections [6, 111-114]. Why different viruses choose different subcellular membranes for their 
replication and how the viral replication proteins are targeted to those membranes are currently 
under intensive investigations. Once the replication proteins and the viral RNA are delivered to 
the precise membrane locations, then they form, likely with the help of yet unidentified host 
proteins, membrane invaginations (called spherules) that contain narrow openings facing toward 
the cytosol [115]. These spherules contain the viral replicase complex and are the places for viral 
RNA synthesis [78, 115, 116]. 
Targeting of the viral replication proteins to the particular membrane location is likely 
driven by host transport proteins that might recognize specific targeting signals within the viral 
replication proteins. In spite of intensive studies, I know only a few cases, where host proteins are 
implicated in intracellular transport of the viral replication proteins. For example, the 126K 
replication protein of Tobacco mosaic virus (TMV) is bound to TOM1 and TOM2 
transmembrane proteins, which might anchor the TMV replication protein to the membrane 
[117]. Also, the transport of BMV replication proteins and the BMV (+)RNAs within the host 
cells is affected by the Lsm1-7p/Pat1p/Dhh1p complex [118]. This complex has been suggested 
to facilitate the pre-assembly of the BMV replicase complex in the P-bodies, prior to the 
transportation of the viral replication proteins and RNAs to the ER, the site of replication [118].  
There are some viruses other than tombusviruses that utilize peroxisomes at some stage 
of their multiplication cycle albeit not replication per se (reviewed by [119]). E.g. Rotavirus’ 
spike protein VP4 is targeted to peroxisomes and may utilize lipid metabolic machinery [120]. 
Nef protein of Human immuno deficiency virus  (HIV) interacts physically and functionally with 
a peroxisomal thioesterase that also might get some help in the fatty acid modification of proteins 
[121]. Moreover, NS1 of influenza viruses interacts with a multifunctional peroxisomal enzyme 
17β-HSD4/MFP-2 [122]. Exact relevance of this interaction for virus or the host is not clear 
presently.   
Interaction of the NS5A and NS5B replication proteins of hepatitis C virus (HCV) with 
intracellular membranes is affected by hVAP-A SNARE-like protein. The proposed function of 
hVAP-A is to serve as a membrane receptor and to anchor the replication proteins to the 
intracellular membrane [123].  Moreover, FBL2, a geranylgeranylated cellular protein might be 
involved in recruitment of HCV NS5A to intracellular membranes [124]. Overall, none of the 
above cellular proteins fit the definition of a traditional transporter protein, which is expected to 
be released and recycled from the membrane after delivering the cargo viral proteins/viral RNA.  
Among the (+)RNA viruses of plants, tombusviruses have emerged as highly suitable 
model viruses for studying basic questions in viral RNA replication and recombination, including 
the role of the host [6, 68]. The genomic (+)RNA of TBSV and the closely related Cucumber 
necrosis virus (CNV) codes for p33 and p92pol replication proteins, which are produced via 
translational readthrough strategy [27]. p33 is an essential replication co-factor involved in 
selection/recruitment of the viral RNA template [30, 71, 72], and in the assembly of the viral 
replicase [75], whereas p92pol is a RNA-dependent RNA polymerase (RdRp) [13, 25, 125]. Both  
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replication proteins are integral parts of the tombusvirus replicase complex in combination with 
4-10 host proteins [17, 32, 89]. One of the major breakthroughs in tombusvirus research is the 
development of yeast as a model host for virus - host interactions, allowing the utilization of 
poIrful genomics and proteomics tools developed for yeast [13]. Yeast cells expressing 
tombusvirus p33 and p92pol replication proteins can efficiently replicate a short TBSV-derived 
replicon (rep)RNA, which is a defective interfering (DI) RNA identified in TBSV infected plants 
[13, 82]. The tombusviral repRNA not only serves as a template for replication, but as an 
assembly platform for the viral replicase complex as well [75, 82].  
Replication of both TBSV and CNV RNAs takes place on the cytosolic surfaces of the 
peroxisomal membranes in plant and yeast host cells [30, 78]. The peroxisomal membranes 
contain the typical virus-induced membrane spherules and the viral replicase [30, 78], suggesting 
that transport of the viral replication proteins to peroxisomal membranes likely occurs in TBSV 
infected cells. Deletion analysis of the p33 replication cofactor in combination with intracellular 
localization studies revealed that three redundant peroxisomal targeting sequences are present in 
p33 [78]. Unfortunately, among ~160 host genes identified in recent systematic genome-wide 
screens of single gene knock out library and the essential gene library of yeast that affected TBSV 
replication or recombination [16, 20, 21, 75], I could not yet identify any outstanding host protein 
candidates for transportation of the tombusvirus replication proteins to the peroxisomes. This is 
likely due to gene/functional redundancy within the yeast host. Indeed, later works demonstrated 
that replication of TBSV and the closely related Cymbidium ringspot virus (CyRSV) was able to 
switch to the ER membrane in the absence of peroxisomes in yeast [106, 126]. This unexpected 
finding suggested that the membrane requirement for tombusvirus replication is flexible and that 
tombusvirus replication proteins can be transported to the ER by default [106].    
The objective of this work was to identify the host transporter protein for p33 replication 
cofactor to the peroxisomal membrane, where TBSV RNA replication takes place [30, 78]. I 
reasoned that p33 likely interacts with host proteins involved in intracellular trafficking of 
peroxisomal membrane proteins. To identify those host proteins that could be involved in 
transportation of the tombusvirus p33 replication co-factor to peroxisomal membranes, I tested 
whether yeast proteins involved in transport to peroxisome membrane could bind to p33 in vitro. 
These preliminary experiments have led to the identification of Pex19p that bound to p33 
specifically under in vitro conditions. Further approaches validated that the Pex19p- p33 
interaction is important for intracellular transport of p33. Altogether, data presented in this work 
support the model that Pex19p is the transporter for p33 replication protein. 
 
RESULTS 
The Pex19p host protein binds to the tombusvirus p33 replication cofactor in vitro.  
To identify if one of the yeast proteins involved in transportation of membrane proteins to 
the peroxisome could interact with p33 replication cofactor, I performed preliminary pull-down 
experiments with purified recombinant p33 fused with the Maltose binding protein (MBP) 
immobilized on beads and five separately expressed GST-tagged host proteins affecting transport 
to peroxisomes. These experiments have shown that Pex19p bound to MBP-p33, but only poorly 
to the MBP control (Figure 3.1B, lane 1 versus 2). The GST protein expressed in yeast serving as 
a control for Pex19p-GST, did not bind to MBP-p33 in the pull-down experiments, confirming 
that the in vitro interaction took place between Pex19p and p33 and was not facilitated by the 
sequence tags. 
To test if the previously defined three peroxisomal membrane-targeting sequences 
(mPTS) in p33 [78] are important for the interaction with Pex19p, I purified recombinant MBP-
p33 proteins with defined deletions. These experiments revealed that p33DPTS that lacked all 
three mPTS sequences (Figure 3.1A) bound poorly to Pex19p in the pull-down experiment 
(Figure 3.1C, lane 3). Similarly, p33C, which misses the entire N-terminal domain, including the 
3 mPTS sequences and the two predicted transmembrane domains (Figure 3.1A) bound poorly to 
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Pex19p in vitro (Figure 3.1C, lane 4). Deletion of the N-terminal 11 amino acids in p33, which 
includes one of the mPTS sequences and an ER-targeting sequence [78], did not inhibit its 
binding to Pex19p in vitro (Figure 3.1C, lane 2). Interestingly, deletion of short N-terminal 
stretches did not inhibit the peroxisomal localization of p33 in N. benthamiana or yeast cells [30], 
whereas deletion of all three mPTSs did inhibit p33 localization [78]. 
To define if the C-terminal sequence of Pex19p is involved in interaction with p33, I 
tested a C-terminally-truncated Pex19p, termed Pex19-N206.  The C-terminal portion of Pex19p 
is known to bind to other cargo peroxins that are transported to the peroxisomal membrane by 
Pex19p [127]. The in vitro pull-down experiment has shown that Pex19-N206 did not bind to p33 
(Figure 3.1D, lane 2). This was expected, since the N-terminal portion of Pex19p is involved in 
binding to Pex3p docking protein, not to the cargo proteins [127].      
Co-purification of p33 replication protein with Pex19p host protein from yeast.  
To test if Pex19p and p33 replication cofactor form a complex in yeast, first I cross-
linked proteins with formaldehyde in intact yeast cells co-expressing GST-Pex19p and p33HF 
(6xHis/FLAG-tagged), followed by quenching with glycine. Then, the cells were broken and 
GST-Pex19p was affinity purified. Western blot analysis of the GST-affinity purified Pex19p 
revealed that p33HF was readily co-purified with GST-Pex19p, but not with GST (Figure 3.2A, 
lane 1 versus 3).  
To test if the presence of the peroxisomal membrane is important for p33 and Pex19p 
interaction, I repeated the co-purification experiment from pex3D yeast, which lacks peroxisomes 
and peroxisomal “ghosts” or membranes [128-131]. I co-purified p33 from pex3Δ yeast, 
suggesting that the peroxisomal membrane is not necessary for Pex19p-p33 interaction. Since the 
co-purified p33 was less from pex3Δ yeast than from the wt yeast, it is possible that the 
peroxisomal membrane might increase/stabilize the Pex19p-p33 interaction. I also tested if the 3 
mPTS sequences are important for p33 co-purification with Pex19p. These experiments have 
demonstrated that p33DPTS that lacked all three mPTS sequences (Figure 3.1A) was not co-
purified efficiently with GST-Pex19p (Figure 3.2B, lane 3), whereas p33ΔN11 with deletion of 
the N-terminal 11 amino acids [that includes one of the mPTS sequences and an ER-targeting 
sequence [78]], was co-purified with Pex19p (Figure 3.2B, lane 4). Overall, these co-purification 
data from intact yeast cells are in agreement with the in vitro binding experiments, further 
supporting the model that the mPTS sequences in p33 are important for p33 - Pex19p interaction.    
Pex19p is temporarily present in the viral replicase.  
To test if Pex19p is present within the membrane-associated tombusvirus replicase, I 
purified the replicase from yeast actively replicating the TBSV repRNA. I have used a two-step 
purification procedure based on FLAG-6xHis double-tagged p33 solubilized from the membrane 
fraction of yeast lysate that results in a replicase preparation, which still has RNA-dependent 
RNA polymerase activity and contains a small number of host proteins in addition to the viral p33 
and p92pol [17]. Western blot analysis of the two-step purified tombusvirus replicase using anti-
Pex19p antibody revealed trace amount of Pex19p, which was absent in the control preparation 
(Figure 3.3, lane 3 versus 4). The control was prepared using the same procedure, but the sample 
was based on yeast expressing a single 6xHis-tagged p33 [17].  
As Pex19p is known to interact with other peroxins only temporarily [132, 133], I cross-
linked proteins with formaldehyde prior to breaking the cells, followed by the above two-step 
affinity purification. Western blotting with anti-Pex19p antibody revealed that Pex19p was 
present in the highly purified replicase preparation, while it was missing in the control 
preparations (Figure 3.3, lanes 1 versus 2). Altogether, the higher recovery rate for Pex19p in the 
cross-linked samples than in the uncross-linked preparations (Figure 3.3, lanes 1 versus 3) 
supports that Pex19p is likely present in the tombusvirus replicase temporarily.  
Re-targeting Pex19p to the mitochondria leads to redistribution of p33. 
 Finding evidence that supports the relevance of Pex19p in tombusvirus replication is 
challenging for several reasons. First, deletion of PEX19 results in the complete loss of 
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peroxisomes in yeast [130]. Second, p33 is re-targeted to the ER in pex19Δ yeast that could be 
due to the lack of Pex19p or the absense of peroxisomal membranes. Moreover, TBSV replication 
takes place efficiently in the ER membrane in pex19Δ yeast [106], due to apparent functional 
redundancy in the cell that can support TBSV replication.  
To circumvent the above problems, I redirected Pex19p to the mitochondria using a 
strong viral mitochondrial targeting sequence [MTS, derived from the N-terminal portion of 
Carnation Italian ringspot virus, CIRV [134]]. I reasoned that if Pex19p interacts with p33 in the 
cell, then MTS-Pex19p should re-directthe localization of a fraction of p33 to the mitochondria. 
Confocal laser microscopy analysis revealed that p33-YFP co-localized with a mitochondrial 
marker (MTS-CFP) [134] in yeast co-expressing MTS-Pex19p (Figure 3.4., panel A). The co-
localization occurred even at an early time point (7 hours), suggesting that MTS-Pex19p can 
redirectp33-YFP to the mitochondria. Similar mitochondrial localization of p33-YFP was 
observed in pex19Δ yeast expressing MTS-Pex19p (Figure 3.4A, right panels). Over-expression 
of the 6xHis-tagged Pex19p did not lead to co-localization of p33-YFP and MTS-CFP (Figure 
3.4B). Moreover, expression of MTS-CFP in the absence of MTS-Pex19p in wt BY4741 or 
pex19Δ yeast did not lead to co-localization of p33-YFP and MTS-CFP (Figure 3.4C), arguing 
against the possible role of MTS-CFP in the mitochondrial localization of p33-YFP in yeast also 
over-expressing MTS-Pex19p (Figure 3.4A). Altogether, the presented data is in agreement with 
the model that re-targeting of Pex19p to the mitochondria results in re-localization of p33-YFP to 
the mitochondria as well. 
Re-targeting Pex19p to the mitochondria interferes with TBSV repRNA accumulation.  
Re-targeting of the tombusvirus replication proteins to the mitochondria via MTS-Pex19p 
might cause problems during the assembly of the viral replicase, because other key peroxisomal 
membrane proteins, such as Pex3p docking protein, which is localized to the peroxisomes via the 
ER pathway and not via the cytosolic Pex19p-driven pathway [128, 129], will not be present in 
the mitochondrial membrane. To test the effect of re-targeting of MTS-Pex19p-p33 complex to 
the mitochondrial membranes, I measured TBSV repRNA accumulation in yeast cells expressing 
6xHis-tagged MTS-Pex19p. These experiments have shown 60% reduction in TBSV repRNA 
accumulation when compared with yeast expressing a short peptide from the pYES plasmid 
(compare lanes 4-6 with 10-12 in Figure 3.5A). Additional control was yeast expressing 6xHis-
tagged Pex19p, which affected TBSV repRNA accumulation by less than 30% in wt yeast, 
whereas expressing HisMTS did not affect repRNA accumulation (Figure 3.5A, lanes 1-3 and 7-
9). The trend was similar in pex19Δ yeast, in which the re-targeted 6xHis-tagged MTS-Pex19p 
inhibited TBSV repRNA accumulation (lanes 16-18), while the control proteins did not. Overall, 
these data are consistent with a model that the re-targeted MTS-Pex19p can interfere with TBSV 
replication. 
Since the expression level of 6xHis-tagged MTS-Pex19p was low in yeast (Figure 3.5B, 
lanes 4-6 and 16-18), I also expressed MTS-Pex19p, which was expressed to a level comparable 
to that of His-Pex19p (Figure 3.5C). In these experiments, I used p33-YFP, and p92H replication 
proteins to support TBSV repRNA replication, because the evidence on re-distribution of p33 to 
the mitochondria was obtained using this system (see Figure 3.4). I found that expression of 
MTS-Pex19p inhibited TBSV repRNA accumulation by 70-75% in wt and pex19Δ yeast (Figure 
3.5C), confirming the dominant negative effect of MTS-Pex19p on TBSV replication.  
Re-targeting Pex19p to the mitochondria decreases the efficiency of the tombusvirus 
replicase. 
 Re-targeting of the tombusvirus replication proteins to the mitochondria via expression 
of the dominant negative MTS-Pex19p could inhibit TBSV replication due to several reasons, 
including affecting the assembly of the viral replicase. To test if the viral replicase is active in 
yeast expressing MTS-Pex19p, I isolated the tombusvirus replicase, which was present in a 
membrane-enriched fraction. This replicase preparation is highly active in vitro [75, 82], as 
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shown in the control sample obtained from yeast expressing a short peptide from pYES plasmid 
(Figure 3.6A, lanes 10-12). On the contrary, the replicase preparation obtained from yeast 
expressing MTS-Pex19p showed poor replicase activity (down by 80%, Figure 3.6A, lanes 1-3), 
albeit the amount of p33 replication protein was comparable to the control samples (Figure 6B, 
lane 3 versus lanes 1 and 2). The additional control replicase samples obtained from yeast 
expressing either 6His-tagged Pex19p or MTS-CFP showed 100% and 70% activities, 
respectively (Figure 3.6A, lanes 4-9). Overall, the in vitro assays revealed that the activity of the 
tombusvirus replicase is poor when isolated from yeast expressing the functional viral replication 
proteins in the presence of the re-targeted MTS-Pex19p.     
  
DISCUSSION 
 The assembly of replicase complexes of (+)RNA viruses requires the targeting of the 
viral replication proteins from the site of translation (cytosol or rough ER) to specialized 
subcellular membranes [111, 135]. For example, the tombusvirus p33 and p92pol replication 
proteins are targeted to the peroxisomal membranes in plant and wt yeast cells [30, 78]. For the 
targeting of the viral replication proteins, tombusviruses might take advantage of host proteins 
involved in subcellular protein transportation. Indeed, this work shows evidence that Pex19p 
could serve as a transporter for the p33 replication protein in the yeast model host. The following 
evidence has been obtained: (i) the binding of Pex19p to p33 requires the 3 mPTS sequences in 
p33, which are also known to be essential for peroxisomal targeting in plant cells [78]; (ii) 
Pex19p was shown to be present, at least temporarily, in the viral replicase complex (Figure 3.3); 
(iii) re-targeting the Pex19p to the mitochondria has led to re-distribution of p33 to the 
mitochondria as well; (iv) Pex19p with the mitochondrial targeting sequence had a dominant 
negative effect on TBSV repRNA accumulation; and (v) expression of the MTS-Pex19p also 
reduced the activity of the tombusvirus replicase.  
Based on the above evidence, I propose that Pex19p is the primary transporter of 
tombusvirus p33 replication protein (Figure 3.7, step 1), and likely p92pol as well due to the 
presence of overlapping sequence at the N-terminus of p92pol and the requirement of the N-
terminal region of p92pol for peroxisomal localization [30]. It is also possible that a fraction of 
p92pol is ‘piggy-backing” on p33 to reach to the peroxisomal membranes [30]. Based on the 
proposed function of Pex19p in yeast, it is likely that the Pex19p-p33 complex can directly reach 
the peroxisome from the cytosol (Figure 3.7A, step 2), without entering the ER or the Golgi 
compartment [130, 133]. After reaching the peroxisomal membrane, the Pex19p-p33 complex 
might bind to Pex3p, which is the docking protein for Pex19p [136]. Binding to Pex3p might 
facilitate the unloading of the cargo p33 from Pex19p, which could then be recycled to the 
cytosol for new rounds of transport (Figure 3.7A, step 3). 
What makes the function of Pex19p in tombusvirus replication difficult to study is the 
presence of a default pathway that targets p33/p92pol efficiently to the ER in the absence of the 
peroxisomes [30, 106, 126]. Thus, the function of Pex19p is not essential for tombusvirus 
replication in yeast. Yet, re-targeting of Pex19p to the mitochondria inhibited TBSV replication 
and reduced the activity of the viral replicase. This dominant negative function of MTS-Pex19p 
suggests that the peroxisomal pathway for tombusviruses is the primary pathway, while the ER 
targeting pathway is secondary. Moreover, I interpret the dominant negative effect of MTS-
Pex19p as the consequence of the inappropriate environment in the mitochondrial membrane for 
assembling fully functional viral replicase complexes. It is possible that the short N-terminal 
sequence of p33 adapted to the peroxisomal membrane is not fully functional when inserted into 
the outer membrane of the mitochondria. In addition, the MTS-Pex19p - p33 complex could be 
more stable in the mitochondrial membrane due to the absence of Pex3p docking protein than in 
the peroxisomal membrane where Pex3p is present to recycle Pex19p. Also, due to the 
transmembrane domains within the MTS sequence, MTS-Pex19p likely stays integrated into the 
mitochondrial membrane, where it could inhibit p33 functions. Unfortunately, I cannot study the 
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effect of Pex19p - p33 complex on the viral replicase in the peroximal membrane in the absence 
of Pex3p, because there are no peroxisomes present in pex3Δ yeast [128, 133].  
I should mention that the mitochondrial environment could be supportive for 
tombusviruses, since CIRV does replicate on the surfaces of the mitochondria [134]. In addition, 
re-targeting CyRSV p33/p92 proteins from peroxisomes to the mitochondria via replacing the 
mPTS-carrying N-terminal sequence with the longer MTS sequence in p33/p92pol resulted in 
active CyRSV replication [137, 138]. However, I have to point out that, in these experiments, the 
mitochondrial transport system was likely recruited by the chimeric tombusvirus replication 
proteins carrying MTS, thus resulting in proper transport and unloading of the replication proteins 
to the outer membrane of the mitochondria. Alternatively, the original N-terminal sequence of 
p33 does not have the optimal sequence for the proper insertion to the mitochondrial membrane, 
unlike the chimeric MTS-p33/p92pol proteins that carried the entire N-terminal portion of CIRV 
p36 protein, which are adapted to the mitochondrial membrane, where CIRV replicates [134]. 
Altogether, in our experiments, the p33 tombusvirus replication protein did not have MTS, and 
therefore its transport, unloading and/or insertion to the outer membrane of the mitochondria as 
the MTS-Pex19p / p33 complex could have taken place "improperly", thus, inhibiting the 
assembly/function of the viral replicase complex. 
The known cellular functions of Pex19p fit well with the proposed role in p33 
transportation to the peroxisomes. Pex19p is a cytosolic chaperone protein that binds to selected 
peroxin proteins and targets them for insertions to the peroxisomal membranes with the help of 
the Pex3p docking protein [132, 133, 136]. Re-cycling of the Pex3p after cargo delivery to the 
cytosol allows the multiple use of this protein for transport. Altogether, this work adds Pex19p as 
a new host factor to the growing list of host factors that are involved in tombusvirus replication. 
Future experiments will address if Pex19p is also involved in recruitment of additional host 
proteins to the viral replicase complex.     
 
MATERIALS AND METHODS 
Yeast strains.  
Saccharomyces cerevisiae strains BY4741α (MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0) and its 
derivatives Pex19Δ and Pex3Δ were obtained from Open Biosystems (Huntsvwelle, AL, USA). 
The yeast GST-ORF over-expression library was provided by Dr Brenda Andrews, University of 
Toronto, Ontario, Canada.  
Yeast and Escherichia coli plasmids.  
pEG(KT/KG)-GST6xHis-pex19 and pEG(KT/KG)-GST6xHis were from the yeast GST 
library [139]. pESC-DI72-p33, co-expressing 6xHis-tagged p33 of CNV from the GAL1 promoter 
and TBSV DI-72 repRNA from the GAL10 promoter was obtained as follows: The p33 ORF with 
the N-terminal 6xHis-tag was amplified by high-fidelity PCR using primer #1402 
(GCGGCAGATCTTACCAT-GGGGGGTTCTCA) and #1403 
(GCCGCTCGAGCTATTTCACACCAAGGGACTCA) and then ligated to pESC vector 
(Invitrogen) digested with BamHI and XhoI. In addition, the full-length cDNA of DI-72(+), 
including the 3' ribozyme [82] was cloned between EcoRI and SacI sites. Construct pESC-DI72-
YFPp33 expressing 6xHis-tagged p33 and the yellow fluorescent protein (YFP) at the N-terminus 
from the GAL1 promoter was described earlier [30, 106]. Plasmids pGBK-HF33 and pGAD-
HF92 expressing 6xHis/FLAG-tagged p33 and 6xHis/FLAG-tagged p92, respectively, were 
described previously [17]. pHisGBK-His33 and pGAD-His92, expressing 6xHis-tagged p33 and 
6xHis-tagged p92, respectively from the constitutive ADH1 promoter were described [13]. 
For the in vitro binding assays, I used pMAL-33 (full length), pMAL-33C, and pMAL-empty 
as described earlier [28]. To obtain pMAL-p33ΔN11, a portion of p33 ORF was amplified by 
PCR using primers #2020 (GAGGAATTCGAAATTTTTATTGGCACGTTC) and #871 
(CCCGTCTAGAGGCCTCCCTATTTCACACCAAGGGA), followed by cleavage with EcoRI 
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and XbaI and dwerectional cloning into vector pMAL-c2X digested with same pair of restriction 
enzymes. pMAL-p33ΔPTS was constructed by a a two-step ligation of p33 cDNA fragments. The 
5' portion of the p33 ORF was amplified with PCR using primers #2020 and #1703 
(GCCGCTAGCCCATTTGGCTGCACAATCTGT), followed by treatment with EcoRI and NheI. 
A 3' portion downstream from the 130 aa position of p33 was amplified using primers #2041 
(GCCGCTAGCCCTAAGAAAGGCTTGCTACTG) and #871, followed by cleavage with NheI 
and XbaI. After gel-isolation of both PCR products, I ligated them and then used PCR with 
primers #2041 and #871 to amplify the correctly ligated PCR product. The obtained PCR product 
was cloned into pMAL-c2X digested with EcoRI and XbaI. 
To obtain pESC-DI72-HisFLAGp33, the p33 ORF together with the N-terminal 6xHis/FLAG 
tag was amplified from pGBK-HF33 [17] by using primers #1402 
(GCGGCAGATCTTACCATGGGGGGTTCTCA) and #1403 (GCCGCTC-
GAGCTATTTCACACCAAGGGACTCA) digested with BglII and XhoI and then ligated to 
pESC digested with BamHI and XhoI. For generating the pESC-HisFLAGp33ΔN11 and pESC-
HisFLAGp33ΔPTS, the ORFs of p33ΔN11 and p33ΔPTS were amplified by PCR from pMAL-
p33ΔN11 and pMAL-p33ΔPTS using primers  #2222 
(CGACGGATCCAAAGAAATTTTTATTGGCACGTTCGCGA) and #1403 
(GCCGCTCGAGCTATTTCACACCAAGGGACTCA), followed by digestion of the PCR 
product with BamHI and XhoI and cloning into pESC-HisFLAGp33 plasmid digested with the 
same pair of restriction enzymes.  
To obtain pYES-HIS-PEX19, the PEX19 ORF was amplified by PCR from yeast genomic 
DNA with primers #1915 (CCCGGATCCATGCCAAA-CATACAACACGAAGTAATG) and 
#1916 (CCCCTCGAGTTATTGTTGTTT-GCAACCGTCGGT), followed by cloning into pYES 
at BamHI and XhoI sites.  
To generate pYES-MTS-PEX19, the first 666 base pairs of CIRV p36 ORF sequence 
(containing the MTS) was amplified from pGAD-CIRVp95 by PCR using primers #969 
(CCGCGAAGCTTAAAGAT-GGAGGGTTTGAAGGCTGAGTCT) and #2609 
(CCAGGGATCCATCC-TTACCCTTGAGCTC), followed by ligation with PEX19 cDNA 
generated by PCR using primers #1915 and #1916 via three-piece ligation into pYES digested 
with HindIII and XhoI. 
To construct pYES-MTS-CFP and pGAD-MTS-CFP, I PCR-amplified the MTS of CIRV 
p36 ORF sequence amplified from pGAD-CIRVp95 by PCR using  #969 
(CCGCGAAGCTTAAAGATGGA-GGGTTTGAAGGCTGAGTCT) and #2609 
(CCAGGGATCCATCCTTACCCTTGAGCTC), followed by ligation to the CFP ORF, PCR-
amplified from pYES-CFP using primers #1291 
(CGGCGGATCCGTGAGCAAGGGCGAGGAGCTGTTCA) and  
#2044 (CGACCTCGAGTCATCTAGACTTGTACAGCTCGTCCATGC). Three-piece-based 
cloning into pYES-NT/C resulted in pYES-MTS-CFP, and cloning into pGAD generated pGAD-
MTS-CFP.  
To construct pYES-HIS-MTS-PEX19, I PCR amplified the MTS-PEX19 ORF from the 
expression plasmid pYES-MTS-PEX19 using primers #642 
(GGAGGAATTCATGGAGGGTTTGAAGGC) and #1916, followed by cloning into the multiple 
cloning site of pYES-NT/C via EcoRI and XhoI sites. 
To generate pYES-HIS-MTS, the 5' 684 base pairs of CIRV p36 ORF sequence was 
amplified from pGAD-CIRVp95 by PCR using primers #642 
(GGAGGAATTCATGGAGGGTTTGAAGGC) and #2692 
(GGACTCGAGTTACCGAGCAGGCTCAACCAA) and then cloning into pYES-NT/C via 
EcoRI and XhoI sites. To construct pYES-HIS-PEX19-N206, the 5’ portion of PEX19 ORF 
representing the N-terminal 206 aa was PCR amplified using primers #1915 
(CCCGGATCCATGCCAAACATACAACACGAAGTAATG) and #2290 
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(CCCTCGAGTTATGTTATTGCGTCGTCCATCTC) and cloned into pYES/NT-C digested with 
BamHI and XhoI. 
The source of Antibodies for Western blotting.  
I used the following antibodies in standard Western blotting as described [67]: Anti-His 
(dilution of 1:20000) from GE Healthcare, Piscataway, NJ, USA; Anti-FLAG (dilution of 
1:10000) from Sigma-Aldrich, St Louis, MO, USA; Anti-GST (dilution of 1:2000) from Santa 
Cruz Biotechnology, Inc Santa Cruz, CA. USA. Anti-pex19 (dilution of 1:20000) from Dr. R. 
Erdmann, Bochum, Germany; Anti-Mouse conjugated Alkaline Phosphatase (dilution of 
1:20000) from Sigma-Aldrich St Louis, MO, USA; Anti-Rabbit Alkaline Phosphatase (dilution of 
1:5000) from Sigma-Aldrich, St Louis, MO, USA; and Anti-Mouse Horse Radish Peroxidase 
(dilution of 1:15000) from Bio-Rad, Hercules, CA, USA. 
In vitro pull-down assay with recombinant p33.  
The recombinant TBSV p33, and its derivatives p33ΔN11, p33ΔPTS and p33C (the C-
terminal half of p33, Figure 3.1A) were expressed as fusion proteins with maltose binding protein 
(MBP) in E. coli Epicurian BL21-CodonPlus (DE3)-RIL (Stratagene, La Jolla, CA, USA) and 
purified as described earlier [26, 28]. The purified recombinant MBP-p33, its derivatives and 
MBP were bound to amylose beads as described [28]. 
Yeast strains expressing GST/6xHis-tagged Pex19p or only GST/6xHis as a control were 
from the yeast GST-ORF library, in which the expression is driven by GAL1 promoter [139]. 
Yeast cells were first pre-grown in SC-U- with 2% glucose at 29°C and then in SC-U- media with 
2% galactose at 29°C until mid-logarithmic phase (an optical density at 600 nm = 0.8-1.0). Cells 
were suspended in binding buffer (20 mM Tris pH 7.5, 100 mM NaCl, 1mM EDTA, 10% 
Glycerol, 0.1% NP-40, 10 mM β-mercaptoethanol and 1% yeast protease inhibitor mix) and were 
broken using Talboys™ high throughput homogenizer (Thorofare, NJ, USA). The total yeast 
lysate was cleared by centrifugation at 21,000 × g for 10 min at 4°C and then it was loaded on 
either MBP-p33 or MBP-immobilized amylose beads. The binding reaction was performed at 4°C 
for 1 hour with gentle rotation. This was followed by washing the beads twice with 1 column 
volume of binding buffer containing 100 mM NaCl, followed by two washings of 150 mM NaCl 
binding buffer and finally with two more washings of binding buffer containing 200 mM NaCl. 
Proteins retained on the beads were eluted by incubation in SDS-PAGE loading buffer at 85°C 
for 10 min and centrifugation. Samples were subjected to SDS-PAGE followed by Western 
blotting with anti-His antibody as described [75].  
GST-based pull-down of cross-linked Pex19p complex.  
Yeast BY4741 and pex3Δ strains were co-transformed with pEG(KT/KG)-GST6xHis-
pex19 and pESC-HisFLAGp33 or with pESC-HisFLAGp33 and pEG(KT/KG)-GST6xHis as a 
control. For additional analysis, BY4741 strain was also co-transformed with pEG(KT/KG)-
GST6xHis-pex19 and pESC-HisFLAGp33ΔN11 or pESC-HisFLAGp33ΔPTS. Transformed 
yeast cells were cultured in 15-ml culture tubes containing 3 ml SC-UH- (2% glucose) media for 
24 h at 29°C. Yeast cells were pelleted, and washed with SC-UH- (2% galatose) media, followed 
by inoculation to 200 ml SC-UH- (2% galatose) and culturing at 29°C until reaching A600 0.8-1.0. 
Yeast was pelleted, and washed once with 1X Phosphate Buffered Saline (PBS) buffer, then 
suspended in 200 ml 1X PBS buffer, and cooled on ice. The yeast cells then were treated with 5.5 
ml of 37% formaldehyde (1% final concentration) and incubated for 1 h on ice. The cross-linking 
reaction was stopped by quenching in 10 ml 2.5 M glycine (final concentration 0.125 M). Yeast 
was then pelleted, washed once with 1X PBS buffer, and stored at –80°C. This was followed by 
breaking yeast cells in the lysis buffer (1X PBS, 10% Glycerol, 1mM EDTA, 0.1% NP-40, 1% 
yeast protease inhibitor cocktail™ [Sigma-Aldrich] and 10mM β-mercaptoethanol) using a 
homogenizer as described above. The unbroken cells were removed by centrifugation at 100g for 
5 min. The total yeast lysate was solubilized in the lysis buffer also containing 0.5 M NaCl and 1 
% NP-40 via rotation at 4°C for 1 h, followed by further incubation at 37°C for 5 min and snap 
45 
chilling on ice. The solubilized membrane fraction was centrifuged at 21,000 g for 10 min at 4°C. 
The supernatant was loaded onto GST-resin (Bio-Rad™ Spin chromatography column) 
equilibrated twice with the lysis buffer with 0.5 M NaCl and 1% NP-40. The samples were 
rotated for 1 h at 4 oC. The affinity column was drained by gravity flow, washed twice with 600 
µl lysis buffer containing 0.5 M NaCl and 1 % NP-40, and then twice with 600 µl lysis buffer, 
followed by centrifugation at 1000 g for 2 min. The bound proteins were then recovered from the 
column in 50mM Tris buffer containing 20mM glutathione in a two-step elution. Finally, the 
protein samples were incubated at 100°C for 20 min to reverse cross-linking, and mixed with the 
SDS sample buffer and subjected to SDS-PAGE and Western blotting using anti-FLAG antibody. 
The detection of FLAG was via chemiluminescence according to manufacturer’s 
recommendations (GE Healthcare, Piscataway, NJ, USA).  
A two-step His/FLAG affinity-based co-purification of the viral replicase and Pex19p.  
This procedure is the modification of a previously published approach [17]. Briefly, yeast 
SC1 strain was transformed to express 6xHis/FLAG-tagged p33 or only 6xHis-tagged p33 
together with plasmids expressing p92 and DI-72 repRNA. The yeast were grown at 23°C until 
reaching OD600 0.8-1.0. 200 mg of yeast was resuspended and homogenized in TG buffer (50 mM 
Tris-HCl [pH 7.5], 10% glycerol, 15 mM MgCl2, and 10 mM KCl) buffer supplemented with 0.5 
M NaCl, 0.1% Nonidet P-40 (NP-40), and 1% yeast protease inhibitor cocktail by glass beads 
using Talboys™ high throughput homogenizer (Thorofare, NJ, USA). The cell debris was 
removed by centrifugation for 5 min at 100 × g at 4°C. The enriched membrane fraction 
containing the active viral replicase complex was collected by centrifugation for 15 min at 21,000 
× g at 4°C and then solubilized in 1 ml TG buffer with 0.5 M NaCl, 1% NP-40, 5% SB3-10 
[caprylyl sulfobetaine] [Sigma] via gentle rotation for 2 h at 4°C. The samples were then 
incubated at 37°C for 5 min and centrifuged at 21,000 × g at 4°C g for 15 min. 5mM imidazole 
was added to the supernatant, followed by gentle rotation for 1 h at 4°C with ProBond resin 
(Invitrogen) pre-equilibrated with TG buffer supplemented with 0.5 M NaCl and 1% NP-40 and 
5% SB3-10. The unbound materials were removed by gravity flow, and the resin was washed 
twice with TG buffer supplemented with 0.5 M NaCl, 1% NP-40, and 1% SB3-10. The resin-
bound proteins were eluted in 200 µl TG buffer supplemented with 0.5 M NaCl, 1% NP-40, 1% 
SB3–10 and 300 mM imidazole. The eluates were then loaded onto anti-FLAG M2-agarose 
affinity gel (Sigma) pre-equilibrated with 0.6 ml TG buffer supplemented with 0.5 M NaCl, 1% 
NP-40, 1% SB3–10 and 1% yeast protease inhibitor cocktail. After 2 h gentle rotation at 4°C, the 
unbound materials were removed by gravity flow and the resin-column was washed 3 times with 
1 ml TG buffer with 0.5 M NaCl, 1% NP-40, and 1% SB3-10 and twice with 1 ml TG buffer with 
150 mM NaCl and 0.1% NP-40. Proteins bound to affinity bead were eluted by incubating in 
SDS-PAGE loading buffer at 85 °C for 10 min and the subjected to SDS-PAGE and Western 
blotting with anti-Pex19 antibodies (generous gift from Dr. R. Erdmann).  
 
Confocal laser microscopy. 
  Yeast strains BY4741 and pex19Δ were co-transformed with pESC-DI72-YFPp33 under 
GAL1 promoter, pGAD-MTS-CFP (as mitochondrial protein marker) under ADH1 promoter and 
pYES-MTS-PEX19 or pYES-PEX19 behind GAL1 promoter. In another set of experiments, 
above strains were transformed with GAL1 controlled pYES-MTS-CFP and pESC-DI72-
YFPp33. Yeast transformants were pre-grown in SC-ULH- media supplemented with 2% glucose 
for 16 hrs at 29 °C and then transferred to 2% galactose media, followed by shaking at 29 °C. 
Samples were collected at 7 h and 24 hours for confocal microscopy. Confocal laser scanning 
micrographs were acquired on a Olympus FV1000 microscope (Olympus America Inc., Melville, 
New York) as described earlier [106].  ECFP was excited using 440 nm laser light, attenuated to 
4.5-11.0% of the maximum laser power, while EYFP was excited using 515 nm laser line (3.5-
8.0% of the maximum laser power). The images were acquired using sequential line-by-line 
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mode in order to reduce excitation and emission cross-talk. The primary objective used was a 
water-immersion PLAPO60XWLSM (Olympus). Image acquisition was conducted at a resolution 
of 512x512 pixels and a scan-rate of 10 ms/pixel. Image acquisition and exportation of TIFF files 
were controlled by using Olympus Fluoview software version 1.5. Figures of micrographs were 
assembled using Photoshop 9.0 (Adobe Systems Incorporated, San Jose, CA).  
Replication assay.  
The p92 replication protein with N-terminal 6xHis-tag was expressed constitutively in S. 
cerevisiae strains from pGAD-His92 plasmid under ADH1 promoter, while the 6xHis-tagged p33 
and the full-length DI-72(+)RNA were launched from a dual-expression construct, pESC-DI72-
p33 based on the galactose-inducible GAL1 and GAL10 promoters, respectively. Pex19p and its 
mutant derivatives were expressed under GAL1 promoter. Yeast strains (BY4741 and pex19Δ) 
were pre-grown in SC-ULH− medium containing 2% glucose. After 16 h shaking at 29°C, the 
cultures were transferred to 2% galactose media and grown for additional 24 h at 29°C.Total 
RNA extraction and Northern-blotting was performed as described [21] using probe RIII/IV(−), 
which selectively binds to the 3′ end region of the plus-stranded TBSV DI-72 RNA. The 
quantitative analysis was performed using phospho-imaging with a Typhoon (GE) instrument as 
described [21, 82]. 
In vitro replicase assay.  
The isolation of the membrane-enriched fraction from yeast was similar to that developed 
earlier [75, 82]. The template activities of the obtained replicase preparations were tested after 
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Figure 13 Figure 3.1. In vitro interaction between Pex19p and p33 depends on the 
redundant peroxisomal targeting sequences in p33.  
 
(A) Schematic representation of known domains in p33 and its deletion derivatives used in this 
study. PTS is the peroxisomal targeting sequence; TMD is the predicted transmembrane domain; 
P indicates phosphorylation site; RPR is a proline-arginine-rich motif involved in viral RNA 
binding; while S1 and S2 represent subdomains involved in p33:p33/p92 interactions. The deleted 
sequences are represented with thin lines. (B) A pull-down experiment demonstrates interaction 
between p33 and Pex19p in vitro. The purified recombinant MBP-p33 or the controls MBP were 
immobilized on affinity beads. GST-Pex19p (top panel) or the control GST (bottom panel), both 
of which carry a 6xHis tag, were expressed in yeast and the yeast lysates were applied to the 
affinity columns with immobilized MBP-p33 or the control MBP. This panel shows the Western 
analysis (lanes 1-2 and 5-9) with anti-His antibody or the coomassie blue stained gel (lanes 3-4). 
(C) Western blot analysis of GST-Pex19p bound to the affinity columns with immobilized MBP-
p33 derivatives or MBP as a control. (D) A pull-down experiment demonstrates the lack of 
interaction between p33 and a Pex19p mutant in vitro. Pex19p-N206 lacks the C-terminal 137 



























Figure 14 Figure 3.2. Co-purification of p33 with Pex19p from yeast. 
 
 (A) GST-Pex19p or GST were purified via GST-affinity purification from the wt (BY4741) and 
pex3Δ yeast co-expressing the FLAG/6xHis-tagged p33HF. Proteins were cross-linked with 
formaldehyde in intact yeast cells, followed by quenching with glycine, breaking the cells and 
affinity purification. The Western-blotting was done with anti-FLAG antibody to detect the co-
purified p33HF (lanes 1-4). Total proteins were analyzed with Western blotting using anti-GST 
antibody (lanes 5-8). (B) Demonstration of co-purification of p33 derivatives with GST-Pex19p. 
The Western-blotting was done with anti-FLAG antibody. See further details in panel A. Asterisk 
marks the co-purified minute amount of p33ΔPTS. 
 
 






























































Figure 15 Figure 3.3. Temporary presence of Pex19p in the viral replicase preparation.  
 
Protein cross-linking was done in intact yeast cells as described in Figure 3.2. The yeast cells 
expressed p33 from a plasmid and wt Pex19p from its natural chromosomal location. The 
membrane-enriched fraction of yeast was solubilized with 1% NP-40 + 5% SB3-10 detergents, 
followed by a two-step affinity purification of p33HF based on nickel and FLAG columns. The 
presence of Pex19p was detected with Western blotting of the proteins eluted from the affinity 
columns using anti-Pex19p antibody. Note that the control p33H (single 6xHis-tagged) samples 
were also used for two-step purification to identify nonspecific binders to the columns. The 
position of the wt monomeric Pex19p is marked with an arrow. The trace amount of Pex19p 
present in the purified sample obtained without cross-linking is indicated with an asterisk. A 
slower migrating Pex19p-specific band in the purified samples could be either Pex19p dimer or 
Pex19p-p33 heterodimer (not fully denatured by heating the samples at 100 0C). The presence of 
this band does not change the interpretation of the data, because it is only present in the samples 
also containing p33HF and monomeric Pex19p (lanes 1 and 3), excluding that it is a 






Figure 16 Figure 3.4. Re-targeting Pex19p via an MTS sequence leads to mitochondrial 
localization of a fraction of p33 replication protein.  
 
(A) Confocal laser microscopy analysis of subcellular localization of p33 in the presence of 
mitochondrial-targeted Pex19p. The images were taken at 24 or 7 hours time points. MTS-
Pex19p and p33-YFP were expressed from the GAL1 promoter, whereas the mitochondrial 
marker MTS-CFP was expressed from ADH1 promoter in wt BY4741 (left panels) or pex19Δ 
(right panels) yeast cells. (B) Confocal laser microscopy analysis of subcellular localization of 
p33 in the presence of cytosolic Pex19p (6xHis-tagged). A false color, blue/red image is shown 
on the right to highlight the lack of co-localization in the merged image. See further details in 
panel A. (C) Confocal laser microscopy analysis of subcellular localization of p33 in the presence 
of mitochondrial-targeted CFP. Note that the expression of MTS-CFP did not result in re-





Figure 17 Figure 3.5. Dominant negative effect of the mitochondrial targeted MTS-Pex19p 
on TBSV replication.  
 
(A) Northern blot analysis of TBSV repRNA accumulation in BY4741 (left panels) or pex19D 
(right panels) yeast cells co-expressing the 6xHis-tagged MTS-Pex19p with p33/p92/repRNA. 
The control yeast samples contained 6xHis-tagged Pex19p, 6xHis-tagged MTS sequence and a 
short peptide from pYES. RepRNA accumulation in yeast carrying pYES was taken as 100%. 
The 18S ribosomal RNA was used as a loading control. Quantification was done with Imagequant 
software. The experiments were repeated 3-8 times. (B) Western blot analysis of p33 (6xHis-
tagged) and the co-expressed proteins using anti-His antibody. Asterisks point at the host proteins 
expressed with various tags as shown. The yeast samples were the same as used for Northern 
blotting in panel A. (C) Accumulation of repRNA in BY4741 (left panels) or pex19D (right 
panels) yeast cells co-expressing MTS-Pex19p (without extra-tag) and p33/p92/repRNA. I 
analyzed 12 independent samples per experiment. See further details in panel A. The Western 
blot (bottom panel) was done using anti-His antibody.  
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Figure 18 Figure 3.6. Reduced replicase activity of preparations obtained from yeast 
expressing the mitochondrial targeted MTS-Pex19p.  
 
(A) Standard tombusvirus replicase assays with membrane-enriched fraction prepared from 
BY4741 yeast cells expressing MTS-Pex19p, 6xHis-tagged Pex19p, MTS-CFP or a short peptide 
from pYES are shown. Note that these replicase preparations contain the co-purified repRNA, 
which is used as a template during the in vitro assay in the presence of 32P-UTP and cold 
additional ribonucleotides. The replicase activity of the preparation obtained from yeast carrying 
pYES was taken as 100%. (B) Western blot analysis of p33-YFP (6xHis-tagged) and the co-
expressed proteins using anti-His antibody. The yeast samples were the same as used in the 





Figure 19 Figure 3.7. A model for the proposed transporter function of Pex19p during 
tombusvirus replication.  
 
(A) In the wt yeast cells, the cytosolic Pex19p is proposed to bind to p33 replication co-factor 
after translation and shuttle p33, which likely forms a multiprotein-viral RNA complex as shown, 
to the peroxisomal membrane. There, the membrane-bound Pex3p “cargo-docking” protein might 
help unloading the p33 cargo and recycling the Pex19p protein to the cytosol. (B) In the absence 
of Pex19p in pex19D yeast, an unknown host protein, shown as host factor X, is suggested to 
transport the p33/multiprotein-viral RNA complex to the ER as a default mechanism [106]. Note 
that TBSV replication is as efficient in the ER as in the peroxisomes. (C) I propose that the MTS-
Pex19p targeted to mitochondria facilitates the re-localization of p33 to the outer membrane of 
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the mitochondria, where p33 might be less efficient in assembling the functional tombusvirus 




















































Chapter 4. Protein-protein interaction domain of Cucumber necrosis virus p33 and p92 is 
needed for viral RNA binding and assembly of replication complex 
 
INTRODUCTION 
 Positive strand (+) RNA viruses are the largest group of viruses affecting plants and 
animals. Their genome is gene-deficient when compared to the genomes of their hosts. To 
compensate for a lack of their own proteins, (+)RNA viruses usurp host proteins [5, 7, 113] and 
exploit their limited genetic information to get maximum number of proteins [140].  Apart from 
polymerase proteins, most of the (+) RNA viruses code for multi-functional ancillary replication 
proteins. Viral RNA translation, replication and virion assembly depend upon the ability of viral 
proteins to interact with themselves, other viral proteins, viral RNA and cellular proteins. Viral 
replication proteins perform several functions important for replication like:  selectively 
recognizing the RNA template, followed by recruiting the RNA to the site of replication, 
targeting cellular membranes followed by assembling replicase complexes and finally producing 
the progeny RNAs (reviewed by [68] and [27].  The emerging picture is that almost all of the 
above-mentioned processes utilize viral protein-protein interactions. With a deeper understanding 
of the biochemistry of protein-protein interaction during viral multiplication it has become 
possible for virologists to develop chemical inhibitors that can specifically disrupt the viral 
protein-protein complexes and thus jeopardize viral functions [141]. Many examples for critical 
protein-protein interaction exist for virus replication; e.g. BMV protein 1a via interacting to other 
1a and 2a molecules forms replication complexes on ER membranes [142, 143]. Another example 
is from Tobacco mosaic virus (TMV) 126K that is also known to interact with other 126K 
molecules and the polymerase 186K. Using temperature sensitive mutants of the same this 
interaction was shown to be critical for viral replication [144, 145]. Other examples of interaction 
between replication proteins important for (+)RNA viral replication are: poliovirus [146-148]. 
Hepatitis C virus [reviewed by [149]], cucumovirus [150] and potyviruses [151]. In general, there 
are many evidences of protein-protein interaction of viral replication proteins but detailed 
mechanisms by which this affects viral replication is not fully elaborated.  
Apart from the polymerase p92, TBSV codes for p33, a multifunctional protein, which 
also forms the NH2-terminal third of p92, latter being a translational read-through product of p33. 
These two proteins are indispensable for viral replication both in plant and yeast a model host 
[13].  Other TBSV proteins are expressed via two subgenomic RNAs are involved in virion 
assembly, cell-to-cell movement, and suppression of gene silencing [27, 68]. The auxiliary 
replcation protein p33 is emerging as a major player in TBSV/CNV replication by regulating 
various steps in the viral replication like: (i) specifically binding to the viral RNA via RPR 
domain [25, 28] (ii) recruiting the RNA and other proteins to site of replication via two 
transmembrane domains and three peroxisomal targeting signals [30, 80, 152] (iii) ubiquitination 
of p33 to regulate the ESCRT pathway is crucial in formation of replication complex [95, 153] 
(iv) binding to multiple host proteins viz. Ssa1p , Tdh1p, Cpr1p, pex19p, Tef1p [19, 76, 80, 85, 
89] that is important for successful replication and (v) also has RNA chaperone activity [96].  
The importance of ability of p33 to interact with p33/p92 was discovered using 
systematic site-specific single amino acid mutations [26] . The study revealed two subdomains S1 
and S2 important in p33:p33/p92 interaction. Also the tyrosine and arginine at 244 and 246 
positions respectively were found to be critical for viral RNA replication [26]. In follow up work 
surface plasmon resonance (SPR) was used to study the kinetics of this interaction which revealed 
that S1 sub-domain has stronger affinity to other S1  [32].  Also the correlation among interaction   
 




data and replication was found. The replication studies were conducted in vivo so each or all of 
the steps during replication process like: template selection, recruitment, replicase assembly and 
RNA synthesis could have been affected because of a lack of interaction between p33:p33/p92. 
This lack of pinpoint detail was addressed in this study. 
This chapter describes the novel use of cell free yeast extract based (CFE) replication 
system to figure out the exact mechanism by which interaction among p33 and p92 affects 
CNV/TBSV replication. Recently, CFE has been developed that can launch an authentic RNA 
replication using membranes, host factors, a TBSV defective interfering RNA DI72(+) as a 
replicon (repRNA) and E. coli purified p33 and p92 [73].  
I studied the S1 and S2 single amino acid mutants in the CFE replication system and 
found strong correlation between interaction and viral RNA replication. In vitro gel-shift assays 
showed deficient viral RNA binding ability by some mutants.  Assembly of replicase complex 
was the final step that was negatively affected due to mutations in the S1/S2 sub-domains. Some 
mutants showed strong inhibition of replication launched even by wild type p33/p92. This 
inhibitory effect was gone if already assembled and purified replicase from Turnip crinkle virus 
(TCV) or Cucumber necrosis virus (CNV) was tested. These data not only establish the role of 
protein-protein interaction for RNA template selection and replicase assembly but also adds 






S1/S2 sub-domains mutations abolish TBSV replication.  
Previously, using yeast two hybrid and Surface Plasmon Resonance (SPR) assays, 
Rajendaran and co-workers showed that TBSV replication proteins p33 and p92 interact with 
themselves via two subdomains S1 (241-252 amino acid positions) and S2 (271-283 amino acid 
positions) respectively [32]]. Trans-membrane domain together with RPR and S1/S2 domains 
(Figure 4.1A) play roles to make p33 a functional molecule for RNA replication in yeast and in 
plants. One indication was that protein-protein interaction domain is likely important for initial 
steps of RNA replication. To gain insight into the mechanisms by which protein-protein 
interaction domain might affect the TBSV replication, I utilized the recently developed cell free 
(CFE) replication system. I fused MBP tag to the N-terminus of p33 or p92 and to their respective 
S1/S2 mutants (created by Quick change mutagenesis: see Materials and methods) and used 
them in CFE replication assay programmed with repRNA DI72(+). In these assays, C273F (CF) 
and Q245F (QF) mutations on p33 reduced the level of replication to 4% and 2% respectively 
almost to the levels of our negative control MBP (Figure 4.1A, Lanes 1-3).  Another mutation on 
p33, I243V (IV) halved the activity and C272T (CT) activity was 14% when compared to wild type 
levels (Figure 4.1A Lane 4, 5 vs 6, 7). R241A (RA) and LI242-243CT (LT) failed to show any 
activity CF reduced the activity five-fold (Figure 4.1A Lanes 8-10). Coomassie blue staining 
analysis of SDS-PAGE (Figure 4.1B) showed that the different levels of activites were not 
because of the variations in amounts of recombinant proteins. Thus, the S1 and S2 domains are 
very critical for replication proteins p33 and p92 to retain their in vitro replication ability. 
Wild type p33/p92 couldn’t rescue the activity of loss of function S1/S2 mutants. 
 Protein-protein interaction domains have been indicated to play roles in assembly of 
replication complex of TBSV and CNV [26, 30, 32]. It is envisaged that p33 dimers help the 
formation of vesicular structures on the peroxisomal membranes [30, 80, 152] and ER in the 
absence of peroxisomes [106] together with the help of host factors like ESCRT proteins and 
HSP70 [73, 85, 95]. Inactivity of the above discovered mutants might be because of less-efficient 
formation of replicase complex due to poor dimerization or oligomerization. To check if the 
poorly formed replication complexes in the mutant replication proteins could gain some function 
if wild type replication proteins were supplied exogenously I utilized the CFE replication assay. 
This in vitro replication was programmed with repRNA and only two (rATP, rGTP) of the four 
nucleotides to arrest the replication process just after RNA recruitment and replication complex 
assembly. Assay consisted of wild type proteins (Figure 4.2A Lanes 1-4, left and right panels) or 
p92 mutants (Figure 4.2A Lanes 5-10, left panel) or p33 mutants (Figure 4.2A Lanes 5-10, right 
panel).  After washing and removal of supernatant the supplementation of wild type p92 to the 
replication complexes assembled by using p92 mutants had minimal effect on the RNA 
accumulation (Compare lanes 5-7 vs 8-10 in Figure 4.2A, left panel). Also p92 mutants couldn’t 
affect the activity of replication complexes assembled with wild type p33 and p92 (Lane 1 vs 2-4 
in Figure 4.2A, left panel). In case of p33 mutants the addition of wild type p33 improved the 
activity marginally from 39% to 47% in case of IV (lane 5 vs 8 in Figure 4.2A, right panel) and 
10% to 17% in CT (lane 7 vs 10 in Figure 4.2A, right panel). Similar to p92 mutants p33 mutants 
also couldn’t affect the activity of replicase complexes assembled with wild type p33 and p92 
(compare lane 1A to 2-4 in Figure 4.2A right panel). Overall, the mutant replication proteins 
could neither inhibit the activity of wild-type replicase complex nor the wild-type proteins could 
rescue the low activity of replication complexes assembled by mutant proteins when provided 
after the assembly process.  
 It is known that for the proper membrane insertion, TBSV replication proteins depend on 
host factors (especially chaperones from Hsp70 family) [85, 154], which are provided by the 
supernatant in CFE replication assay. The inability of wild type p33 and p92 to rescue the 
inactivity of their respective mutants in the above experiments might be due to a lack of host 
factors in the 2nd step of replication. To test, if providing host factors in the above experiments 
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could reverse the outcome, I provided supernatant together with the wild type p33 to the 
complexes assembled using p33 mutants. (Figure 4.2B lanes 4-6). The replication activity of the 
mutant proteins was minimally changed using the supernatant together with wild-type p33. Also, 
when mutant p33 proteins were provided to replicase assembled with wild type p33/p92 (Figure 
4.2B lanes 1-3), the activity was 100%, 94% and 75% for Q245F, C272T and ΔRPR mutant p33 
respectively. Altogether, these results suggested that replicase complexes assembled using mutant 
replication proteins either are permanently deranged beyond the capability of wild-type proteins 
to be able to rescue the lethal effects or too closed structures to be entered by huge proteins like 
MBP-p33 (75 kDa) or MBP-p92 (134 kDa). 
Q245F mutant inhibits the wt p33/p92 mediated RNA replication. 
 In the previous experiments, the p33 or p92 mutant proteins were unable to decrease the 
activity of replication complex assembled using wild type p33/p92. It has to be noted that the 
mutant proteins were added after the assembly of replicase complexes. It is possible that the p33 
mutants, due to their inability to interact properly with p33 will form an improper replication 
complex if added together with them. To test these predictions, I used CFE replication assay and 
programmed it with repRNA, wild type replication proteins. 0.5, 1, 2 and 4 pmol of wild type p33 
or mutant p33 were added simultaneously to the reaction (Figure 4.3A).  Q245F mutant reduced 
the replication to 3% and 7% at the highest concentration when compared to wt 33 or MBP only 
(Figure 4.3A, compare lane 18 vs lanes 1-3 and lane 24 vs lanes 25-27).  IV and CT reduced the 
replication to 31% and 45% respectively with high standard deviation (Figure 4.3A lanes 6 and 
12). 
Assembly of replicase complex in vitro mostly occurs during the first hour of the CFE 
replication assay [55, 73]. Later on, the replicase complexes probably form special structures that 
are nuclease as well as proteinase resistant. To investigate that indeed the dominant negative p33 
mutants are exerting their deleterious effect on replication during or before replicase assembly I 
performed a time-course experiment. To this end, I added Q245F or ΔRPR or MBP only as a 
control protein to in vitro CFE reaction at different time points as indicated in Figure 4.3B.  
Maximum negative effect on replication (5% and 6% respectively) was observed when the 
mutant proteins were added simultaneously with wild-type replication proteins (compare Figure 
4.3B lane 8 vs 7 and 14 vs 13). The deleterious effect was gradually reduced to only upto 45% 
and 67% of the mock treated sample (compare Figure 4.3B. lane 12 vs 7 and lane 18 vs 13) for 
Q245F and ΔRPR respectively. As expected, minimal effect was observed on the replication levels 
by addition of MBP (Figure 4.3B. lanes 1-6). Consistent with the results in Fig 1A, the mutant 
replication proteins exert their dominant negative effect on TBSV replication during early events 
viz. RNA recruitment, replicase assembly.  
LT and RA mutations in p92pol reduces its efficiency of RNA recruitment.  
The in vitro replication assays indicated that the mutants are debilitated in their ability to 
perform some of the early events during replication. To determine, if the mutations on the 
replication proteins had any effect on their ability to recruit viral RNA to the membrane, I 
performed an in vitro RNA recruitment assay. For this purpose, I purified the MBP tagged 
versions of wild type and mutant proteins and tested them in CFE with equal amounts of 
radiolabeled RNAs  (i) Wt-RIISL(+) that is known to positively bind to the viral replication 
proteins and (ii) a C→G mutation containing RNA (G:C-RII-SL(+) as a control as it is unable to 
bind to viral replication proteins efficiently. Only two of the four ribonucleotides (rATP and 
rGTP) were supplied so that the reaction wouldn’t progress to replication. Autoradiography of the 
RNA samples isolated from the pelleted and washed membranes, revealed that LT and RA 
mutants were able to recruit only 17% and 26% of the viral RNA when compared to wild type 
p33/p92 (Compare lanes 2,3 to 4 in Figure 4.4, left panel). Please note that there was 11% 
recruitment (Lane 9 Figure 4.4, left panel) of viral RNA, in spite of absence of any replication 
proteins. Also the G:C-RII-SL(+) RNA was recruited to the membrane non-specifically at low 
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levels and was unaffected by addition of different recombinant proteins (Figure 4.4. lanes 1-9, 
right panel). Together, these results indicate that LI to CT and R to A mutations in p92pol may 
decrease the efficiency of RNA recruitment. 
S1/S2 subdomains are required for efficient RNA binding of p33.  
Since Q245F p33 mutant was very strong in inhibiting the viral replication in vitro, and 
also because the effect was mainly restricted in the first 20 minutes of the replication (Figure 
4.3B), I decided to test this protein’s ability to bind to viral RNA, as without this 
accomplishment, the template can’t be selected and recruited to replication. Prior results [32] 
showed that functional protein-protein interaction domain was critical for p33 to be able to bind 
specifically to viral RNA as deletion of the S1-S2 subdomains converted the p33 from a highly 
specific viral RNA binder to a non-specific promiscuous RNA binding protein. Importance of 
high specificity of RNA binding is also exemplified by the fact that a single mutation from C→G 
in RIISL(+) not only incapacitates its p33 binding ability but also destroys viral replication both 
in yeast and plants [71]. In keeping with these results I performed an electro mobility gel-shift 
assay (EMSA) with the purified p33, QF and IV proteins (in different concentrations) tested 
against wild type RII(+)SL or a C:G mutant hairpin. To increase the solubility of the above 
proteins and thus improving the EMSA, instead of full-length proteins I used the truncated 
versions [p33C (150-296 aa, devoid of the two transmembrane domains)]. Wt-p33C bound to the 
wt-RII(+)SL RNA whereas no shift was visualized with the C:G mutant RNA (Figure 4.5. 
compare lanes 5-8 vs 1-4). Q245F-p33C was unable to shift both types of RNA tested (Figure 4.5. 
lanes 9-16). With I243V I could see a full shift with wildtype RNA hairpin at the maximum 
concentration of 4 pmol whereas with the mutant hairpin, there was no shift (Figure 4.5 lane 24 
and lanes 17-20). Thus, Q to F mutation at 245th aa position completely destroys the ability of p33 
to bind to either wt or the mutant RNA; I243V mutation just debilitates the capacity to bind to wt 
RNA while still maintaining the no binding phenotype to the mutant hairpin similar to wildtype 
p33. 
Assembled and purified TCV or CNV RdRps are resistant to inhibitory effects of S1/S2 
mutants.  
Previous results of inhibition of in vitro replication by the dominant negative mutants 
might be due to the deranged protein-protein interaction or protein-RNA interaction, resulting in 
incompetent replication complex formation. In keeping with these results, I wanted to see if these 
mutants could wield their inhibitory effect on an already assembled, purified and functionally 
active RdRp complex. To achieve this, I utilized C-terminal truncation of p88, a very active RdRp 
from TCV (Figure 4.6.A) and CNV replicase purified from yeast co-expressing p33, p92 and 
repRNA (Figure 4.6.B).  1 and 2 pmol of purifed recombinant proteins (p33, p92 and their mutant 
versions) were added in parallel to the RdRp reaction set up with p88C and DI72(-) as a template 
or CNV replicase and RI/III(-) as template. I failed to find any significant changes in the 
accumulation of RdRp product(s) in both p88C and CNV replicase containing reactions. Thus, I 
conclude that once the RdRp is activated, these mutants can’t exert their effect. Also, previously 
observed deleterious effect on replication was not because of any modification to the RNA or its 
polymerized products during replication. 
Q245F doesn’t alter the localization or the structures formed by wt-p33 in yeast cells. 
 CNV and TBSV replicate on the membranes of peroxisomes or ER when peroxisomes 
are absent [30, 80, 106]. p33 alone is able to form punctate structures on these organellar 
membranes when visualized under confocal microscope [30, 152] and special spherular structures 
when analyzed with an electron microscope [7]. Moreover, in the yeast cells where HSP70 
protein’s functions are knocked down, instead of punctuates structures p33 gets diffused in 
cytoplasm at the same time replication is undetectable in such cells [154]. To get a deeper insight 
of the mechanism by which, QF was inhibiting I wanted to check the localization pattern of 
wildtype p33 in the presence of QF. For this purpose, I transformed BY4741 wt yeast cells with 
GAL1 driven NH2-terminal YFP tagged p33 and constitutively expressed Q245F mutant. To track 
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peroxisomal membranes I used constitutively expressed pex13-CFP and to visualize ER 
membranes, pho86-CFP was employed. Expressing QF had no significant affect on p33 
peroxisomal localization pattern when compared to an empty vector control  [Compare (–) vs QF 
in Figure 4.7.A]. I also didn’t notice localization of wt-p33 with ER marker in cells expressing 
either empty vector or QF (Figure 4.7.B). 
S1/S2 sub-domain determines the quality of replication complex.  
I previously showed that mutations in S1/S2 subdomains of p33 or p92 abolish or 
compromise RNA replication. In conjunction with such inhibition previous results also showed 
that a lack of RNA binding and thus very poor replicase complex assembly possibly reduced the 
RNA replication. To more accurately and precisely comprehend this process, I tested the 
efficiency of replicase complex assembly using the above mutants in parallel. For this purpose, 
p33 and S1/S2 mutants were dually tagged with MBP and 6X His residues. Amylose column 
purified proteins were used in an in vitro replicase assembly reaction (see materials and methods). 
The assembled replicases on yeast membranes were pelleted and solubilized with non-ionic 
detergents and the RdRp was purified by Ni++ column chromatography. Finally, equal amounts of 
RdRps were tested for complementary RNA synthesis using a minus strand template (Figure 
4.8.A).  All mutants except IV and CF were less than 15% active in replicase assembly when 
compared to wtp33/p92 (Fig 3.8.B. lanes 2,3,4,5,7 vs 8). In agreement to the in vitro CFE 
replication data, IV and CF were 52% and 23% active to assemble replicases (Figure 4.8.B. lanes 
1,6 vs 8). Thus, the loss or decrement of in vitro replication by S1/S2 mutants was closely linked 
with their ability to assemble an active replication complex.  
 
DISCUSSION 
Positive-strand viruses of plants utilize their replication auxiliary proteins to accomplish 
different processes during replication. These proteins play a major role in: RNA template 
selection, targeting specific membranes, recruitment of viral and cellular factors and replication 
complex assembly. These multifunctional proteins rely heavily on their ability to directly interact 
with other copies to execute different steps of replication. Thus, the mechanisms by which viral 
replication proteins interact with themselves and others are crucial to have deeper understanding 
of the entire viral replication process. In the case of CNV, the versatile replication protein p33 
plays crucial roles in binding to the viral RNA and recruiting it and other p33 and p92 molecule 
to the site of replication i.e. peroxisome [30, 152]. p33 is membrane targeted via two of its 
transmembrane domains and by ability to interact with cellular proteins pex19p and ssa1p [80, 
85]. Apart from being able to ubiquitinated and hijack the host ESCRT pathway for replicase 
assembly [95, 153] recently p33 has been shown to possess RNA chaperone activity [96]. 
Previously, I mapped two subdomains S1 (241-252 aa) and S2 (271-283 aa) crucial for p33-p33 
interaction [26, 32]. The domain was important not only for interaction but also for viral 
replication. Additionally, S1-S2 was needed for the specific recognition of viral RNA. p33 
molecules containing RPR sequence but without S1/S2 subdomains bound even to minus 
stranded DI72-RIII(-) sequences [26, 32], which was in contrast to the finding of complete lack of 
binding by wt-p33 to  DI72(+) containing a C:G mutation on a RII stem loop [71, 72].  
 
Role of S1/S2 in p33:p33/p92 interaction. 
 Previously, using yeast two hybrid and surface plasmon resonance assays it was shown 
that S1/S2 domains are critical for p33/p92 to directly bind to p33/p92. Utilizing CFE in vitro 
replication assay this report shows that mutations in the above mentioned domains had drastic 
affect on DI72(+) replication (Figure 4.1). Q to F, C to F in p33 and R to A, LI to CT changes in 
p92 abolished the replication whereas I to V, C to T in p33 and C to F mutations affected the 
replication albeit to a lesser extent.  Interaction data from previous work and replication results 
from this report are well correlated. In other words, the interaction strength of different mutants is 
directly proportional to the accumulation of replicon RNA in vitro. Interestingly, the same amino 
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acid change from C to F on p33 and p92 had different phenotypes in the CFE assay, the mutation 
being not as deleterious on p92 as on p33. It’s interesting to note that NH2-terminal third of p92 
that contains p33 sequence in entirety has been previously shown to possess extra functions 
during viral replication [30]. Using different truncations on p92 from NH2-terminal I had found 
that the p92 molecules lacking trans-membrane domains but possessing S1/S2 still could be 
targeted to the peroxisomal membranes probably via “piggy-backing” on p33[30]. Also, p92 
alone is not able to support RNA replication in vitro unlike the purified C terminal half of TCV 
polymerase p88 devoid of p28 portion analogous to p33. This suggests that p33 portion of p92 or 
p33 in trans provides extra-function related to replication. It might help to activate the 
polymerase, or load it properly on to the RNA. S1 deletion p33 molecules have been shown to 
partially localize to ER and form less punctate structures [30]. I envisaged that proper protein-
protein interaction is important to efficiently assemble functional replication complex and 
spherules on peroxisomal membranes. Figure 4.2 suggests that even though the S1/S2 mutants 
might form inefficient replication complexes but those structures are not easily accessible to wild-
type replication proteins therefore I could not see any rescue of diminished replication in spite of 
providing active proteins exogenously. To rule out that the lack of stimulus from wt p33/p92 is 
because of undersupply of Heat shock protein 70 (Ssa1p) that is known to be critical for 
membrane targeting and function of replication proteins [73], I added supernatant from yeast 
extract containing soluble cellular proteins including Ssa1p. Thus, these results indicate that 
either the structures formed by the assembled replicase is too close/inaccessible to exogenously 
added biomolecules; or once the replicase is assembled it can’t change its structure or makeup. 
There are evidences for the prior model: as I have found that the in vitro assembled 
(approximately one hour after in vitro reconstitution) replicase complex is accessible to neither 
proteinase K nor RNAse 1 [55, 73]. In contrast, the RdRp preparation obtained from purification 
of assembled replicase complex was influenced by the addition of auxiliary protein p33 could 
stimulate the TCV polymerase p88 activity on minus strand template [96]. Although this 
stimulation of plus strand synthesis might be via RNA chaperonic activity instead of protein-
protein interaction, as it is known that p33 is unable to interact to p88 [26].  
 The main process during replication that is hurt by mutating S1/S2 domains seems to be 
the selection of RNA template as revealed in Figure 4.5. Q to F mutation in p33 completely 
abolishes binding ability of p33 to the viral RNA. This step of RNA binding is critical for 
replication as it has been shown that DI72(+) RNA containing C→G mutation in RII stem loop 
that makes it non-binder to p33, cannot replicate in yeast or plants. In vitro RNA replication 
activity is well correlated to the binding ability to wild type RNA, as I to V mutation, which can 
still bind to the RNA albeit with lower efficiency had a mild negative effect on RNA replication 
in Figure 4.4 The drastic affect of S1/S2 mutation on RNA binding ability is in contrast with the 
previous data from our lab where a polypeptide devoid of S1/S2 domains but still possessing RPR 
domain efficiently bound cooperatively to the viral RNA. In previous studies the protein carried 
major deletion of S1/S2 deletion and thus could have opened the juxtaposed RPR domain 
structure making it accessible to any kind of viral RNA with loss of specific binding.  
 
Novel replication inhibitory dominant negative mutants. 
 The ability of S1 mutant Q245F to prohibit the replication launched by using wild type 
p33 and p92 (Figure 4.3) reveals significant insights into the pathways by which TBSV RNA 
replication complexes assemble. CFE based replication assay indicated that the even at the 
equimolar ratio, QF could inhibit p33 based replication. This inhibition was profound when 
mutant was used in increasing amounts. Previous results showed that S1 deletions in p33 
molecule changed the localization from peroxisome to ER [30]; the inability of QF to alter either 
the localization or pattern of punctate structures made by p33 on peroxisomal membranes 
indicated an alternative mechanism of this dominant negative phenotype. Fig 4.5 showed 
complete absence of RNA binding by QF, which indicated the inhibitory mechanism towards 
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template selection process. In congruence, when I tested a p33 devoid of a highly conserved RPR 
domain (critical for RNA binding) in CFE based in vitro replication assays, I found that this 
mutant also greatly reduced RNA replication and the pattern of inhibition observed was similar to 
that of the QF (Figure 4.3). The inability of both the mutants to act after the assembly of replicase 
complex was also similar. 
 All the S1/S2 mutants and even the wildtype p33/p92 proteins failed to impart any effect 
when were used with the purified RdRp preparations of CNV or TCV p88C (Figure 4.6). From 
previous experiments it is known that p33 and p88C don’t interact, thus the neutral behavior of 
the added proteins in p88C based RdRp assay also indicates that protein-protein interaction is 
needed for any effect on the replication; or once the RdRp is active, then protein-protein 
interaction plays minor role(s) in replication thereby, above mentioned mutants or wild type 
proteins had little effect. Lack of previously demonstrated positive effect of p33 on p88C based 
RdRp reaction [96] might be due to a minus stranded template used in this study instead of a plus 
strand RNA.   
These results suggest that QF and ΔRPR mutants inhibit the replication earlier than RNA 
synthesis steps, probably during template selection and recruitment and replicase assembly. The 
mechanism behind the dominant negative phenotype may lie in QF’s ability to weakly interact 
with the wild-type p33 molecules but then rendering these protein-protein complexes unable to 
bind to the viral RNA, thus inhibiting the entire cascade of replication events in accordance with 
the prior results that suggest that for specific recognition of plus strand TBSV DI72(+) RNA, 
p33-p33 dimerization is needed. 
In summary, I find that protein-protein interaction subdomains S1 and S2 play critical 
roles in TBSV RNA replication. They regulate the essential p33/p92 functions contingent upon 
protein-protein interaction like RNA template selection and its recruitment and replication 
complex assembly. In addition, they might play a role in inducing proper spherule formation via 
multimerization. I also discovered dominant negative mutants abolishing viral replication 
highlighting the potential of these mutants as an antiviral approach. Protein-protein interaction 
among many viral proteins plays crucial roles in replication. Dominant negative mutants have 
also been reported for viruses. Using ubiquitin-mimicking p33 chimeras, earlier work has 
demonstrated that high level of p33 ubiquitination is inhibitory for TBSV replication. A mutant of 
the two-exon HIV-1 Tat protein (Nullbasic) was described to potently inhibit multiple steps of the 
HIV-1 replication cycle [155]. Another HIV-1 protein (the capsid-spacer peptide 1 Gag) also is a 
dominant-negative inhibitor of virion maturation [156]. Glycoprotein D based dominant-negative 
recombinant of herpes simplex virus 2 was used to make viral vaccines [157].  Such similitude 
suggest that protein-protein interaction is used by viruses to increase the functionality of their 
proteins and also that it can exploited by virologist to add one strategy to fight against viruses.  
 
MATERIALS AND METHODS 
Yeast and E. coli strains  
 BY4741 , Top10, Codon plus described in chapters 2 and 3. 
Plasmids:  
pMAL-CNV-33, pMAL-CNV-92, pMAL-CNV-mutants, pMAL-CNV-33C, pMAL-
CNV-33C(Mutants), Desired ORFs were amplified and cloned into pMAL vector digested with 
the same pair of enzymes. 
Site directed mutagenesis.  
A full-length cDNA clone of CNV, was used to generate the RPR motif mutants of 
p33/p92 listed in Figure 4.1. Mutagenesis was performed by PCR using the QuickChange XL 
Site-Dwerected Mutagenesis Kit (Stratagene). The PCR reactions included the Pfu Turbo DNA 
polymerase, different sets of primer pairs designed for each mutant and 40 ng of DNA as a 
template. PCR products were digested with DpnI before transformation into E. coli (DH5α). The 
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presence of the desired mutations was confirmed by sequencing with primer (5′-
GTATTTCACACCAAGGGAC-3′). 
Cell free extract based in vitro replication assay.  
The cell-free extract was prepared from yeast strain BY4741, untransformed as described 
[55, 73]. Briefly, the CFE (1 µl) was pre-incubated on ice for 10 min in 10 µl cell-free replication 
buffer containing 50 mM HEPES-KOH, pH 7.4, 150 mM potassium acetate, 5 mM magnesium 
acetate, 0.2 M sorbitol, and 0.4 µl actinomycin D (5 mg/ml). Then, the reaction volume was 
adjusted to 20 µl with 1x cell-free replication buffer also containing 2 µl of 150 mM creatine 
phosphate; 2 µl of 10 mM ATP, CTP, and GTP and 0.25 mM UTP; 0.3 µl of [32P]UTP, 0.2 µl of 
10-mg/ml creatine kinase, 0.2 µl of RNase inhibitor, 0.2 µl of 1 M dithiothreitol, and 0.5 µg RNA 
transcript. The reaction mixture also contained 4 pmol MBP tagged CNV p33 and 1 pmol MBP-
p92 purified from E. coli cells.  This reaction mixture was incubated at 25°C for 3 h. The reaction 
was terminated by adding 110 µl stop buffer (1% sodium dodecyl sulfate [SDS] and 0.05 M 
EDTA, pH 8.0), followed by phenol-chloroform extraction, isopropanol-ammonium actetate 
precipitation, and a washing step with 70% ethanol as described earlier. The RNA samples were 
electrophoresed under denaturing conditions (5% PAGE containing 8 M urea) and analyzed by 
phospho-imaging using a Typhoon (GE) instrument as described [75]. 
Purification of the recombinant tombusvirus replicase from yeast.  
Yeast cells transformed with pGBK-His33, pGAD-His92 and pYC-DI72 were pre-grown 
in SC-ULH- medium containing 2% glucose for 15 h at 29 °C with shaking at 250 rpm. The 
affinity-purification of the solubilized tombusvirus replicase was performed using ProBond resin 
(Invitrogen) as described [82]. The obtained template-dependent replicase was then used in a 
standard replicase reaction using either DI-72(-) or RI/RIII(-) exogenous templates and [32P]UTP 
[75, 82]. 
In vitro RNA recruitment assay.  
The recruitment assay was performed as described [76]. Briefly, recruitment assay based 
on yeast CFE and recombinant p33/p92 is similar to the replication assay, except for the 
following changes: [32P]-labeled RNAs (2 pmol) were added to the CFE. In addition, only rATP 
and rGTP were used, while [32P]UTP was omitted. The assay was performed at room temperature 
for 1 h. Then, the mixture was suspended in 980 µl of pre-chilled Buffer A and centrifuged at 
35,000g for 30 min at 4°C. Supernatant was discarded and the washing of the pellet was repeated 
twice. After final washing, the pellet was dissolved in 120 µl of stop buffer (1% sodium dodecyl 
sulfate [SDS] and 0.05 M EDTA, pH 8.0). Afterwards standard RNA extraction and purification 
was performed followed by autoradiography of the electrophoresed RNA samples as described 
[75]. 
In vitro assembly and purification of replicase complex.  
The cell free replication assay was conducted at 20°C for 1 h as described above except 
for following changes: The reaction volume was increased to 200 µl, while the final concentration 
of DTT was reduced from 10 mM to 2.5 mM. In addition, only rATP and rGTP were used, while 
[32P]UTP was omitted. The recombinant p33 was dually tagged with both MBP and 6xHis. After 
incubation, the assay mixture was diluted with 800 µl chilled solubilization buffer and affinity-
purification was done exactly as described [75, 82]. 
In vitro RdRp assay.  
I used affinity-purified recombinant TCV p88C or affinity-purified CNV replicase from 
yeast in an RdRp assay as described [82, 110]. Briefly, the RdRp reaction was performed in 100 
µl volume containing RdRp buffer [40 mM Tris pH 8.0, 10 mM MgCl2, 10 mM DTT, 0.2µl 
RNase inhibitor, 1 mM ATP, CTP, GTP, 0.1 µl radioactive [32P]UTP and 50 µl RdRp fraction. 
As an external template, 300 ng of DI-72(-) RNA or RI/III(-) RNA were added. Samples were 
incubated at 25 °C for 2 h. The reaction was terminated by adding 70 µl SDS/EDTA (1% SDS, 
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50 mM EDTA pH 8.0) and 100 µl phenol-chloroform (1:1). The analysis of RdRp products was 
as described [82, 110]. 
Electromobility gel shift assay.  
The affinity-purified recombinant proteins in twofold dilution series were incubated with 
1 ng of radioactively labeled probe (see above) in a binding buffer (50 mM Tris-HCl [pH 8.2], 10 
mM MgCl2, 10 mM dithiothreitol, 10% glycerol, 100 ng of yeast tRNA [Sigma], and 2 U of 
RNase inhibitor [Ambion]) at 25°C for 15 min [28]. After the binding reaction, the samples were 
analyzed by 4 or 5% nondenaturing PAGE in Tris-acetate-EDTA buffer at 200 V in a cold room 
[28]. The gels were dried, exposed, and analyzed in a phosphorimager and quantified by using 
ImageQuant version 1.2 (Amersham). 
Protein purification from E. coli. 
 The MBP-tagged p33, p92, p33/p92 mutants and Turnip crinkle virus p88C were 
purified from E. coli as described by [28, 110]. Briefly, expression of the MBP tagged proteins 
was induced by isopropyl-d-thiogalactopyranoside (IPTG) in Epicurion BL21-codon-plus (DE3)-
RIL cells (Stratagene). Cells were suspended in the column buffer (10 mM Tris–HCl [pH 7.4], 1 
mM EDTA, 25 mM NaCl, 10 mM β-mercaptoethanol) and were broken by sonication, and then 
the cell lysate was passed through the equilibrated amylose columns to bind MBP tagged 
proteins. After passing the cell lysate, the columns were washed three times with ice-cold column 
buffer and eluted with column buffer containing 10 mM maltose and stored at -80°C until further 
use. 
Confocal microscopy.  
Confocal laser scanning micrographs were acquired on a Olympus FV1000 microscope 
(Olympus America Inc., Melville, New York) as described earlier [106].  ECFP was excited using 
440 nm laser light, attenuated to 4.5-11.0% of the maximum laser power, while EYFP was 
excited using 515 nm laser line (3.5-8.0% of the maximum laser power). The images were 
acquired using sequential line-by-line mode in order to reduce excitation and emission cross-talk. 
The primary objective used was a water-immersion PLAPO60XWLSM (Olympus). Image 
acquisition was conducted at a resolution of 512x512 pixels and a scan-rate of 10 ms/pixel. Image 
acquisition and exportation of TIFF files were controlled by using Olympus Fluoview software 
version 1.5. Figures of micrographs were assembled using Photoshop 9.0 (Adobe Systems 













Figure 20 Figure 4.1.  Mutations in S1/S2 domains of p33/p92 inhibits viral replication in 
vitro.  
 
(A) Cartoons of p33 (positions 1-296 aa) and p92 (positions 1-818 aa). A read through product 
depicting protein-protein interactions sub-domains S1, S2 in context of other functional domains 
like RNA binding (RPR) and two trans-membrane domains. S1 domain (positions 241-251 aa) 
and S2 domain (positions 271-283 aa) are zoomed to show their amino acid sequences. Quick-
change site-specific mutagenesis approach was used to introduce specific mutations (see 
Materials and methods) in the S1/S2 domains followed by fusing the MBP tag on NH2-terminal 
end of mutant p33/p92. The two-letters names show respective amino acid changes and WT 
represents wild-type proteins. (B) A representative denaturing PAGE gel of newly synthesized 
32P-labeled repRNA in an in vitro CFE replication assay (shown as a flowchart) using purified 
recombinant proteins (rec.pr.) with equal amounts of DI72(+) as a repRNA. The full-length 
product is shown with arrowhead.  Experiments were repeated three times and quantified using 
Imagequant. (C) Coomassie blue staining after SDS-PAGE shows similar amounts of the 
amylose column purified recombinant MBP-p33 proteins (top panel) or MBP-p92 (bottom panel) 





Figure 21 Figure 4.2. Mutant replication proteins’ activity can’t be rescued by wild-type 
p33/p92.  
 
(A) Denaturing PAGE analysis of the CFE-based replication assay for wild type p92 and its 
mutants on left-hand side and for p33 and its mutants on right-hand panel. The ability of wild 
type or mutant replication proteins to affect the in vitro replication assay was tested after the first 
step (see scheme) of replication assay that was started using yeast CFE, repRNA and affinity 
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purified recombinant TBSV wild type or mutant p33 and p92pol (as shown) and only two 
ribonucleotides (rATP and rGTP) so that the replication process could be arrested just after 
assembly of the replicase complex. Thereafter, the assembled replicase was centrifuged, 
supernatant discarded and the replication assay was continued with all four nucleotides including 
radiolabeled rUTP and the additional recombinant replication proteins. The authentic replication 
product is depicted with arrowheads on the left. (B) The CFE replication assay was performed as 
in (A) with only difference being that supernatant (+Sup) obtained after centrifuging yeast extract 
at 35000 g (containing soluble host factors) was added at the second step (see scheme) to help 
membrane insertion of the added wild-type p33 (lanes 4-6) or the p33 mutants (lanes 1-3). The 




Figure 22 Figure 4.3 Dominant negative effect of p33-Q245F mutant during in vitro CFE 
replication.  
 
The replication assay was performed as shown in the scheme at the top. (A) Increasing amounts 
of test proteins (MBP and MBP-p33 as controls or p33 mutants) were added simultaneously with 
wild type p33, p92, repRNA, CFE and ribonucleotides to see their effect on replication. DI-72 
sized product is depicted with arrowheads on both panels. (B) The maximum dominant negative 
effect of the mutants is exerted early during replication assembly. The in vitro replicase assay in 
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CFE was done using two different p33 mutants as shown. I provided the recombinant proteins at 
the 0, 10, 20, 40 or 60 min time points followed by continuation of the in vitro replicase assay up 
to 2 hours. The denaturing PAGE analysis of the 32P-labeled repRNA products obtained is shown. 
(C) Graphical representation of the data from (B). The experiments were repeated and mock 
treated samples were arbitrarily assigned 100% value. 
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Figure 23 Figure 4.4 In vitro RNA recruitment to membranes affected by p92 mutants.  
 
As depicted in the top scheme, the CFE was programmed with recombinant proteins, and 
radiolabeled wt-RII-SL(+) on the left-side panel and C→G mutation containing RNA shown on 
the right-hand panel. Retention of RNA to the membranes was checked by centrifuging the CFE 
and collecting the membranes followed by PAGE and autoradiography of phenol-chloroform 
extracted RNA samples.  Please note that only rATP and rGTP were provided so that recruitment 
of the respective RNAs may not be carried to replication. 
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Figure 24 Figure 4.5. p33-Q245F mutant is inefficient in binding viral RNA.  
 
(A) EMSA was performed with 2, 4, 8 or 16 pmol purified MBP tagged wt or mutant p33C (150-
296 aa) [shown with grey triangles]. 10 nM of Wt-RII(+)SL RNA or C→G mutation containing 
RII(+)SL RNA were used. Solid arrowhead depicts the unbound RNA probe whereas bound 
RNA-protein complexes are depicted by empty arrowhead. (B) SDS-PAGE followed by 
Coomassie blue staining of the proteins used in (A).  
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Figure 25 Figure 4.6 p33 mutants do not exert dominant negative effect on the RdRp 
activity of purified replicase complexes.  
 
(A) Increasing amounts (2, 4 pmol) of wt p33 or wt p92 or different mutants were added to the E. 
coli purified and highly active RdRp (p88C) from TCV into the in vitro RdRp assay together with 
ribonucleotides including radiolabeled rUTP and template RNA DI72(-). Full-length de novo 
RNA product is shown with an arrowhead on left. (B) As shown in the scheme, effect of the 
mutant or wild type recombinant proteins (2, 4 pmol) were tested on the RdRp activity of CNV 
replicase, affinity purified from yeast co-expressing p33, p92 and DI72(+). RI/III(-) RNA was 
used as a template. Empty arrowhead depicts terminal extension product (tex), the solid 




Figure 26 Figure 4.7. Peroxisomal localization and punctate pattern of wt-p33 is not 
affected by expression of Q245F-p33 mutant in yeast.  
 
Confocal laser microscopy analysis of subcellular localization [tracked for peroxisomes by 
pex13-CFP in (A) or ER by pho86-CFP in (B)] of NH2-terminally YFP tagged wt-p33 in the 
presence Q245F-p33 mutant (QF) or an empty vector (−). The images were taken 24 h post-
induction. QF, pex13-CFP and pho86-CFP were expressed under constitutive ADH1 promoter 





Figure 27 Figure 4.8. Denaturing PAGE analysis of the CFE-based replication assay.  
 
The in vitro reconstitution assay contained yeast CFE, affinity purified recombinant CNV p33 
and p92pol or the p33 mutants with wild type p92 or the p92 mutants with wild type p33, and the 
same amount of various TBSV repRNA templates (as shown). After the in vitro reconstitution, 
the assembled replication complexes were purified (see scheme) by affinity chromatography and 
then the activity was tested using RI/RIII(-) template. The full-length RNA product is depicted 
with an arrowhead on the right. Note that the repRNAs (see scheme) serve only as assembly 
factor in this assay. (B) Graphical representation of the data obtained in panel (A) after three 
repeats. Wild type was arbitrarily assigned a value of 100%. Abscissa denotes the different 
mutants (lanes 1-7) and wild type control (lane 8) and ordinate represents the percentage activity 
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Chapter 5. Summary 
 
Two of the vital replication proteins p33 and p92 of tombusvirus a model positive strand 
RNA virus also directly interact with themselves via protein-protein interaction sub-domains S1 
and S2. To dissect the different steps during RNA replication where this interaction plays 
essential role(s) I tested selected p33 and p92 interaction mutants in the replicase assay based on 
cell free extract from yeast that can support authentic replication of TBSV RNA in vitro utilizing 
purified replication proteins and host factors. This assay demonstrated that some of the S1 or S2 
mutants were completely defunct for replication. Further RNA binding analyses revealed that 
Glutamine to Phenylalanine mutation at 245 aa position in p33 (Q245F) completely abolished its 
ability to bind to viral RNA. I also found strong dominant negative effect of Q245F on the 
replication started by wild type replication proteins. Using in vitro replicase assembly assay, I 
found close correlation between interaction and the ability to assemble active replication 
complex. In addition, I show that the interaction defective mutants are not able to modify RNA 
dependent RNA polymerase (RdRp) activity of purified Turnip crinckle virus (TCV) polymerase 
p88 and CNV replicase preparations suggesting that already assembled replicases are not prone to 
modification through protein-protein interaction domain. The results provide new insights into the 
replication proteins RNA template selection and subsequently in replicase complex assembly. 
Also I discovered a novel dominant negative replication protein mutant that can abolish viral 
replication.  
Replication of Tomato bushy stunt virus (TBSV) RNA takes place on the cytosolic 
membrane surface of peroxisomes in plants and in yeast, a model host. To identify the host 
proteins involved in assisting the peroxisomal localization of the tombusvirus p33 replication 
protein, I tested if p33 could bind directly to yeast proteins involved in peroxisomal transport in 
vitro. This work led to the demonstration of Pex19p-p33 interaction via pull-down and co-
purification experiments. Pex19p was also detected in the tombusvirus replicase after protein 
cross-linking, suggesting that Pex19p transiently binds to the replicase as could be expected from 
a transporter. To validate the importance of Pex19p - p33 interaction in TBSV replication in 
yeast, I re-targeted Pex19p to the mitochondria, which resulted in the re-distribution of a large 
fraction of p33 to the mitochondria. The expression of the mitochondrial-targeted Pex19p 
inhibited TBSV RNA accumulation by 2-4-fold in vivo and reduced the in vitro activity of the 
tombusvirus replicase by 80%. These data support the model that Pex19p is the cellular 
transporter for localization of p33 replication protein to the host peroxisomal membranes.   
The studies presented in Chapter two revealed the critical role of viral genome in its 
replication beyond its usage as a genetic carrier. In addition to its central role as a template for 
replication and translation, the viral (+)RNA genome also has non-template functions, such as 
recruitment to the site of replication and assembly of the viral replicase; activities that are 
mediated by cis-acting RNA elements within viral genomes.  Two non-contiguous RNA 
elements, RII(+)-SL, located internally in the tombusvirus genome and RIV, located at the 3’-
terminus, are involved in template recruitment into replication and replicase assembly. However, 
the importance of each of these RNA elements for these two distinct functions is unknown.  I 
used an in vitro replicase assembly assay based on yeast cell-free extract and purified 
recombinant tombusvirus replication proteins to show that RII(+)-SL, in addition to its known 
requirement for recruitment of the (+)RNA into replication, is also necessary for assembly of an 
active viral replicase complex.  Additional studies using a novel two-component RNA system 
revealed that the recruitment function of RII(+)-SL can be provided in trans by a separate RNA 
and that the replication silencer element, located within RIV, defines the template that is used for 
initiation of minus strand synthesis.  Collectively, this work has revealed new functions for 
tombusvirus cis-acting RNA elements and provided insights into the pioneering round of minus 
strand synthesis.  
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These findings put the viral RNA into the central stage of it’s own replication where it 
orchestrates the entire series of events starting from disassembly, template selection/recruitment, 
formation of replication complex and transcription of the complementary strands and in the 
ensuing steps. Different viruses positive strand RNA viruses share some common principles like, 
viral RNA codes for a specific region in order to bind to the early replication proteins and it also 
contains some other secondary structures that are subsequently needed in order to form active 
replicase complexes utilizing viral proteins, host factors and host membranes. Contemporarily, 
many essential questions remain or have become apparent from these works. Among these 
unsettled queries are the thorough molecular mechanisms by which the RNA helps to assemble 
the replication complexes. It is evident that RNA doesn’t play a major role in targeting of the 
proteins to the organellar membranes for formation of specialized replication structures. 
Discovery of many viral RNA binding proteins affecting replication indicates that RNAs might 
coordinate the usurping of critical host factors for assembly of replication complex. Related 
issues would be how the viruses temporally and spatially regulate the replication processes using 
just its RNA. Clues may lie in the dynamics of the secondary structures and long-range 
interactions occurring on the RNA molecule. It can be imagined that the structural studies will 
become even more complex because of discoveries of more host-factors binding to the RNA and 
heavily modifying its structure to achieve a different secondary/tertiary structure. It is also 
possible that positive strand RNA viruses use their RNAs upon entry into the cells to monitor the 
conduciveness of their hosts for replication by sensing protein(s) via binding. Making an analogy 
of viral RNA role during replicase assembly to the rRNA role in ribosomal assembly is also not 
far-fetched. As during both, ribosome assembly and replicase complex assembly, RNAs provide 
necessary factors as well as an assembly platform. The viral RNA is already known to play a 
critical role during assembly of virion particles, henceforth extending their ability to assemble a 
complex using proteins onto the membranous compartments for replication. 
The novel roles of viral RNA, viral proteins and host factor should enrich the 
understanding of viral replication at the same time provide new challenges and opportunities to 
virologists to help improve antiviral strategies. In this regards, one crucial area to work on will be 
to disrupt the viral RNA:viral/host-protein or viral protein:viral/host-protein interaction through 
chemicals or RNA biology tools. Undoubtedly, the emerging picture is complicated but will 
























1. Ray D, White KA. An internally located RNA hairpin enhances replication of Tomato 
bushy stunt virus RNAs. J Virol 2003,77:245-257. 
2. Lai M, Liaw YF. Chronic hepatitis B: past, present, and future. Clinics in liver disease 
2010,14:531-546. 
3. Ahlquist P, Noueiry AO, Lee W-M, Kushner DB, Dye BT. Host Factors in Positive-
Strand RNA Virus Genome Replication. J. Virol. 2003,77:8181-8186. 
4. Li Z, Nagy PD. Diverse roles of host RNA binding proteins in RNA virus replication. 
RNA Biol 2011,8:305-315. 
5. Nagy PD. Yeast as a model host to explore plant virus-host interactions. Annu Rev 
Phytopathol 2008,46:217-242. 
6. Nagy PD, Pogany J. Yeast as a model host to dissect functions of viral and host factors in 
tombusvirus replication. Virology 2006,344:211-220. 
7. Nagy PD, Pogany J. Global genomics and proteomics approaches to identify host factors 
as targets to induce resistance against tomato bushy stunt virus. Adv Virus Res 
2010,76:123-177. 
8. Birn AE. Small(pox) success? Ciencia & saude coletiva 2011,16:591-597. 
9. Wommack KE, Colwell RR. Virioplankton: viruses in aquatic ecosystems. Microbiology 
and molecular biology reviews : MMBR 2000,64:69-114. 
10. Lu TK, Koeris MS. The next generation of bacteriophage therapy. Current opinion in 
microbiology 2011. 
11. Herzog RW, Cao O, Srivastava A. Two decades of clinical gene therapy--success is 
finally mounting. Discovery medicine 2010,9:105-111. 
12. Tarascon JM. Nanomaterials: Viruses electrify battery research. Nature nanotechnology 
2009,4:341-342. 
13. Panavas T, Nagy PD. Yeast as a model host to study replication and recombination of 
defective interfering RNA of Tomato bushy stunt virus. Virology 2003,314:315-325. 
14. Panavas T, Serviene E, Pogany J, Nagy PD. Genome-wide screens for identification of 
host factors in viral replication. Methods Mol Biol 2008,451:615-624. 
15. Panavas T, Serviene E, Brasher J, Nagy PD. Yeast genome-wide screen reveals dissimilar 
sets of host genes affecting replication of RNA viruses. Proc Natl Acad Sci U S A 
2005,102:7326-7331. 
16. Jiang Y, Serviene E, Gal J, Panavas T, Nagy PD. Identification of essential host factors 
affecting tombusvirus RNA replication based on the yeast Tet promoters Hughes 
Collection. J Virol 2006,80:7394-7404. 
17. Serva S, Nagy PD. Proteomics analysis of the tombusvirus replicase: Hsp70 molecular 
chaperone is associated with the replicase and enhances viral RNA replication. J Virol 
2006,80:2162-2169. 
18. Li Z, Pogany J, Panavas T, Xu K, Esposito AM, Kinzy TG, et al. Translation elongation 
factor 1A is a component of the tombusvirus replicase complex and affects the stability of 
the p33 replication co-factor. Virology 2009,385:245-260. 
19. Mendu V, Chiu M, Barajas D, Li Z, Nagy PD. Cpr1 cyclophilin and Ess1 parvulin prolyl 
isomerases interact with the tombusvirus replication protein and inhibit viral replication 
in yeast model host. Virology 2010,406:342-351. 
20. Serviene E, Shapka N, Cheng CP, Panavas T, Phuangrat B, Baker J, et al. Genome-wide 
screen identifies host genes affecting viral RNA recombination. Proc Natl Acad Sci U S 
A 2005,102:10545-10550. 
82 
21. Serviene E, Jiang Y, Cheng CP, Baker J, Nagy PD. Screening of the yeast yTHC 
collection identifies essential host factors affecting tombusvirus RNA recombination. J 
Virol 2006,80:1231-1241. 
22. Friedel CC, Haas J. Virus-host interactomes and global models of virus-infected cells. 
Trends in microbiology 2011. 
23. Scholthof KB, Scholthof HB, Jackson AO. The tomato bushy stunt virus replicase 
proteins are coordinately expressed and membrane associated. Virology 1995,208:365-
369. 
24. Oster SK, Wu B, White KA. Uncoupled expression of p33 and p92 permits amplification 
of tomato bushy stunt virus RNAs. Journal of virology 1998,72:5845-5851. 
25. Panaviene Z, Baker JM, Nagy PD. The overlapping RNA-binding domains of p33 and 
p92 replicase proteins are essential for tombusvirus replication. Virology 2003,308:191-
205. 
26. Rajendran KS, Nagy PD. Interaction between the replicase proteins of Tomato bushy 
stunt virus in vitro and in vivo. Virology 2004,326:250-261. 
27. White KA, Nagy PD. Advances in the molecular biology of tombusviruses: gene 
expression, genome replication, and recombination. Prog Nucleic Acid Res Mol Biol 
2004,78:187-226. 
28. Rajendran KS, Nagy PD. Characterization of the RNA-binding domains in the replicase 
proteins of tomato bushy stunt virus. J Virol 2003,77:9244-9258. 
29. Panavas T, Panaviene Z, Pogany J, Nagy PD. Enhancement of RNA synthesis by 
promoter duplication in tombusviruses. Virology 2003,310:118-129. 
30. Panavas T, Hawkins CM, Panaviene Z, Nagy PD. The role of the p33:p33/p92 interaction 
domain in RNA replication and intracellular localization of p33 and p92 proteins of 
Cucumber necrosis tombusvirus. Virology 2005,338:81-95. 
31. Navarro B, Rubino L, Russo M. Expression of the Cymbidium ringspot virus 33-
kilodalton protein in Saccharomyces cerevisiae and molecular dissection of the 
peroxisomal targeting signal. Journal of virology 2004,78:4744-4752. 
32. Rajendran KS, Nagy PD. Kinetics and functional studies on interaction between the 
replicase proteins of Tomato Bushy Stunt Virus: requirement of p33:p92 interaction for 
replicase assembly. Virology 2006,345:270-279. 
33. Huang AS. Defective interfering viruses. Annu Rev Microbiol 1973,27:101-117. 
34. Simon AE, Roossinck MJ, Havelda Z. Plant virus satellite and defective interfering 
RNAs: new paradigms for a new century. Annu Rev Phytopathol 2004,42:415-437. 
35. Perrault J. Origin and replication of defective interfering particles. Curr Top Microbiol 
Immunol 1981,93:151-207. 
36. Qiu W, Scholthof KB. Defective interfering RNAs of a satellite virus. J Virol 
2001,75:5429-5432. 
37. Luytjes W, Gerritsma H, Spaan WJ. Replication of synthetic defective interfering RNAs 
derived from coronavirus mouse hepatitis virus-A59. Virology 1996,216:174-183. 
38. White KA, Morris TJ. Nonhomologous RNA recombination in tombusviruses: generation 
and evolution of defective interfering RNAs by stepwise deletions. J Virol 1994,68:14-
24. 
39. Rochon DM. Rapid de novo generation of defective interfering RNA by cucumber 
necrosis virus mutants that do not express the 20-kDa nonstructural protein. Proc Natl 
Acad Sci U S A 1991,88:11153-11157. 
40. Rubino L, Burgyan J, Grieco F, Russo M. Sequence analysis of cymbidium ringspot virus 
satellite and defective interfering RNAs. J Gen Virol 1990,71 ( Pt 8):1655-1660. 
41. Pogany J, Romero J, Huang Q, Sgro JY, Shang H, Bujarski JJ. De novo generation of 
defective interfering-like RNAs in broad bean mottle bromovirus. Virology 
1995,212:574-586. 
83 
42. Li XH, Heaton LA, Morris TJ, Simon AE. Turnip crinkle virus defective interfering 
RNAs intensify viral symptoms and are generated de novo. Proc Natl Acad Sci U S A 
1989,86:9173-9177. 
43. Hillman BI, Carrington JC, Morris TJ. A defective interfering RNA that contains a 
mosaic of a plant virus genome. Cell 1987,51:427-433. 
44. Hernandez C, Carette JE, Brown DJ, Bol JF. Serial passage of tobacco rattle virus under 
different selection conditions results in deletion of structural and nonstructural genes in 
RNA 2. J Virol 1996,70:4933-4940. 
45. Eliasco E, Livieratos IC, Muller G, Guzman M, Salazar LF, Coutts RH. Sequences of 
defective RNAs associated with potato yellow vein virus. Arch Virol 2006,151:201-204. 
46. Desvoyes B, Scholthof HB. Host-dependent recombination of a Tomato bushy stunt virus 
coat protein mutant yields truncated capsid subunits that form virus-like complexes 
which benefit systemic spread. Virology 2002,304:434-442. 
47. Ayllon MA, Lopez C, Navas-Castillo J, Mawassi M, Dawson WO, Guerri J, et al. New 
defective RNAs from citrus tristeza virus: evidence for a replicase-driven template 
switching mechanism in their generation. J Gen Virol 1999,80 ( Pt 3):817-821. 
48. White KA, Morris TJ. Defective and defective interfering RNAs of monopartite plus-
strand RNA plant viruses. Curr Top Microbiol Immunol 1999,239:1-17. 
49. Nagy PD, Simon AE. New insights into the mechanisms of RNA recombination. 
Virology 1997,235:1-9. 
50. Kim MJ, Kao C. Factors regulating template switch in vitro by viral RNA-dependent 
RNA polymerases: implications for RNA-RNA recombination. Proc Natl Acad Sci U S A 
2001,98:4972-4977. 
51. Cheng CP, Nagy PD. Mechanism of RNA recombination in carmo- and tombusviruses: 
evidence for template switching by the RNA-dependent RNA polymerase in vitro. J Virol 
2003,77:12033-12047. 
52. Cheng CP, Pogany J, Nagy PD. Mechanism of DI RNA formation in tombusviruses: 
dissecting the requirement for primer extension by the tombusvirus RNA dependent RNA 
polymerase in vitro. Virology 2002,304:460-473. 
53. Wierzchoslawski R, Bujarski JJ. Efficient in vitro system of homologous recombination 
in brome mosaic bromovirus. J Virol 2006,80:6182-6187. 
54. Wierzchoslawski R, Dzianott A, Kunimalayan S, Bujarski JJ. A transcriptionally active 
subgenomic promoter supports homologous crossovers in a plus-strand RNA virus. J 
Virol 2003,77:6769-6776. 
55. Pogany J, Nagy PD. Authentic replication and recombination of Tomato bushy stunt 
virus RNA in a cell-free extract from yeast. J Virol 2008,82:5967-5980. 
56. Cheng CP, Panavas T, Luo G, Nagy PD. Heterologous RNA replication enhancer 
stimulates in vitro RNA synthesis and template-switching by the carmovirus, but not by 
the tombusvirus, RNA-dependent RNA polymerase: implication for modular evolution of 
RNA viruses. Virology 2005,341:107-121. 
57. Nagy PD, Simon AE. In vitro characterization of late steps of RNA recombination in 
turnip crinkle virus. I. Role of motif1-hairpin structure. Virology 1998,249:379-392. 
58. Nagy PD, Simon AE. In vitro characterization of late steps of RNA recombination in 
turnip crinkle virus.II. The role of the priming stem and flanking sequences. Virology 
1998,249:393-405. 
59. Bujarski JJ, Nagy PD, Flasinski S. Molecular studies of genetic RNA-RNA 
recombination in brome mosaic virus. Adv Virus Res 1994,43:275-302. 
60. Havelda Z, Szittya G, Burgyan J. Characterization of the molecular mechanism of 
defective interfering RNA-mediated symptom attenuation in tombusvirus-infected plants. 
J Virol 1998,72:6251-6256. 
84 
61. Chetverin AB, Chetverina HV, Demidenko AA, Ugarov VI. Nonhomologous RNA 
recombination in a cell-free system: evidence for a transesterification mechanism guided 
by secondary structure. Cell 1997,88:503-513. 
62. Gmyl AP, Korshenko SA, Belousov EV, Khitrina EV, Agol VI. Nonreplicative 
homologous RNA recombination: promiscuous joining of RNA pieces? Rna 
2003,9:1221-1231. 
63. Nagy PD, Dzianott A, Ahlquist P, Bujarski JJ. Mutations in the helicase-like domain of 
protein 1a alter the sites of RNA-RNA recombination in brome mosaic virus. J Virol 
1995,69:2547-2556. 
64. Figlerowicz M, Nagy PD, Bujarski JJ. A mutation in the putative RNA polymerase gene 
inhibits nonhomologous, but not homologous, genetic recombination in an RNA virus. 
Proc Natl Acad Sci U S A 1997,94:2073-2078. 
65. Fodor E, Mingay LJ, Crow M, Deng T, Brownlee GG. A single amino acid mutation in 
the PA subunit of the influenza virus RNA polymerase promotes the generation of 
defective interfering RNAs. J Virol 2003,77:5017-5020. 
66. Panaviene Z, Nagy PD. Mutations in the RNA-binding domains of tombusvirus replicase 
proteins affect RNA recombination in vivo. Virology 2003,317:359-372. 
67. Jaag HM, Stork J, Nagy PD. Host transcription factor Rpb11p affects tombusvirus 
replication and recombination via regulating the accumulation of viral replication 
proteins. Virology 2007,368:388-404. 
68. Nagy PD, Pogany J. Multiple roles of viral replication proteins in plant RNA virus 
replication. Methods Mol Biol 2008,451:55-68. 
69. Pantaleo V, Rubino L, Russo M. Replication of Carnation Italian ringspot virus defective 
interfering RNA in Saccharomyces cerevisiae. J Virol 2003,77:2116-2123. 
70. Li Z, Barajas D, Panavas T, Herbst DA, Nagy PD. Cdc34p ubiquitin-conjugating enzyme 
is a component of the tombusvirus replicase complex and ubiquitinates p33 replication 
protein. J Virol 2008,82:6911-6926. 
71. Pogany J, White KA, Nagy PD. Specific binding of tombusvirus replication protein p33 
to an internal replication element in the viral RNA is essential for replication. J Virol 
2005,79:4859-4869. 
72. Monkewich S, Lin HX, Fabian MR, Xu W, Na H, Ray D, et al. The p92 polymerase 
coding region contains an internal RNA element required at an early step in Tombusvirus 
genome replication. J Virol 2005,79:4848-4858. 
73. Pogany J, Stork J, Li Z, Nagy PD. In vitro assembly of the Tomato bushy stunt virus 
replicase requires the host Heat shock protein 70. Proc Natl Acad Sci U S A 
2008,105:19956-19961. 
74. Pogany J, Fabian MR, White KA, Nagy PD. A replication silencer element in a plus-
strand RNA virus. EMBO J 2003,22:5602-5611. 
75. Panaviene Z, Panavas T, Nagy PD. Role of an internal and two 3'-terminal RNA elements 
in assembly of tombusvirus replicase. J Virol 2005,79:10608-10618. 
76. Li Z, Pogany J, Tupman S, Esposito AM, Kinzy TG, Nagy PD. Translation elongation 
factor 1A facilitates the assembly of the tombusvirus replicase and stimulates minus-
strand synthesis. PLoS Pathog 2010,6:e1001175. 
77. Jiang Y, Li Z, Nagy PD. Nucleolin/Nsr1p binds to the 3' noncoding region of the 
tombusvirus RNA and inhibits replication. Virology 2010,396:10-20. 
78. McCartney AW, Greenwood JS, Fabian MR, White KA, Mullen RT. Localization of the 
Tomato Bushy Stunt Virus Replication Protein p33 Reveals a Peroxisome-to-
Endoplasmic Reticulum Sorting Pathway. Plant Cell 2005,17:3513-3531. 
79. Russo M, Di Franco A, Martelli GP. Cytopathology in the identification and 
classification of tombusviruses. Intervirology 1987,28:134-143. 
85 
80. Pathak KB, Sasvari Z, Nagy PD. The host Pex19p plays a role in peroxisomal 
localization of tombusvirus replication proteins. Virology 2008,379:294-305. 
81. Wang RY, Stork J, Pogany J, Nagy PD. A temperature sensitive mutant of heat shock 
protein 70 reveals an essential role during the early steps of tombusvirus replication. 
Virology 2009. 
82. Panaviene Z, Panavas T, Serva S, Nagy PD. Purification of the cucumber necrosis virus 
replicase from yeast cells: role of coexpressed viral RNA in stimulation of replicase 
activity. J Virol 2004,78:8254-8263. 
83. Gursinsky T, Schulz B, Behrens SE. Replication of Tomato bushy stunt virus RNA in a 
plant in vitro system. Virology 2009,390:250-260. 
84. Wu B, Pogany J, Na H, Nicholson BL, Nagy PD, White KA. A discontinuous RNA 
platform mediates RNA virus replication: building an integrated model for RNA-based 
regulation of viral processes. PLoS Pathog 2009,5:e1000323. 
85. Wang RY, Stork J, Nagy PD. A key role for heat shock protein 70 in the localization and 
insertion of tombusvirus replication proteins to intracellular membranes. J Virol 
2009,83:3276-3287. 
86. Panavas T, Pogany J, Nagy PD. Analysis of minimal promoter sequences for plus-strand 
synthesis by the Cucumber necrosis virus RNA-dependent RNA polymerase. Virology 
2002,296:263-274. 
87. Panavas T, Nagy PD. The RNA replication enhancer element of tombusviruses contains 
two interchangeable hairpins that are functional during plus-strand synthesis. J Virol 
2003,77:258-269. 
88. Panavas T, Nagy PD. Mechanism of stimulation of plus-strand synthesis by an RNA 
replication enhancer in a tombusvirus. J Virol 2005,79:9777-9785. 
89. Wang RY, Nagy PD. Tomato bushy stunt virus co-opts the RNA-binding function of a 
host metabolic enzyme for viral genomic RNA synthesis. Cell Host Microbe 2008,3:178-
187. 
90. Stork J, Panaviene Z, Nagy PD. Inhibition of in vitro RNA binding and replicase activity 
by phosphorylation of the p33 replication protein of Cucumber necrosis tombusvirus. 
Virology 2005,343:79-92. 
91. Shapka N, Stork J, Nagy PD. Phosphorylation of the p33 replication protein of Cucumber 
necrosis tombusvirus adjacent to the RNA binding site affects viral RNA replication. 
Virology 2005,343:65-78. 
92. Barajas D, Li Z, Nagy PD. The Nedd4-type Rsp5p ubiquitin ligase inhibits tombusvirus 
replication via regulating degradation of the p92 replication protein and decreasing the 
activity of the tombusvirus replicase. J Virol 2009. 
93. Na H, White KA. Structure and prevalence of replication silencer-3' terminus RNA 
interactions in Tombusviridae. Virology 2006,345:305-316. 
94. Novoa RR, Calderita G, Arranz R, Fontana J, Granzow H, Risco C. Virus factories: 
associations of cell organelles for viral replication and morphogenesis. Biol Cell 
2005,97:147-172. 
95. Barajas D, Jiang Y, Nagy PD. A unique role for the host ESCRT proteins in replication 
of Tomato bushy stunt virus. PLoS Pathog 2009,5:e1000705. 
96. Stork J, Kovalev N, Sasvari Z, Nagy PD. RNA chaperone activity of the tombusviral p33 
replication protein facilitates initiation of RNA synthesis by the viral RdRp in vitro. 
Virology 2011,409:338-347. 
97. den Boon JA, Ahlquist P. Organelle-Like Membrane Compartmentalization of Positive-
Strand RNA Virus Replication Factories. Annual Review of Microbiology 2010,64:241-
256. 
98. Pathak KB, Nagy PD. Defective Interfering RNAs: Foes of Viruses and Friends of 
Virologists. Viruses-Basel 2009,1:895-919. 
86 
99. Goregaoker SP, Culver JN. Oligomerization and activity of the helicase domain of the 
tobacco mosaic virus 126- and 183-kilodalton replicase proteins. J Virol 2003,77:3549-
3556. 
100. Osman TA, Buck KW. Identification of a region of the tobacco mosaic virus 126- and 
183-kilodalton replication proteins which binds specifically to the viral 3'-terminal 
tRNA-like structure. J Virol 2003,77:8669-8675. 
101. Sullivan ML, Ahlquist P. A brome mosaic virus intergenic RNA3 replication signal 
functions with viral replication protein 1a to dramatically stabilize RNA in vivo. J Virol 
1999,73:2622-2632. 
102. Wang X, Lee WM, Watanabe T, Schwartz M, Janda M, Ahlquist P. Brome mosaic virus 
1a nucleoside triphosphatase/helicase domain plays crucial roles in recruiting RNA 
replication templates. J Virol 2005,79:13747-13758. 
103. Iwakawa HO, Mine A, Hyodo K, An M, Kaido M, Mise K, et al. Template recognition 
mechanisms by replicase proteins differ between bipartite positive-strand genomic RNAs 
of a plant virus. J Virol 2011,85:497-509. 
104. An M, Iwakawa HO, Mine A, Kaido M, Mise K, Okuno T. A Y-shaped RNA structure in 
the 3' untranslated region together with the trans-activator and core promoter of Red 
clover necrotic mosaic virus RNA2 is required for its negative-strand RNA synthesis. 
Virology 2010,405:100-109. 
105. Ray D, Na H, White KA. Structural properties of a multifunctional T-shaped RNA 
domain that mediate efficient tomato bushy stunt virus RNA replication. J Virol 
2004,78:10490-10500. 
106. Jonczyk M, Pathak KB, Sharma M, Nagy PD. Exploiting alternative subcellular location 
for replication: tombusvirus replication switches to the endoplasmic reticulum in the 
absence of peroxisomes. Virology 2007,362:320-330. 
107. Bertrand E, Chartrand P, Schaefer M, Shenoy SM, Singer RH, Long RM. Localization of 
ASH1 mRNA particles in living yeast. Mol Cell 1998,2:437-445. 
108. Spear A, Sharma N, Flanegan JB. Protein-RNA tethering: the role of poly(C) binding 
protein 2 in poliovirus RNA replication. Virology 2008,374:280-291. 
109. Panavas T, Pogany J, Nagy PD. Internal initiation by the cucumber necrosis virus RNA-
dependent RNA polymerase is facilitated by promoter-like sequences. Virology 
2002,296:275-287. 
110. Rajendran KS, Pogany J, Nagy PD. Comparison of turnip crinkle virus RNA-dependent 
RNA polymerase preparations expressed in Escherichia coli or derived from infected 
plants. J Virol 2002,76:1707-1717. 
111. Salonen A, Ahola T, Kaariainen L. Viral RNA replication in association with cellular 
membranes. Curr Top Microbiol Immunol 2005,285:139-173. 
112. Snijder EJ, van der Meer Y, Zevenhoven-Dobbe J, Onderwater JJ, van der Meulen J, 
Koerten HK, et al. Ultrastructure and origin of membrane vesicles associated with the 
severe acute respiratory syndrome coronavirus replication complex. J Virol 
2006,80:5927-5940. 
113. Ahlquist P, Noueiry AO, Lee WM, Kushner DB, Dye BT. Host factors in positive-strand 
RNA virus genome replication. J Virol 2003,77:8181-8186. 
114. Miller S, Krijnse-Locker J. Modification of intracellular membrane structures for virus 
replication. Nat Rev Microbiol 2008,6:363-374. 
115. Schwartz M, Chen J, Janda M, Sullivan M, den Boon J, Ahlquist P. A positive-strand 
RNA virus replication complex parallels form and function of retrovirus capsids. Mol 
Cell 2002,9:505-514. 
116. Kopek BG, Perkins G, Miller DJ, Ellisman MH, Ahlquist P. Three-dimensional analysis 
of a viral RNA replication complex reveals a virus-induced mini-organelle. PLoS Biol 
2007,5:e220. 
87 
117. Hagiwara Y, Komoda K, Yamanaka T, Tamai A, Meshi T, Funada R, et al. Subcellular 
localization of host and viral proteins associated with tobamovirus RNA replication. 
Embo J 2003,22:344-353. 
118. Beckham CJ, Light HR, Nissan TA, Ahlquist P, Parker R, Noueiry A. Interactions 
between brome mosaic virus RNAs and cytoplasmic processing bodies. J Virol 
2007,81:9759-9768. 
119. Lazarow PB. Viruses exploiting peroxisomes. Current opinion in microbiology 
2011,14:458-469. 
120. Mohan KV, Som I, Atreya CD. Identification of a type 1 peroxisomal targeting signal in 
a viral protein and demonstration of its targeting to the organelle. Journal of virology 
2002,76:2543-2547. 
121. Liu LX, Margottin F, Le Gall S, Schwartz O, Selig L, Benarous R, et al. Binding of HIV-
1 Nef to a novel thioesterase enzyme correlates with Nef-mediated CD4 down-regulation. 
The Journal of biological chemistry 1997,272:13779-13785. 
122. Wolff T, O'Neill RE, Palese P. Interaction cloning of NS1-I, a human protein that binds 
to the nonstructural NS1 proteins of influenza A and B viruses. Journal of virology 
1996,70:5363-5372. 
123. Tu H, Gao L, Shi ST, Taylor DR, Yang T, Mircheff AK, et al. Hepatitis C virus RNA 
polymerase and NS5A complex with a SNARE-like protein. Virology 1999,263:30-41. 
124. Wang C, Gale M, Jr., Keller BC, Huang H, Brown MS, Goldstein JL, et al. Identification 
of FBL2 as a geranylgeranylated cellular protein required for hepatitis C virus RNA 
replication. Mol Cell 2005,18:425-434. 
125. Oster SK, Wu B, White KA. Uncoupled expression of p33 and p92 permits amplification 
of tomato bushy stunt virus RNAs. J Virol 1998,72:5845-5851. 
126. Rubino L, Navarro B, Russo M. Cymbidium ringspot virus defective interfering RNA 
replication in yeast cells occurs on endoplasmic reticulum-derived membranes in the 
absence of peroxisomes. J Gen Virol 2007,88:1634-1642. 
127. Matsuzono Y, Matsuzaki T, Fujiki Y. Functional domain mapping of peroxin Pex19p: 
interaction with Pex3p is essential for function and translocation. J Cell Sci 
2006,119:3539-3550. 
128. Hoepfner D, Schildknegt D, Braakman I, Philippsen P, Tabak HF. Contribution of the 
endoplasmic reticulum to peroxisome formation. Cell 2005,122:85-95. 
129. Kragt A, Voorn-Brouwer T, van den Berg M, Distel B. Endoplasmic reticulum-directed 
Pex3p routes to peroxisomes and restores peroxisome formation in a Saccharomyces 
cerevisiae pex3Delta strain. J Biol Chem 2005,280:34350-34357. 
130. Lazarow PB. Peroxisome biogenesis: advances and conundrums. Curr Opin Cell Biol 
2003,15:489-497. 
131. Tam YY, Fagarasanu A, Fagarasanu M, Rachubinski RA. Pex3p initiates the formation 
of a preperoxisomal compartment from a subdomain of the endoplasmic reticulum in 
Saccharomyces cerevisiae. J Biol Chem 2005,280:34933-34939. 
132. Rottensteiner H, Kramer A, Lorenzen S, Stein K, Landgraf C, Volkmer-Engert R, et al. 
Peroxisomal membrane proteins contain common Pex19p-binding sites that are an 
integral part of their targeting signals. Mol Biol Cell 2004,15:3406-3417. 
133. Hettema EH, Girzalsky W, van Den Berg M, Erdmann R, Distel B. Saccharomyces 
cerevisiae pex3p and pex19p are required for proper localization and stability of 
peroxisomal membrane proteins. Embo J 2000,19:223-233. 
134. Weber-Lotfi F, Dietrich A, Russo M, Rubino L. Mitochondrial targeting and membrane 
anchoring of a viral replicase in plant and yeast cells. J Virol 2002,76:10485-10496. 
135. Mackenzie J. Wrapping things up about virus RNA replication. Traffic 2005,6:967-977. 
136. Fang Y, Morrell JC, Jones JM, Gould SJ. PEX3 functions as a PEX19 docking factor in 
the import of class I peroxisomal membrane proteins. J Cell Biol 2004,164:863-875. 
88 
137. Burgyan J, Rubino L, Russo M. The 5'-terminal region of a tombusvirus genome 
determines the origin of multivesicular bodies. J Gen Virol 1996,77 ( Pt 8):1967-1974. 
138. Rubino L, Russo M. Membrane targeting sequences in tombusvirus infections. Virology 
1998,252:431-437. 
139. Sopko R, Papp B, Oliver SG, Andrews BJ. Phenotypic activation to discover biological 
pathways and kinase substrates. Cell Cycle 2006,5:1397-1402. 
140. Dreher TW, Miller WA. Translational control in positive strand RNA plant viruses. 
Virology 2006,344:185-197. 
141. Loregian A, Marsden HS, Palu G. Protein-protein interactions as targets for antiviral 
chemotherapy. Reviews in medical virology 2002,12:239-262. 
142. O'Reilly EK, Kao CC. Analysis of RNA-dependent RNA polymerase structure and 
function as guided by known polymerase structures and computer predictions of 
secondary structure. Virology 1998,252:287-303. 
143. Kao CC, Quadt R, Hershberger RP, Ahlquist P. Brome mosaic virus RNA replication 
proteins 1a and 2a from a complex in vitro. Journal of virology 1992,66:6322-6329. 
144. Watanabe T, Honda A, Iwata A, Ueda S, Hibi T, Ishihama A. Isolation from tobacco 
mosaic virus-infected tobacco of a solubilized template-specific RNA-dependent RNA 
polymerase containing a 126K/183K protein heterodimer. Journal of virology 
1999,73:2633-2640. 
145. Goregaoker SP, Lewandowski DJ, Culver JN. Identification and functional analysis of an 
interaction between domains of the 126/183-kDa replicase-associated proteins of tobacco 
mosaic virus. Virology 2001,282:320-328. 
146. Agol VI, Paul AV, Wimmer E. Paradoxes of the replication of picornaviral genomes. 
Virus research 1999,62:129-147. 
147. Hope DA, Diamond SE, Kirkegaard K. Genetic dissection of interaction between 
poliovirus 3D polymerase and viral protein 3AB. Journal of virology 1997,71:9490-9498. 
148. Lyle JM, Bullitt E, Bienz K, Kirkegaard K. Visualization and functional analysis of 
RNA-dependent RNA polymerase lattices. Science 2002,296:2218-2222. 
149. Tellinghuisen TL, Rice CM. Interaction between hepatitis C virus proteins and host cell 
factors. Current opinion in microbiology 2002,5:419-427. 
150. Suzuki M, Yoshida M, Yoshinuma T, Hibi T. Interaction of replicase components 
between Cucumber mosaic virus and Peanut stunt virus. The Journal of general virology 
2003,84:1931-1939. 
151. Schaad MC, Jensen PE, Carrington JC. Formation of plant RNA virus replication 
complexes on membranes: role of an endoplasmic reticulum-targeted viral protein. The 
EMBO journal 1997,16:4049-4059. 
152. McCartney AW, Greenwood JS, Fabian MR, White KA, Mullen RT. Localization of the 
tomato bushy stunt virus replication protein p33 reveals a peroxisome-to-endoplasmic 
reticulum sorting pathway. The Plant cell 2005,17:3513-3531. 
153. Barajas D, Nagy PD. Ubiquitination of tombusvirus p33 replication protein plays a role 
in virus replication and binding to the host Vps23p ESCRT protein. Virology 
2010,397:358-368. 
154. Wang RY, Stork J, Pogany J, Nagy PD. A temperature sensitive mutant of heat shock 
protein 70 reveals an essential role during the early steps of tombusvirus replication. 
Virology 2009,394:28-38. 
155. Meredith LW, Sivakumaran H, Major L, Suhrbier A, Harrich D. Potent inhibition of 
HIV-1 replication by a Tat mutant. PLoS One 2009,4:e7769. 
156. Checkley MA, Luttge BG, Soheilian F, Nagashima K, Freed EO. The capsid-spacer 
peptide 1 Gag processing intermediate is a dominant-negative inhibitor of HIV-1 
maturation. Virology 2010,400:137-144. 
89 
157. Akhrameyeva NV, Zhang P, Sugiyama N, Behar SM, Yao F. Development of a 
glycoprotein D-expressing dominant-negative and replication-defective herpes simplex 







Author’s Name: Kunj Bihari Pathak 
Date of Birth: April 8, 1978 
Place of Birth: Dhanbad, India 
 
Education  
• M.V.Sc. 9/2002-8/2004, Veterinary Virology; Indian Veterinary Research Institute, 
Mukteswar, India. Thesis: Prokaryotic expression and characterization of blue tongue 
virus serotype-23 VP7 protein.  
• B.V.Sc. & A.H. 8/1997-7/2002, Veterinary Medicine, Govind Ballabh Pant University of 
Agriculture & Technology, Pantnagar, India.  
 
 
Publications and Presentations  
1)   Pathak KB, Pogany J, Xu K, White KA and Nagy PD (2011). Critical role of RNA in 
assembly of tombusviral replicase complex. J. Virol. Oct 19 [Epub ahead of print]. 
2)   Pathak KB, Pogany J and Nagy PD (2011). Non-template functions of viral RNA in plant 
virus replication. Current Opinions in Virology (In press). 
3) Pathak KB and Nagy PD (2009). Defective interfering RNAs: Foes of viruses and friends 
of virologists. Viruses 1:895-919.  
4) Pathak KB, Sasvari Z and Nagy PD (2008). The host Pex19p plays a role in peroxisomal 
localization of tombusvirus replication proteins. Virology 379:294-305.  
5) Jonczyk M, Pathak KB, Sharma M and Nagy PD (2007). Exploiting alternative 
subcellular location for replication: tombusvirus replication switches to the endoplasmic 
reticulum. Virology 362:320-30.  
6) Tembhurne, PA, Mondal B, Pathak KB, Biswas SK, Sanyal A, Yadav MP, 
Bandyopadhyay SK and Singh RK (2009). Segment-2 sequence analyses and 
crossneutralization studies on some Indian bluetongue viruses suggest isolates are VP2- 
variants of serotype 23. Archives of Virology. 155:89-95.  
7) Pathak KB, Biswas SK, Tembhurne PA, Hosamani M, Bhanuprakash V, Prasad G, Singh 
RK, Rasool TJ and Mondal B (2008). Prokaryotic expression of truncated VP7 of 
bluetongue virus (BTV) and reactivity of the purified recombinant protein with all BTV 
type-specific sera. Journal of Virological Methods 152:6-12.  
8) Pathak KB and Nagy PD (2010) Critical role of RNA in assembly of tombusviral 
replicase complex. American Society of Virology, July 17-21. Oral presentation, 
Montana State University, Bozeman, MT.  
9) Pathak KB, Sasvari Z and Nagy PD (2008) Role of host pex19p in transportation of 
tombusviral replication proteins. American Society of Virology, July 14-18. Oral 
presentation, Cornell University, Ithaca, NY.  
10) Pathak KB, Pogany J and Nagy PD (2006) Role of viral RNA in assembly of tombusvirus 
replicase complex. American Society of Virology, July 13-17. Oral presentation, 
University of Wisconsin, Madison, WI.  
11) Nagy PD, Pogany J and Pathak KB (2006) Role of viral RNA as an assembly platform 
for the tombusvirus replicase complex. Rustbelt RNA Meeting, October 20-21. Mt. 
Sterling, OH.  
12) Pathak KB, Bhanuprakash V, Hosamani M, Singh RK, Singh N and Mondal B (2004) 
Potential of recombinant VP7 as an antigen for detection of bluetongue antibody in sera, 
Presented in XI Annual Convention of Indian Society for Veterinary Immunology and 
91 
Biotechnology and “National on Alternate Strategies for Livestock Production and 
Protection: Role of Biotechnology and Immunology.” November 3-4, at Indian 
Veterinary Research Institute, Mukteswar, India.Symposium 
Honors And Awards  
1) Philip Morris, USA, Graduate Fellowship to support Ph.D. program, 2004-2009.  
2) Student Travel Award by American Society for Virology (ASV) to attend annual meeting 
at Bozeman, MT. July, 2010.  
3) Student Travel Support Award by Graduate School, University of Kentucky, to attend 
ASV annual meeting at Bozeman, MT. July, 2010.  
4) Student Travel Award by ASV to attend annual meeting at Ithaca, NY. July, 2008.  
5) Student Travel Support Award by Graduate School, University of Kentucky, to attend 
ASV annual meeting at Ithaca, NY. July, 2008.  
6) Student Travel Award by ASV to attend annual meeting at Madison, WI. July, 2006.  
7) Student Travel Support Award by Graduate School, University of Kentucky, to attend 
ASV annual meeting at Madison, WI. July, 2006.  
8) Indian Council of Agricultural Research National Talent Search (ICAR-NTS) scholarship 
to support undergraduate studies from 1997-2002.  
9) ICAR award for winning team participant in All India Agricultural University Cultural 
Festival (2000) held in Assam Agricultural University, Jorhat, Assam, India. 10) Junior 
Research Fellowship during Masters program after gaining an all India First rank in joint 
entrance examination conducted by ICAR New Delhi, 2002-2004. 
 
